Details of the Researcher

PHOTO

Toshiyuki Takai
Section
Institute of Development, Aging and Cancer
Job title
Specially Appointed Professor(Research)
Degree
  • 医学博士(京都大学)

  • 薬学修士(岡山大学)

Profile

略歴
昭和33年 岡山県生まれ
昭和55年 岡山大学薬学部 卒業
昭和61年 京都大学大学院医学研究科修了 医学博士
昭和61年 国立循環器病センター研究所 研究員
昭和63年 岡山大学工学部生物応用工学科 助手
平成元年 同 講師
平成2年 同 助教授
平成4〜5年 米国スローン・ケタリング研究所訪問研究員(文部省在外研修として)
平成9年 東北大学加齢医学研究所 教授

令和5年 同 特任教授(研究)

受賞
平成16年 第7回 日本免疫学会賞
平成24年 文部科学大臣表彰科学技術賞(研究部門)

Research History 1

  • 2023/04 - Present
    Tohoku University Institute of Development, Aging and Cancer Division of Gene Research Experimental Immunology Specially Appointed Professor (Research)

Education 2

  • Kyoto University Graduate School, Division of Medicine 生理系

    - 1986/03

  • Okayama University Faculty of Pharmaceutical Science 製薬化学

    - 1980/03

Committee Memberships 7

  • International Immunology 編集委員

    2002/04 - Present

  • 日本免疫学会 評議員

    2008/10 - 2023/09

  • 日本生化学会 評議員

    1998/04 - 2021/03

  • 日本免疫学会 理事

    2016/10 - 2018/09

  • Europeal Journal Immunology 編集委員

    2001/04 - 2003/03

  • 東北医学会 評議員

    1998/04 - 1999/03

  • 東北医学会 評議員

    1998/04 - 1999/03

Show all ︎Show first 5

Professional Memberships 14

  • 日本生化学会(1998/04- 評議員)

    1998/04 - 2021/03

  • 日本免疫学会(2008/10- 評議員)

  • 日本学術振興会(2005/04-2007/03 専門委員)

  • Europeal Journal Immunology(2001/04- 編集委員)

  • International Immunology(2002/04- 編集委員)

  • Springer Seminars in Immunopathology(2007/04- 顧問)

  • 東北医学会(1998/04-1999/03 評議員)

  • 免疫と疾患研究会(1998/04- 世話人)

  • 東北免疫研究会(1999/04- 顧問)

  • American Association of Immunologists(1993/04-)

  • 日本再生医学会(1995/04-)

  • 日本アレルギー学会(1995/04-)

  • 日本分子生物学会(1993/04-)

  • 日本免疫学会(1993/04-)

︎Show all ︎Show first 5

Research Interests 11

  • Immune checkpoint

  • Inhibitory receptor

  • Immunotherapy

  • Immunoregulation

  • Fc receptor

  • LILRB

  • Fc受容体

  • 免疫療法

  • 免疫制御

  • 抑制受容体

  • immunoglobulin-like receptor

Research Areas 2

  • Life sciences / Immunology / immunology

  • Life sciences / Medical biochemistry / medical chemistry

Awards 3

  1. 科学技術分野の文部科学大臣表彰 科学技術賞 研究部門

    2012/04 文部科学省 「免疫制御Fc受容体の研究」

  2. 平成16年度免疫学会賞

    2004/12 日本免疫学会 「イムノグロブリン様受容体による免疫制御と免疫疾患に関する研究」

  3. 岡山工学振興会科学技術賞

    1994/07 岡山工学振興会 「遺伝子ノックアウトを用いたマウス局所免疫系におけるFc受容体の機能解析」

Papers 276

  1. TLR7/8 stress response drives histiocytosis in SLC29A3 disorders Peer-reviewed

    Takuma Shibata, Ryota Sato, Masato Taoka, Shin-Ichiroh Saitoh, Mayumi Komine, Kiyoshi Yamaguchi, Susumu Goyama, Yuji Motoi, Jiro Kitaura, Kumi Izawa, Yoshio Yamauchi, Yumiko Tsukamoto, Takeshi Ichinohe, Etsuko Fujita, Ryosuke Hiranuma, Ryutaro Fukui, Yoichi Furukawa, Toshio Kitamura, Toshiyuki Takai, Arinobu Tojo, Mamitaro Ohtsuki, Umeharu Ohto, Toshiyuki Shimizu, Manabu Ozawa, Nobuaki Yoshida, Toshiaki Isobe, Eicke Latz, Kojiro Mukai, Tomohiko Taguchi, Hiroaki Hemmi, Shizuo Akira, Kensuke Miyake

    Journal of Experimental Medicine 220 (9) 2023/07/18

    Publisher: Rockefeller University Press

    DOI: 10.1084/jem.20230054  

    ISSN: 0022-1007

    eISSN: 1540-9538

    More details Close

    Loss-of-function mutations in the lysosomal nucleoside transporter SLC29A3 cause lysosomal nucleoside storage and histiocytosis: phagocyte accumulation in multiple organs. However, little is known about the mechanism by which lysosomal nucleoside storage drives histiocytosis. Herein, histiocytosis in Slc29a3−/− mice was shown to depend on Toll-like receptor 7 (TLR7), which senses a combination of nucleosides and oligoribonucleotides (ORNs). TLR7 increased phagocyte numbers by driving the proliferation of Ly6Chi immature monocytes and their maturation into Ly6Clow phagocytes in Slc29a3−/− mice. Downstream of TLR7, FcRγ and DAP10 were required for monocyte proliferation. Histiocytosis is accompanied by inflammation in SLC29A3 disorders. However, TLR7 in nucleoside-laden splenic monocytes failed to activate inflammatory responses. Enhanced production of proinflammatory cytokines was observed only after stimulation with ssRNAs, which would increase lysosomal ORNs. Patient-derived monocytes harboring the G208R SLC29A3 mutation showed enhanced survival and proliferation in a TLR8-antagonist-sensitive manner. These results demonstrated that TLR7/8 responses to lysosomal nucleoside stress drive SLC29A3 disorders.

  2. Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer Peer-reviewed

    Sakiko Kumata, Hirotsugu Notsuda, Mei‐Tzu Su, Ryoko Saito‐Koyama, Ryota Tanaka, Yuyo Suzuki, Junichi Funahashi, Shota Endo, Isao Yokota, Toshiyuki Takai, Yoshinori Okada

    Thoracic Cancer 2023/06/08

    Publisher: Wiley

    DOI: 10.1111/1759-7714.14991  

    ISSN: 1759-7706

    eISSN: 1759-7714

  3. Fibronectin on target cells attenuates natural cytotoxicity of NK cells via myeloid immune checkpoint ILT3/LILRB4/gp49B Peer-reviewed

    Fumika Itagaki, Keita Nakatsuka, Haruka Sakai, Shota Endo, Mei-Tzu Su, Toshiyuki Takai

    International Immunology 35 (7) 339-348 2023/04/21

    Publisher: Oxford University Press (OUP)

    DOI: 10.1093/intimm/dxad012  

    eISSN: 1460-2377

    More details Close

    Abstract Natural killer (NK) cells play pivotal roles in innate immunity as well as in anti-tumor responses via natural killing, while their activity is tightly regulated by cell-surface inhibitory receptors. Immunoglobulin-like transcript 3/leukocyte immunoglobulin-like receptor B4 (ILT3/LILRB4, also known as gp49B in mice) is an inhibitory receptor expressed on activated NK cells as well as myeloid-lineage cells. The common physiologic ligand of human LILRB4 and gp49B was identified very recently as fibronectin, particularly the N-terminal 30 kDa domain (FN30). We hypothesized that LILRB4 could bind fibronectin on target cells in trans together with integrins, classical fibronectin receptors, in cis and deliver an inhibitory signal in NK cells, leading to attenuated natural killing. Flow cytometric and confocal microscopic analyses of NK cell-surface gp49B and integrins suggested that these novel and classical fibronectin receptors, respectively, co-engage fibronectin immobilized on a culture plate. Biochemical analyses indicated that tyrosine phosphorylation of spleen tyrosine kinase was augmented in gp49B-deficient NK cells upon binding to the immobilized fibronectin. While surface fibronectin-poor YAC-1 cells were evenly sensitive as to natural killing of both gp49B-positive and -negative NK cells, the killing of fibronectin-rich Lewis lung carcinoma cells, but not the FN30-knockout cells, was augmented among gp49B-deficient NK cells. These results suggest that the natural cytotoxicity of NK cells is negatively regulated through LILRB4/gp49B sensing fibronectin on target cells, which sheds light on the unexpected role of LILRB4 and fibronectin as a potential attenuator of NK cell cytotoxicity in the tumor microenvironment.

  4. INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model Peer-reviewed

    Akihiro Iguchi, Sho Takatori, Shingo Kimura, Hiroki Muneto, Kai Wang, Hayato Etani, Genta Ito, Haruaki Sato, Yukiko Hori, Junko Sasaki, Takashi Saito, Takaomi C. Saido, Tsuneya Ikezu, Toshiyuki Takai, Takehiko Sasaki, Taisuke Tomita

    iScience 26 (4) 106375-106375 2023/04

    Publisher: Elsevier BV

    DOI: 10.1016/j.isci.2023.106375  

    ISSN: 2589-0042

  5. LILRB4/gp49B Co-Localizes with Integrin via Fibronectin at Focal Adhesion Sites on Mast Cells Peer-reviewed

    Shotaro Miyamoto, Takumi Chiba, So Itoi, Mei-Tzu Su, Toshiyuki Takai

    The Tohoku Journal of Experimental Medicine 259 (4) 273-284 2023

    Publisher: Tohoku University Medical Press

    DOI: 10.1620/tjem.2023.j001  

    ISSN: 0040-8727

    eISSN: 1349-3329

  6. Fibronectin-LILRB4/gp49B interaction negatively regulates osteoclastogenesis through inhibition of RANKL-induced TRAF6/TAK1/NF-kB/MAPK signaling. International-journal Peer-reviewed

    Mei-Tzu Su, Karin Ono, Dai Kezuka, Shotaro Miyamoto, Yu Mori, Toshiyuki Takai

    International immunology 2022/11/04

    DOI: 10.1093/intimm/dxac051  

    More details Close

    Dysregulation of osteoclasts, the multinucleated cells responsible for bone resorption, contributes to several degenerative bone disorders. Previously, we showed that blocking the leukocyte immunoglobulin (Ig)-like receptor B4 (LILRB4), a kind of inhibitory receptor that plays an important role in immune regulation, promotes osteoclast differentiation in vitro. Here, we explored whether gp49B, the murine ortholog of LILRB4, regulates osteoclastogenesis in vivo, and whether fibronectin (FN), a ligand of LILRB4/gp49B, certainly contributes to LILRB4/gp49B-mediated osteoclastogenesis. In comparison with wild-type mice, gp49B deficiency mice exhibited a loss of trabecular bone number and an increase in osteoclast formation. Gp49B knockout improved the bone resorptive capacity of osteoclasts derived from murine Raw264.7 cells by increasing osteoclast formation. We further revealed that gp49B deficiency increased the receptor activator of nuclear factor (NF)-κB ligand (RANKL)-induced signaling transduction by increasing the phosphorylation of TGF-activated kinase 1 (TAK1), NF-κB and mitogen-activated protein kinases (MAPKs). Furthermore, the N-terminal 30 kDa proteolytic fragments of FN promoted gp49B-mediated inhibition of osteoclastogenesis by increasing Src homology-2-containing tyrosine phosphatase 1 (SHP-1) phosphorylation and tumor necrosis factor receptor-associated factor 6 (TRAF6)-SHP-1 association. In summary, the FN-LILRB4/gp49B interaction negatively regulates RANKL-induced TRAF6/TAK1/NF-𝜅B/MAPK signaling in osteoclastogenesis.

  7. Myeloid immune checkpoint ILT3/LILRB4/gp49B can co-tether fibronectin with integrin on macrophages. International-journal Peer-reviewed

    So Itoi, Naoyuki Takahashi, Haruka Saito, Yusuke Miyata, Mei-Tzu Su, Dai Kezuka, Fumika Itagaki, Shota Endo, Hiroshi Fujii, Hideo Harigae, Yuzuru Sakamoto, Toshiyuki Takai

    International immunology 34 (8) 435-444 2022/06/11

    DOI: 10.1093/intimm/dxac023  

    More details Close

    LILRB4 (B4, also known as ILT3/CD85k) is an immune checkpoint of myeloid-lineage cells, albeit its mode of function remains obscure. Our recent identification of a common ligand for both human B4 and its murine ortholog gp49B as the fibronectin (FN) N-terminal 30-kDa domain poses the question of how B4/gp49B regulate cellular activity upon recognition of FN in the plasma and/or the extracellular matrix. Since FN in the extracellular matrix is tethered by FN-binding integrins, we hypothesized that B4/gp49B would tether FN in cooperation with integrins on the cell surface, thus they should be in close vicinity to integrins spatially. This scenario suggests a mode of function of B4/gp49B by which the FN-induced signal is regulated. FN pull-down complex was found to contain gp49B and integrin β1 in bone marrow-derived macrophages. The confocal fluorescent signals of the three molecules on the intrinsically FN-tethering macrophages were correlated to each other. When FN-poor macrophages adhered to culture plate, the gp49-integrin β1 signal correlation increased at the focal adhesion, supporting the notion that gp49B and integrin β1 become spatially closer to each other there. While adherence of RAW264.7 and THP-1 cells to immobilized FN induced phosphorylation of spleen tyrosine kinase, whose level was augmented under B4/gp49B deficiency. Thus, we concluded that B4/gp49B can co-tether fibronectin in cooperation with integrin in the cis configuration on the same cell, forming a B4/gp49B-FN-integrin triplet as a regulatory unit of focal adhesion-dependent proinflammatory signal in macrophages.

  8. Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface Peer-reviewed

    Naoyuki Takahashi, So Itoi, Mei-Tzu Su, Shota Endo, Toshiyuki Takai

    The Tohoku Journal of Experimental Medicine 257 (3) 171-180 2022

    Publisher: Tohoku University Medical Press

    DOI: 10.1620/tjem.2022.j014  

    ISSN: 0040-8727

    eISSN: 1349-3329

  9. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. International-journal Peer-reviewed

    Mei-Tzu Su, Sakiko Kumata, Shota Endo, Yoshinori Okada, Toshiyuki Takai

    Oncoimmunology 11 (1) 2060907-2060907 2022

    Publisher: Informa UK Limited

    DOI: 10.1080/2162402X.2022.2060907  

    eISSN: 2162-402X

    More details Close

    Myeloid-derived suppressor cells (MDSCs) are a population of immune suppressive cells that are involved in tumor-associated immunosuppression, and dominate tumor progression and metastasis. In this study, we report that the leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4, murine ortholog gp49B) orchestrates the polarization of MDSCs to exhibit pro-tumor phenotypes. We found that gp49B deficiency inhibited tumor metastases of cancer cells, and reduced tumor-infiltration of monocytic MDSCs (M-MDSCs) in tumor-bearing mice. Gp49B-/- MDSCs inhibited pro-tumor immune responses, such as activation of Treg cells, promotion of cancer cell migration, and stimulation of tumor angiogenesis. Treatment of wild-type tumor-bearing mice with gp49B-/- M-MDSCs reduced cancer metastasis. Furthermore, gp49B knockout affected plasma exosome composition in terms of increased miR-1 family microRNAs (miRNAs) expression, which correlates with the upregulation of gp49B-/- MDSC-derived anti-tumor miRNAs. Collectively, our findings reveal that LILRB4/gp49B promotes MDSC-mediated tumor metastasis by regulating the M2-polarization of MDSCs and suppressing the secretion of miR-1 family miRNAs, which facilitate tumor migration and invasion. Abbreviations CTLA-4: cytotoxic T-lymphocyte-associated protein-4; FBS: fetal bovine serum; G-MDSCs: granulocytic-MDSCs; GP49B: glycoprotein 49B; HE: hematoxylin-eosin; ICI: immune checkpoint inhibitor; ITIM: immunoreceptor tyrosine-based inhibition motif; LILRB4: leukocyte immunoglobulin-like receptor B4; M-CSF: macrophage colony stimulating factor; MDSC: myeloid-derived suppressor cell; M-MDSC: monocytic MDSC; MMP-9: metallopeptidase-9; mAb: monoclonal antibody; PBS: phosphate-buffered saline; PCR: polymerase chain reaction; PD-1: programmed death-1; PD-L1: programmed death ligand-1; PMN-MDSC: polymorphonuclear-MDSC; qRT-PCR: quantitative reverse transcription PCR; TAM: tumor associated macrophage; TME: tumor microenvironment; TMM: trimmed mean of M value; VEGFA: vascular endothelial growth factor A.

  10. Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation. International-journal Peer-reviewed

    Ayumi Mitsune, Mitsuhiro Yamada, Naoya Fujino, Tadahisa Numakura, Tomohiro Ichikawa, Ayumi Suzuki, Shuichiro Matsumoto, Yoshiya Mitsuhashi, Koji Itakura, Tomonori Makiguchi, Akira Koarai, Tsutomu Tamada, Shota Endo, Toshiyuki Takai, Yoshinori Okada, Satoshi Suzuki, Masakazu Ichinose, Hisatoshi Sugiura

    Respiratory research 22 (1) 232-232 2021/08/23

    DOI: 10.1186/s12931-021-01828-3  

    More details Close

    BACKGROUND: Leukocyte immunoglobulin-like receptor B4 (LILRB4) is one of the inhibitory receptors in various types of immune cells including macrophages. Previous reports suggested that LILRB4 could be involved in a negative feedback system to prevent excessive inflammatory responses. However, its role has been unclear in chronic obstructive pulmonary disease (COPD), in which macrophages play a crucial role in the pathogenesis. In this study, we aimed to examine the changes of LILRB4 on macrophages both in the lung specimens of COPD patients and the lungs of a mouse emphysema model. We then tried to compare the differences in both inflammation and emphysematous changes of the model between wild-type and LILRB4-deficient mice in order to elucidate the role of LILRB4 in the pathogenesis of COPD. METHODS: We prepared single-cell suspensions of resected lung specimens of never-smokers (n = 21), non-COPD smokers (n = 16), and COPD patients (n = 14). The identification of LILRB4-expressing cells and the level of LILRB4 expression were evaluated by flow cytometry. We analyzed the relationships between the LILRB4 expression and clinical characteristics including respiratory function. In the experiments using an elastase-induced mouse model of emphysema, we also analyzed the LILRB4 expression on lung macrophages. We compared inflammatory cell accumulation and emphysematous changes induced by elastase instillation between wild-type and LILRB4-deficient mice. RESULTS: The levels of surface expression of LILRB4 are relatively high on monocyte linage cells including macrophages in the human lungs. The percentage of LILRB4+ cells in lung interstitial macrophages was increased in COPD patients compared to non-COPD smokers (p = 0.018) and correlated with the severity of emphysematous lesions detected by CT scan (rs = 0.559, p < 0.001), whereas the amount of smoking showed no correlation with LILRB4 expression. Increased LILRB4 on interstitial macrophages was also observed in elastase-treated mice (p = 0.008). LILRB4-deficient mice showed severer emphysematous lesions with increased MMP-12 expression in the model. CONCLUSIONS: LILRB4 on interstitial macrophages was upregulated both in human COPD lungs and in a mouse model of emphysema. This upregulated LILRB4 may have a protective effect against emphysema formation, possibly through decreasing MMP-12 expression in the lungs.

  11. Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice Peer-reviewed

    Mei-Tzu Su, Masanori Inui, Yi Li Wong, Maika Takahashi, Akiko Sugahara-Tobinai, Karin Ono, Shotaro Miyamoto, Keiichi Murakami, Ari Itoh-Nakadai, Dai Kezuka, So Itoi, Shota Endo, Kouyuki Hirayasu, Hisashi Arase, Toshiyuki Takai

    International Immunology 33 (8) 447-458 2021/06/05

    Publisher: Oxford University Press (OUP)

    DOI: 10.1093/intimm/dxab028  

    eISSN: 1460-2377

    More details Close

    <title>Abstract</title> The extracellular matrix (ECM) is the basis for virtually all cellular processes and is also related to tumor metastasis. Fibronectin (FN), a major ECM macromolecule expressed by different cell types and also present in plasma, consists of multiple functional modules that bind to ECM-associated, plasma, and cell-surface proteins such as integrins and FN itself, thus ensuring its cell-adhesive and modulatory role. Here we show that FN constitutes an immune checkpoint. Thus, FN was identified as a physiological ligand for a tumor/leukemia/lymphoma- as well as autoimmune-associated checkpoint, ILT3/LILRB4 (B4, CD85k). Human B4 and the murine ortholog, gp49B, bound FN with sub-micromolar affinities as assessed by bio-layer interferometry. The major B4-binding site in FN was located at the N-terminal 30-kDa module (FN30), which is apart from the major integrin-binding site present at the middle of the molecule. Blockade of B4–FN binding such as with B4 antibodies or a recombinant FN30-Fc fusion protein paradoxically ameliorated autoimmune disease in lupus-prone BXSB/Yaa mice. The unexpected nature of the B4–FN checkpoint in autoimmunity is discussed, referring to its potential role in tumor immunity.

  12. Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction International-journal Peer-reviewed

    Hiroyuki Konishi, Takayuki Okamoto, Yuichiro Hara, Okiru Komine, Hiromi Tamada, Mitsuyo Maeda, Fumika Osako, Masaaki Kobayashi, Akira Nishiyama, Yosky Kataoka, Toshiyuki Takai, Nobuyuki Udagawa, Steffen Jung, Keiko Ozato, Tomohiko Tamura, Makoto Tsuda, Koji Yamanaka, Tomoo Ogi, Katsuaki Sato, Hiroshi Kiyama

    EMBO J 39 (22) e104464 2020/11

    DOI: 10.15252/embj.2020104464  

    More details Close

    Microglia are the principal phagocytes that clear cell debris in the central nervous system (CNS). This raises the question, which cells remove cell debris when microglial phagocytic activity is impaired. We addressed this question using Siglechdtr mice, which enable highly specific ablation of microglia. Non-microglial mononuclear phagocytes, such as CNS-associated macrophages and circulating inflammatory monocytes, did not clear microglial debris. Instead, astrocytes were activated, exhibited a pro-inflammatory gene expression profile, and extended their processes to engulf microglial debris. This astrocytic phagocytosis was also observed in Irf8-deficient mice, in which microglia were present but dysfunctional. RNA-seq demonstrated that even in a healthy CNS, astrocytes express TAM phagocytic receptors, which were the main astrocytic phagocytic receptors for cell debris in the above experiments, indicating that astrocytes stand by in case of microglial impairment. This compensatory mechanism may be important for the maintenance or prolongation of a healthy CNS.

  13. Nogo receptor antagonist LOTUS exerts suppression on axonal growth‐inhibiting receptor PIR‐B International-journal Peer-reviewed

    Yuji Kurihara, Toshiyuki Takai, Kohtaro Takei

    Journal of Neurochemistry 155 (3) 285-299 2020/11

    Publisher: Wiley

    DOI: 10.1111/jnc.15013  

    ISSN: 0022-3042

    eISSN: 1471-4159

    More details Close

    Damaged axons in the adult mammalian central nervous system have a restricted regenerative capacity mainly because of Nogo protein, which is a major myelin-associated axonal growth inhibitor with binding to both receptors of Nogo receptor-1 (NgR1) and paired immunoglobulin-like receptor (PIR)-B. Lateral olfactory tract usher substance (LOTUS) exerts complete suppression of NgR1-mediated axonal growth inhibition by antagonizing NgR1. However, the regulation of PIR-B functions in neurons remains unknown. In this study, protein-protein interactions analyses found that LOTUS binds to PIR-B and abolishes Nogo-binding to PIR-B completely. Reverse transcription-polymerase chain reaction and immunocytochemistry revealed that PIR-B is expressed in dorsal root ganglions (DRGs) from wild-type and Ngr1-deficient mice (male and female). In these DRG neurons, Nogo induced growth cone collapse and neurite outgrowth inhibition, but treatment with the soluble form of LOTUS completely suppressed them. Moreover, Nogo-induced growth cone collapse and neurite outgrowth inhibition in Ngr1-deficient DRG neurons were neutralized by PIR-B function-blocking antibodies, indicating that these Nogo-induced phenomena were mediated by PIR-B. Our data show that LOTUS negatively regulates a PIR-B function. LOTUS thus exerts an antagonistic action on both receptors of NgR1 and PIR-B. This may lead to an improvement in the defective regeneration of axons following injury.

  14. Abl family tyrosine kinases govern IgG extravasation in the skin in a murine pemphigus model Peer-reviewed

    Sachiko Ono, Gyohei Egawa, Takashi Nomura, Akihiko Kitoh, Teruki Dainichi, Atsushi Otsuka, Saeko Nakajima, Masayuki Amagai, Fumi Matsumoto, Mami Yamamoto, Yoshiaki Kubota, Toshiyuki Takai, Tetsuya Honda, Kenji Kabashima

    Nature Communications 10 (1) 2019/12/01

    DOI: 10.1038/s41467-019-12232-3  

    eISSN: 2041-1723

  15. Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity International-journal Peer-reviewed

    Horiguchi Haruki, Kadomatsu Tsuyoshi, Kurahashi Ryoma, Hara Chiaki, Miyata Keishi, Baba Masaya, Osumi Hironobu, Terada Kazutoyo, Araki Kimi, Takai Toshiyuki, Kamba Tomomi, Linehan W. Marston, Moroishi Toshiro, Oike Yuichi

    GENES & DEVELOPMENT 33 (23-24) 1641-1656 2019/12/01

    DOI: 10.1101/gad.329417.119  

    ISSN: 0890-9369

  16. CTLA4‐Ig Directly Inhibits Osteoclastogenesis by Interfering With Intracellular Calcium Oscillations in Bone Marrow Macrophages International-journal Peer-reviewed

    Hiroyuki Okada, Hiroshi Kajiya, Yasunori Omata, Takumi Matsumoto, Yuiko Sato, Tami Kobayashi, Satoshi Nakamura, Yosuke Kaneko, Shinya Nakamura, Takuma Koyama, Shunichi Sudo, Masashi Shin, Fujio Okamoto, Hisato Watanabe, Naohiro Tachibana, Jun Hirose, Taku Saito, Toshiyuki Takai, Morio Matsumoto, Masaya Nakamura, Koji Okabe, Takeshi Miyamoto, Sakae Tanaka

    Journal of Bone and Mineral Research 34 (9) 1744-1752 2019/09

    Publisher: Wiley

    DOI: 10.1002/jbmr.3754  

    ISSN: 0884-0431

    eISSN: 1523-4681

    More details Close

    CTLA4-Ig (cytotoxic T-lymphocyte antigen 4-immunoglobulin; Abatacept) is a biologic drug for rheumatoid arthritis. CTLA4 binds to the CD80/86 complex of antigen-presenting cells and blocks the activation of T cells. Although previous reports showed that CTLA4-Ig directly inhibited osteoclast differentiation, the whole inhibitory mechanism of CTLA4-Ig for osteoclast differentiation is unclear. Bone marrow macrophages (BMMs) from WT mice were cultured with M-CSF and RANKL with or without the recombinant mouse chimera CTLA4-Ig. Intracellular calcium oscillations of BMMs with RANKL were detected by staining with calcium indicator fura-2 immediately after administration of CTLA4-Ig or after one day of treatment. Calcium oscillations were analyzed using Fc receptor gamma- (FcRγ-) deficient BMMs. CTLA4-Ig inhibited osteoclast differentiation and reduced the expression of the nuclear factor of activated T cells NFATc1 in BMMs in vitro. Calcium oscillations in BMMs were suppressed by CTLA4-Ig both immediately after administration and after one day of treatment. CTLA4-Ig did not affect osteoclastogenesis and did not cause remarkable changes in calcium oscillations in FcRγ-deficient BMMs. Finally, to analyze the effect of CTLA4-Ig in vivo, we used an LPS-induced osteolysis model. CTLA4-Ig suppressed LPS-induced bone resorption in WT mice, not in FcRγ-deficient mice. In conclusion, CTLA4-Ig inhibits intracellular calcium oscillations depending on FcRγ and downregulates NFATc1 expression in BMMs. © 2019 American Society for Bone and Mineral Research.

  17. Gp49B is a pathogenic marker for auto-antibody-producing plasma cells in lupus-prone BXSB/Yaa mice. International-journal Peer-reviewed

    Wong YL, Su MT, Sugahara-Tobinai A, Itoi S, Kezuka D, Endo S, Inui M, Takai T

    International immunology 31 (6) 397-406 2019/05

    DOI: 10.1093/intimm/dxz017  

    ISSN: 0953-8178

    More details Close

    AbstractImmune homeostasis is critically regulated by the balance between activating and inhibitory receptors expressed on various immune cells such as T and B lymphocytes, and myeloid cells. The inhibitory receptors play a fundamental role in the immune checkpoint pathway, thus maintaining peripheral tolerance. We recently found that expression of leukocyte immunoglobulin-like receptor (LILR)B4, an inhibitory member of the human LILR family, is augmented in auto-antibody-producing plasmablasts/plasma cells of systemic lupus erythematosus (SLE) patients. However, the mechanism behind the 'paradoxical' up-regulation of this inhibitory receptor upon pathogenic antibody-secreting cells is yet to be known. To this end, in this study, we examined if glycoprotein 49B (gp49B), the murine counterpart of human LILRB4, is also elevated in auto-antibody-producing cells in several SLE mouse models, and tried to clarify the underlying mechanism. We found that gp49B is expressed on plasma cells of lupus-prone models but not of healthy C57BL/6 mice, and the level was positively correlated to the anti-double-stranded DNA IgG titer in serum. Gp49B genetic deletion, however, did not abolish the serum auto-antibodies or fully ameliorate the lethal glomerulonephritis, indicating that gp49B is not the sole regulator of lupus but a pathogenic element in the disease. We conclude that the elevated expression of this inhibitory receptor on pathogenic plasma cells was also relevant upon the murine SLE model. The mechanism of gp49B underlying the disease progression in lupus-prone mice has been discussed.

  18. Augmented ILT3/LILRB4 Expression of Peripheral Blood Antibody Secreting Cells in the Acute Phase of Kawasaki Disease. International-journal Peer-reviewed

    Sugahara-Tobinai A, Inui M, Metoki T, Watanabe Y, Onuma R, Takai T, Kumaki S

    The Pediatric infectious disease journal 38 (4) 431-438 2019/04

    DOI: 10.1097/INF.0000000000002259  

    ISSN: 0891-3668

    More details Close

    BACKGROUND: Kawasaki disease (KD) is an acute, systemic vasculitis syndrome that occurs in children. The clinical symptoms and epidemiologic features of KD strongly suggest that KD is triggered by unidentified infectious agents in genetically predisposed patients. In addition, a number of studies have described the role of B cells in the development of KD. To obtain a mechanistic insight into the humoral immune response of B-lineage cells in KD patients, we examined peripheral blood antibody secreting cells (ASCs) and inhibitory immunoreceptors, immunoglobulin-like transcript (ILT)/leukocyte immunoglobulin-like receptor (LILR), on each B cell subpopulation. METHODS: Eighteen Japanese KD patients and thirteen healthy control subjects were recruited for this study. Their peripheral blood mononuclear cells were examined by flow cytometry for the number of CD19 B cells, the size of each B cell subset and the expression of the inhibitory isoforms of ILT/LILR on the B cell subset. RESULTS: The frequency of CD19CD27 ASCs was significantly increased in the acute phase of KD and reduced after high-dose intravenous immunoglobulin (IVIG) treatment. Interestingly, while ILT2/LILRB1 expression was ubiquitously observed on every B cell/ASCs subset and the level was not significantly different after IVIG, ILT3/LILRB4 (B4) was uniquely expressed on only ASCs, and its expression was significantly decreased after IVIG. CONCLUSIONS: In the acute phase of KD, the frequency of ASCs is high with augmented B4 expression, whereas it is lower with decreased B4 expression after IVIG. Further studies of B4 expression on ASCs in autoimmune and infectious diseases will be needed to confirm the significance of our findings.

  19. Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells Peer-reviewed

    Ayako Kaitani, Kumi Izawa, Akie Maehara, Masamichi Isobe, Ayako Takamori, Toshihiro Matsukawa, Mariko Takahashi, Yoshinori Yamanishi, Toshihiko Oki, Hiromichi Yamada, Masakazu Nagamine, Shino Uchida, Koichiro Uchida, Tomoaki Ando, Keiko Maeda, Nobuhiro Nakano, Toshiaki Shimizu, Toshiyuki Takai, Hideoki Ogawa, Ko Okumura, Toshio Kitamura, Jiro Kitaura

    Scientific Reports 8 (1) 2018/12/01

    DOI: 10.1038/s41598-018-25646-8  

    ISSN: 2045-2322

    eISSN: 2045-2322

  20. Bone marrow PDGFRα+Sca-1+-enriched mesenchymal stem cells support survival of and antibody production by plasma cells in vitro through IL-6 Peer-reviewed

    Atsuko Kayaba, Ari Itoh-Nakadai, Kunimichi Niibe, Matsuyuki Shirota, Ryo Funayama, Akiko Sugahara-Tobinai, Yi Li Wong, Masanori Inui, Keiko Nakayama, Toshiyuki Takai

    International Immunology 30 (6) 241-253 2018/05/24

    DOI: 10.1093/intimm/dxy018  

    ISSN: 1460-2377 0953-8178

  21. The CD300e molecule in mice is an immune-activating receptor Peer-reviewed

    Masamichi Isobe, Kumi Izawa, Masahiro Sugiuchi, Tamami Sakanishi, Ayako Kaitani, Ayako Takamori, Akie Maehara, Toshihiro Matsukawa, Mariko Takahashi, Yoshinori Yamanishi, Toshihiko Oki, Shino Uchida, Koichiro Uchida, Tomoaki Ando, Keiko Maeda, Nobuhiro Nakano, Hideo Yagita, Toshiyuki Takai, Hideoki Ogawa, Ko Okumura, Toshio Kitamura, Jiro Kitaura

    Journal of Biological Chemistry 293 (10) 3793-3805 2018

    DOI: 10.1074/jbc.RA117.000696  

    ISSN: 1083-351X 0021-9258

    eISSN: 1083-351X

  22. PIR-B repressed IL-6 secretion from mesenchymal stem cells regulating the immunoglobulin production of plasma cells Peer-reviewed

    Atsuko Kayaba, Ari Itoh-Nakadai, Masanori Inui, Toshiyuki Takai

    CYTOKINE 100 163-164 2017/12

    ISSN: 1043-4666

    eISSN: 1096-0023

  23. Secretory leukocyte peptidase inhibitor (SLPI) is highly expressed in long-lived plasma cells Peer-reviewed

    Ari Itoh-Nakadai, Atsuko Kayaba, Toshiyuki Takai

    CYTOKINE 100 166-166 2017/12

    ISSN: 1043-4666

    eISSN: 1096-0023

  24. Identification of Secretory Leukoprotease Inhibitor As an Endogenous Negative Regulator in Allergic Effector Cells Peer-reviewed

    Shintaro Matsuba, Toshiki Yabe-Wada, Kazuya Takeda, Tetsuya Sato, Mikita Suyama, Toshiyuki Takai, Toshiaki Kikuchi, Toshihiro Nukiwa, Akira Nakamura

    FRONTIERS IN IMMUNOLOGY 8 2017/11

    DOI: 10.3389/fimmu.2017.01538  

    ISSN: 1664-3224

  25. Introduction: Antibody-Mediated Therapy Special Issue Part 2 Peer-reviewed

    Nakamura Akira, Tsumoto Kouhei, Takai Toshiyuki

    INTERNATIONAL IMMUNOLOGY 29 (11) 487-489 2017/11

    DOI: 10.1093/intimm/dxx069  

    ISSN: 0953-8178

  26. Introduction: Antibody-Mediated Therapy Special Issue Peer-reviewed

    Akira Nakamura, Kouhei Tsumoto, Toshiyuki Takai

    INTERNATIONAL IMMUNOLOGY 29 (7) 301-302 2017/07

    DOI: 10.1093/intimm/dxx046  

    ISSN: 0953-8178

    eISSN: 1460-2377

  27. PirB regulates asymmetries in hippocampal circuitry Peer-reviewed

    Hikari Ukai, Aiko Kawahara, Keiko Hirayama, Matthew Julian Case, Shotaro Aino, Masahiro Miyabe, Ken Wakita, Ryohei Oogi, Michiyo Kasayuki, Shihomi Kawashima, Shunichi Sugimoto, Kanako Chikamatsu, Noritaka Nitta, Tsuneyuki Koga, Ryuichi Shigemoto, Toshiyuki Takai, Isao Ito

    PLOS ONE 12 (6) 2017/06

    DOI: 10.1371/journal.pone.0179377  

    ISSN: 1932-6203

  28. SLE病原性B細胞を特徴付ける抑制性受容体分子の探索

    高井 俊行, 乾 匡範

    アレルギー 66 (1) 27-31 2017/02

    Publisher: (一社)日本アレルギー学会

    ISSN: 0021-4884

    eISSN: 1347-7935

  29. Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines Peer-reviewed

    Masayuki Hayashi, Taiki Aoshi, Yasunari Haseda, Kouji Kobiyama, Edward Wijaya, Noriyuki Nakatsu, Yoshinobu Igarashi, Daron M. Standley, Hiroshi Yamada, Yoshikazu Honda-Okubo, Hiromitsu Hara, Takashi Saito, Toshiyuki Takai, Cevayir Coban, Nikolai Petrovsky, Ken J. Ishii

    EBIOMEDICINE 15 127-136 2017/02

    DOI: 10.1016/j.ebiom.2016.11.015  

    ISSN: 2352-3964

  30. Exploring of immune inhibitory receptors that characterize pathogenic plasma cells in systemic lupus erythematosus Peer-reviewed

    Toshiyuki Takai, Masanori Inui

    Japanese Journal of Allergology 66 (1) 27-31 2017

    Publisher: Japanese Society of Allergology

    ISSN: 1347-7935 0021-4884

  31. Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibody-producing plasmablasts and plasma cells in non-treated SLE Peer-reviewed

    Masanori Inui, Akiko Sugahara-Tobinai, Hiroshi Fujii, Ari Itoh-Nakadai, Hidehiro Fukuyama, Tomohiro Kurosaki, Tomonori Ishii, Hideo Harigae, Toshiyuki Takai

    INTERNATIONAL IMMUNOLOGY 28 (12) 597-604 2016/12

    DOI: 10.1093/intimm/dxw044  

    ISSN: 0953-8178

    eISSN: 1460-2377

  32. TREM2/DAP12 Signal Elicits Proinflammatory Response in Microglia and Exacerbates Neuropathic Pain Peer-reviewed

    Masaaki Kobayashi, Hiroyuki Konishi, Akira Sayo, Toshiyuki Takai, Hiroshi Kiyama

    JOURNAL OF NEUROSCIENCE 36 (43) 11138-11150 2016/10

    DOI: 10.1523/JNEUROSCI.1238-16.2016  

    ISSN: 0270-6474

  33. The immunosuppressive effect of domain-deleted dimer of HLA-G2 isoform in collagen-induced arthritis mice Peer-reviewed

    Ami Takahashi, Kimiko Kuroki, Yuki Okabe, Yoshiyuki Kasai, Naoki Matsumoto, Chisato Yamada, Toshiyuki Takai, Toyoyuki Ose, Shigeyuki Kon, Tadashi Matsuda, Katsumi Maenaka

    HUMAN IMMUNOLOGY 77 (9) 754-759 2016/09

    DOI: 10.1016/j.humimm.2016.01.010  

    ISSN: 0198-8859

    eISSN: 1879-1166

  34. Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity Peer-reviewed

    Masaki Yugami, Haruki Odagiri, Motoyoshi Endo, Hiroyasu Tsutsuki, Shigemoto Fujii, Tsuyoshi Kadomatsu, Tetsuro Masuda, Keishi Miyata, Kazutoyo Terada, Hironori Tanoue, Hitoshi Ito, Jun Morinaga, Haruki Horiguchi, Taichi Sugizaki, Takaaki Akaike, Tomomi Gotoh, Toshiyuki Takai, Tomohiro Sawa, Hiroshi Mizuta, Yuichi Oike

    JOURNAL OF BIOLOGICAL CHEMISTRY 291 (36) 18843-18852 2016/09

    DOI: 10.1074/jbc.M116.720870  

    ISSN: 0021-9258

    eISSN: 1083-351X

  35. A Histone Methyltransferase ESET Is Critical for T Cell Development Peer-reviewed

    Shoichi Takikita, Ryunosuke Muro, Toshiyuki Takai, Takeshi Otsubo, Yuki I. Kawamura, Taeko Dohi, Hiroyo Oda, Masayuki Kitajima, Kenshiro Oshima, Masahira Hattori, Takaho A. Endo, Tetsuro Toyoda, John Weis, Yoichi Shinkai, Harumi Suzuki

    JOURNAL OF IMMUNOLOGY 197 (6) 2269-2279 2016/09

    DOI: 10.4049/jimmunol.1502486  

    ISSN: 0022-1767

    eISSN: 1550-6606

  36. 好酸球、マスト細胞、好塩基球 好酸球におけるSLPIの制御機構の解明

    松葉 慎太郎, 和田 俊樹, 武田 和也, 佐藤 哲也, 須山 幹太, 高井 俊行, 中村 晃

    アレルギー 65 (4-5) 558-558 2016/05

    Publisher: (一社)日本アレルギー学会

    ISSN: 0021-4884

    eISSN: 1347-7935

  37. TLR signals posttranscriptionally regulate the cytokine trafficking mediator sortilin Peer-reviewed

    Toshiki Yabe-Wada, Shintaro Matsuba, Kazuya Takeda, Tetsuya Sato, Mikita Suyama, Yasuyuki Ohkawa, Toshiyuki Takai, Haifeng Shi, Caroline C. Philpott, Akira Nakamura

    SCIENTIFIC REPORTS 6 2016/05

    DOI: 10.1038/srep26566  

    ISSN: 2045-2322

  38. Mechanism of action of immunoglobulin: Sialylated IgG Peer-reviewed

    Toshiyuki Takai

    Kawasaki Disease: Current Understanding of the Mechanism and Evidence-Based Treatment 223-230 2016/01/01

    Publisher: Springer Japan

    DOI: 10.1007/978-4-431-56039-5_25  

  39. Augmentation of neuropathic pain by DAP12 mediated signal in microglia

    H. Konishi, M. Kobayashi, T. Takai, H. Kiyama

    GLIA 63 E337-E337 2015/08

    ISSN: 0894-1491

    eISSN: 1098-1136

  40. Human CD43(+) B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals Peer-reviewed

    Masanori Inui, Saeko Hirota, Kumiko Hirano, Hiroshi Fujii, Akiko Sugahara-Tobinai, Tomonori Ishii, Hideo Harigae, Toshiyuki Takai

    INTERNATIONAL IMMUNOLOGY 27 (7) 345-355 2015/07

    DOI: 10.1093/intimm/dxv009  

    ISSN: 0953-8178

    eISSN: 1460-2377

  41. A DAP12-Dependent Signal Promotes Pro-Inflammatory Polarization in Microglia Following Nerve Injury and Exacerbates Degeneration of Injured Neurons Peer-reviewed

    Masaaki Kobayashi, Hiroyuki Konishi, Toshiyuki Takai, Hiroshi Kiyama

    GLIA 63 (6) 1073-1082 2015/06

    DOI: 10.1002/glia.22802  

    ISSN: 0894-1491

    eISSN: 1098-1136

  42. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses Peer-reviewed

    Toshifumi Kimura, Shota Endo, Masanori Inui, Shin-Ichiroh Saitoh, Kensuke Miyake, Toshiyuki Takai

    JOURNAL OF IMMUNOLOGY 194 (11) 5426-5436 2015/06

    DOI: 10.4049/jimmunol.1402006  

    ISSN: 0022-1767

    eISSN: 1550-6606

  43. Impaired fracture healing caused by deficiency of the immunoreceptor adaptor protein DAP12 Peer-reviewed

    Masayuki Kamimura, Yu Mori, Akiko Sugahara-Tobinai, Toshiyuki Takai, Eiji Itoi

    PLoS ONE 10 (6) 2015/06/01

    DOI: 10.1371/journal.pone.0128210  

    ISSN: 1932-6203

    eISSN: 1932-6203

  44. Platelets convert peripheral blood circulating monocytes to regulatory cells via immunoglobulin G and activating-type Fc gamma receptors Peer-reviewed

    Masanori Inui, Kino Tazawa, Yoshiro Kishi, Toshiyuki Takai

    BMC IMMUNOLOGY 16 2015/04

    DOI: 10.1186/s12865-015-0086-z  

    ISSN: 1471-2172

  45. Immune complexes regulate bone metabolism through FcR gamma signalling Peer-reviewed

    Takako Negishi-Koga, Hans-Juergen Gober, Eriko Sumiya, Noriko Komatsu, Kazuo Okamoto, Shinichiro Sawa, Ayako Suematsu, Tomomi Suda, Kojiro Sato, Toshiyuki Takai, Hiroshi Takayanagi

    NATURE COMMUNICATIONS 6 2015/03

    DOI: 10.1038/ncomms7637  

    ISSN: 2041-1723

  46. Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases Peer-reviewed

    Atsuo Kanno, Natsuko Tanimura, Masayuki Ishizaki, Kentaro Ohko, Yuji Motoi, Masahiro Onji, Ryutaro Fukui, Takaichi Shimozato, Kazuhide Yamamoto, Takuma Shibata, Shigetoshi Sano, Akiko Sugahara-Tobinai, Toshiyuki Takai, Umeharu Ohto, Toshiyuki Shimizu, Shin-ichiroh Saitoh, Kensuke Miyake

    NATURE COMMUNICATIONS 6 2015/02

    DOI: 10.1038/ncomms7119  

    ISSN: 2041-1723

  47. TREM-1 regulates macrophage polarization in ureteral obstruction Peer-reviewed

    Tzu-Han Lo, Kai-Yu Tseng, Wen-Shan Tsao, Chih-Ya Yang, Shie-Liang Hsieh, Allen Wen-Hsiang Chiu, Toshiyuki Takai, Tak W. Mak, Der-Cherng Tarng, Nien-Jung Chen

    KIDNEY INTERNATIONAL 86 (6) 1174-1186 2014/12

    DOI: 10.1038/ki.2014.205  

    ISSN: 0085-2538

    eISSN: 1523-1755

  48. TLR9シグナルの新規制御分子Sortilinの機能解析

    和田 俊樹, 武田 和也, 松葉 慎太郎, 中村 晃, 佐藤 哲也, 須山 幹太, 大川 恭行, 高井 俊行

    金沢医科大学雑誌 39 (2) 45-45 2014/10

    Publisher: 金沢医科大学医学会

    ISSN: 0385-5759

  49. Dichotomy in Fc gamma RIIB deficiency and autoimmune-prone SLAM haplotype clarifies the roles of the Fc receptor in development of autoantibodies and glomerulonephritis Peer-reviewed

    Yasuyoshi Kanari, Akiko Sugahara-Tobinai, Haruka Takahashi, Masanori Inui, Akira Nakamura, Sachiko Hirose, Toshiyuki Takai

    BMC IMMUNOLOGY 15 2014/10

    DOI: 10.1186/s12865-014-0047-y  

    ISSN: 1471-2172

  50. gp49B-Mediated Negative Regulation of Antibody Production by Memory and Marginal Zone B Cells Peer-reviewed

    Saori Fukao, Kei Haniuda, Takuya Nojima, Toshiyuki Takai, Daisuke Kitamura

    JOURNAL OF IMMUNOLOGY 193 (2) 635-644 2014/07

    DOI: 10.4049/jimmunol.1302772  

    ISSN: 0022-1767

    eISSN: 1550-6606

  51. An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells Peer-reviewed

    Shinsuke Yasukawa, Yoshiyuki Miyazaki, Chika Yoshii, Mako Nakaya, Naoko Ozaki, Shuji Toda, Etsushi Kuroda, Ken-ichi Ishibashi, Tomoharu Yasuda, Yohei Natsuaki, Fumika Mi-ichi, Ei'ichi Iizasa, Takeshi Nakahara, Masanori Yamazaki, Kenji Kabashima, Yoichiro Iwakura, Toshiyuki Takai, Takashi Saito, Tomohiro Kurosaki, Bernard Malissen, Naohito Ohno, Masutaka Furue, Hiroki Yoshida, Hiromitsu Hara

    NATURE COMMUNICATIONS 5 2014/05

    DOI: 10.1038/ncomms4755  

    ISSN: 2041-1723

  52. Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy Peer-reviewed

    Alessandra Tammaro, Ingrid Stroo, Elena Rampanelli, Froilan Blank, Loes M. Butter, Nike Claessen, Toshiyuki Takai, Marco Colonna, Jaklien C. Leemans, Sandrine Florquin, Mark C. Dessing

    PLoS ONE 8 (12) 2013/12/16

    DOI: 10.1371/journal.pone.0082498  

    ISSN: 1932-6203

  53. Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes Peer-reviewed

    Vanessa Montalvo, Laura Quigley, Barbara P. Vistica, Kimberly C. Boelte, Lindsey F. Nugent, Toshiyuki Takai, Daniel W. McVicar, Igal Gery

    IMMUNOLOGY 140 (4) 475-482 2013/12

    DOI: 10.1111/imm.12158  

    ISSN: 0019-2805

    eISSN: 1365-2567

  54. 好塩基球・好酸球におけるSLPIの制御機構の解明

    松葉 慎太郎, 和田 俊樹, 武田 和也, 佐藤 哲也, 須山 幹太, 高井 俊行, 中村 晃

    アレルギー 62 (9-10) 1407-1407 2013/10

    Publisher: (一社)日本アレルギー学会

    ISSN: 0021-4884

    eISSN: 1347-7935

  55. IgG and IgE collaboratively accelerate expulsion of Strongyloides venezuelensis in a primary infection Peer-reviewed

    Makoto Matsumoto, Yuki Sasaki, Koubun Yasuda, Toshiyuki Takai, Masamichi Muramatsu, Tomohiro Yoshimoto, Kenji Nakanishi

    Infection and Immunity 81 (7) 2518-2527 2013/07

    DOI: 10.1128/IAI.00285-13  

    ISSN: 0019-9567 1098-5522

  56. Fc gamma RIIb mediates amyloid-beta neurotoxicity and memory impairment in Alzheimer's disease Peer-reviewed

    Tae-In Kam, Sungmin Song, Youngdae Gwon, Hyejin Park, Ji-Jing Yan, Isak Im, Ji-Woo Choi, Tae-Yong Choi, Jeongyeon Kim, Dong-Keun Song, Toshiyuki Takai, Yong-Chul Kim, Key-Sun Kim, Se-Young Choi, Sukwoo Choi, William L. Klein, Junying Yuan, Yong-Keun Jung

    JOURNAL OF CLINICAL INVESTIGATION 123 (7) 2791-2802 2013/07

    DOI: 10.1172/JCI66827  

    ISSN: 0021-9738

  57. 【免疫グロブリン様受容体による免疫制御と疾患】自己免疫病とPirB

    乾 匡範, 高井 俊行

    医学のあゆみ 245 (3) 225-228 2013/04

    Publisher: 医歯薬出版(株)

    ISSN: 0039-2359

  58. Phenotype conversion from rheumatoid arthritis to systemic lupus erythematosus by introduction of Yaa mutation into Fc gamma RIIB-deficient C57BL/6 mice Peer-reviewed

    Kawano Shinya, Lin Qingshun, Amano Hirofumi, Kaneko Toshiyuki, Nishikawa Keiko, Tsurui Hiromichi, Tada Norihiro, Nishimura Hiroyuki, Takai Toshiyuki, Shirai Toshikazu, Takasaki Yoshinari, Hirose Sachiko

    EUROPEAN JOURNAL OF IMMUNOLOGY 43 (3) 770-778 2013/03

    DOI: 10.1002/eji.201243057  

    ISSN: 0014-2980

  59. Inhibitory Receptor Paired Ig-like Receptor B Is Exploited by Staphylococcus aureus for Virulence International-journal Peer-reviewed

    Nakayama Masafumi, Kurokawa Kenji, Nakamura Kyohei, Lee Bok Luel, Sekimizu Kazuhisa, Kubagawa Hiromi, Hiramatsu Keiichi, Yagita Hideo, Okumura Ko, Takai Toshiyuki, Underhill David M, Aderem Alan, Ogasawara Kouetsu

    JOURNAL OF IMMUNOLOGY 189 (12) 5903-5911 2012/12/15

    DOI: 10.4049/jimmunol.1201940  

    ISSN: 0022-1767

    More details Close

    The innate immune system has developed to acquire a wide variety of pattern-recognition receptors (PRRs) to identify potential pathogens, whereas pathogens have also developed to escape host innate immune responses. ITIM-bearing receptors are attractive targets for pathogens to attenuate immune responses against them; however, the in vivo role of the inhibitory PRRs in host-bacteria interactions remains unknown. We demonstrate in this article that Staphylococcus aureus, a major Gram-positive bacteria, exploits inhibitory PRR paired Ig-like receptor (PIR)-B on macrophages to suppress ERK1/2 and inflammasome activation, and subsequent IL-6 and IL-1β secretion. Consequently, Pirb(-/-) mice infected with S. aureus showed enhanced inflammation and more effective bacterial clearance, resulting in resistance to the sepsis. Screening of S. aureus mutants identified lipoteichoic acid (LTA) as an essential bacterial cell wall component required for binding to PIR-B and modulating inflammatory responses. In vivo, however, an LTA-deficient S. aureus mutant was highly virulent and poorly recognized by macrophages in both wild-type and Pirb(-/-) mice, demonstrating that LTA recognition by PRRs other than PIR-B mediates effective bacterial elimination. These results provide direct evidence that bacteria exploit the inhibitory receptor for virulence, and host immune system counterbalances the infection.

  60. The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis. Peer-reviewed

    Kuroki K, Hirose K, Okabe Y, Fukunaga Y, Takahashi A, Shiroishi M, Kajikawa M, Tabata S, Nakamura S, Takai T, Koyanagi S, Ohdo S, Maenaka K

    Human immunology 74 (4) 433-438 2012/12

    Publisher: ELSEVIER SCIENCE INC

    DOI: 10.1016/j.humimm.2012.11.060  

    ISSN: 0198-8859

  61. 【骨免疫学〜基礎と臨床〜】免疫グロブリン様受容体による破骨細胞の分化制御

    乾 匡範, 高井 俊行

    Clinical Calcium 22 (11) 1651-1657 2012/10

    Publisher: (株)医薬ジャーナル社

    ISSN: 0917-5857

  62. Regulation of plasmacytoid dendritic cell responses by PIR-B. Peer-reviewed

    Yoshiya Mitsuhashi, Akira Nakamura, Shota Endo, Kazuya Takeda, Toshiki Yabe-Wada, Toshihiro Nukiwa, Toshiyuki Takai

    Blood 120 (16) 3256-3259 2012/09

    Publisher: American Society of Hematology

    DOI: 10.1182/blood-2012-03-419093  

    ISSN: 0006-4971

    eISSN: 1528-0020

    More details Close

    <title>Abstract</title> Plasmacytoid dendritic cells (PDCs) produce type I interferons (IFNs) in response to viral nucleic acids to exert antiviral immunity. However, PDCs are related to the progress and severity of autoimmune diseases, such as systemic lupus erythematosus, because they respond to host DNA. Therefore, the regulation of PDC activation is critical for maintaining adequate immune responses. Here we show that an inhibitory major histocompatibility complex class I receptor, paired immunoglobulin-like receptor B (PIR-B), suppressed Fms-like tyrosine kinase 3 ligand-induced PDC differentiation in BM cells, as well as Toll-like receptor 9-mediated IFN-α production by PDCs, through the dephosphorylation of STAT1/STAT2. In particular, PIR-B inhibited IFN-α–mediated STAT phosphorylation, suggesting that PIR-B negatively regulates the positive feedback mechanism of IFN-α secretion triggered by Toll-like receptor 9. These results demonstrate a novel regulatory role for PIR-B in PDCs.

  63. Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7 Peer-reviewed

    Lior Zangi, Yael Zlotnikov Klionsky, Liran Yarimi, Esther Bachar-Lustig, Yaki Eidelstein, Elias Shezen, David Hagin, Yumi Ito, Toshiyuki Takai, Shlomit Reich-Zeliger, Assaf Lask, Oren Milstein, Steffen Jung, Vera Shinder, Yair Reisner

    BLOOD 120 (8) 1647-1657 2012/08

    DOI: 10.1182/blood-2012-02-410803  

    ISSN: 0006-4971

  64. Runx1 deficiency in CD4+ T cells causes fatal autoimmune inflammatory lung disease due to spontaneous hyperactivation of cells. Peer-reviewed

    Wong WF, Kohu K, Nakamura A, Ebina M, Kikuchi T, Tazawa R, Tanaka K, Kon S, Funaki T, Sugahara-Tobinai A, Looi CY, Endo S, Funayama R, Kurokawa M, Habu S, Ishii N, Fukumoto M, Nakata K, Takai T, Satake M

    Journal of immunology (Baltimore, Md. : 1950) 188 5408-5420 2012/06

    Publisher: 11

    DOI: 10.4049/jimmunol.1102991  

    ISSN: 0022-1767

  65. 【骨吸収の正と負の制御】破骨細胞共刺激受容体による正と負の制御

    乾 匡範, 高井 俊行

    炎症と免疫 20 (3) 240-245 2012/04

    Publisher: (株)先端医学社

    ISSN: 0918-8371

  66. Intravenous immunoglobulin suppresses IL-10 production by activated B cells in vitro Peer-reviewed

    Jun Tanaka, Kumiko Hirano, Yuzuru Sakamoto, Akiko Sugahara-Tobinai, Shota Endo, Yumi Ito-Matsuoka, Atsushi Nakano, Masanori Inui, Lars Nitschke, Toshiyuki Takai

    Open Journal of Immunology 02 (04) 149-160 2012

    Publisher: Scientific Research Publishing, Inc.

    DOI: 10.4236/oji.2012.24019  

    ISSN: 2162-450X

    eISSN: 2162-4526

  67. Control of Pathogenic CD4 T Cells and Lethal Immunopathology by Signaling Immunoadaptor DAP12 during Influenza Infection Peer-reviewed

    Sarah McCormick, Christopher R. Shaler, Cherrie-Lee Small, Carly Horvath, Daniela Damjanovic, Earl G. Brown, Naoko Aoki, Toshiyuki Takai, Zhou Xing

    JOURNAL OF IMMUNOLOGY 187 (8) 4280-4292 2011/10

    DOI: 10.4049/jimmunol.1101050  

    ISSN: 0022-1767

  68. Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cells. Peer-reviewed

    Daito H, Kikuchi T, Sakakibara T, Gomi K, Damayanti T, Zaini J, Tode N, Kanehira M, Koyama S, Fujimura S, Ebina M, Ishii KJ, Akira S, Takai T, Watanabe A, Nukiwa T

    The European respiratory journal 38 688-701 2011/09

    Publisher: 3

    DOI: 10.1183/09031936.00177110  

    ISSN: 0903-1936

  69. The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses Peer-reviewed

    Nakano-Yokomizo, Takako, Tahara-Hanaoka, Satoko, Nakahashi-Oda, Chigusa, Nabekura, Tsukasa, Tchao, Nadia K, Kadosaki, Momoko, Totsuka, Naoya, Kurita, Naoki, Nakamagoe, Kiyotaka, Tamaoka, Akira, Takai, Toshiyuki, Yasui, Teruhito, Kikutani, Hitoshi, Honda, Shin-ichiro, Shibuya, Kazuko, Lanier, Lewis L, Shibuya, Akira

    JOURNAL OF EXPERIMENTAL MEDICINE 208 (8) 1661-1671 2011/08

    Publisher: ROCKEFELLER UNIV PRESS

    DOI: 10.1084/jem.20101623  

    ISSN: 0022-1007

    eISSN: 1540-9538

  70. Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells. Peer-reviewed

    Matsushita H, Endo S, Kobayashi E, Sakamoto Y, Kobayashi K, Kitaguchi K, Kuroki K, Söderhäll A, Maenaka K, Nakamura A, Strittmatter SM, Takai T

    The Journal of biological chemistry 286 (29) 25739-25747 2011/07

    DOI: 10.1074/jbc.M110.157859  

    ISSN: 0021-9258

  71. Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. Peer-reviewed

    Arita K, Endo S, Kaifu T, Kitaguchi K, Nakamura A, Ohmori H, Kohu K, Satake M, Takai T

    Journal of immunology (Baltimore, Md. : 1950) 186 (12) 7050-7059 2011/06

    DOI: 10.4049/jimmunol.1001302  

    ISSN: 0022-1767

  72. Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. Peer-reviewed

    Fujita Y, Endo S, Takai T, Yamashita T

    The EMBO journal 30 (7) 1389-1401 2011/04

    DOI: 10.1038/emboj.2011.55  

    ISSN: 0261-4189

  73. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells Peer-reviewed

    Ge Ma, Ping-Ying Pan, Samuel Eisenstein, Celia M. Divino, Clifford A. Lowell, Toshiyuki Takai, Shu-Hsia Chen

    Immunity 34 (3) 385-395 2011/03/25

    DOI: 10.1016/j.immuni.2011.02.004  

    ISSN: 1074-7613 1097-4180

  74. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. International-journal Peer-reviewed

    Nakamura Y, Fujita Y, Ueno M, Takai T, Yamashita T

    The Journal of biological chemistry 286 (3) 1876-1883 2011/01/02

    Publisher: 3

    DOI: 10.1074/jbc.M110.163493  

    ISSN: 0021-9258

    More details Close

    Myelin components that inhibit axonal regeneration are believed to contribute significantly to the lack of axonal regeneration noted in the adult central nervous system. Three proteins found in myelin, Nogo, myelin-associated glycoprotein, and oligodendrocyte-myelin glycoprotein, inhibit neurite outgrowth in vitro. All of these proteins interact with the same receptors, namely, the Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PIR-B). As per previous reports, corticospinal tract (CST) regeneration is not enhanced in NgR-knock-out mice after spinal cord injury. Therefore, we assessed CST regeneration in PIR-B-knock-out mice. We found that hindlimb motor function, as assessed using the Basso mouse scale, footprint test, inclined plane test, and beam walking test, did not differ between the PIR-B-knock-out and wild-type mice after dorsal hemisection of the spinal cord. Further, tracing of the CST fibers after injury did not reveal enhanced axonal regeneration or sprouting in the CST of the PIR-B-knock-out mice. Systemic administration of NEP1-40, a NgR antagonist, to PIR-B knock-out mice did not enhance the regenerative response. These results indicate that PIR-B knock-out is not sufficient to induce extensive axonal regeneration after spinal cord injury.

  75. S12-3 NogoおよびMHC class IによるPIR-Bを介した新たなマスト細胞の制御機構(S12 アレルギー治療標的としてのシグナル受容体,シンポジウム,第61回日本アレルギー学会秋季学術大会)

    乾 匡範, 篠崎 夏子, 遠藤 章太, 高井 俊行

    アレルギー 60 (9) 1232-1232 2011

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.60.1232_2  

  76. MS16-6 NogoおよびMHCクラスIによるPIR-Bへの競合的結合によるマスト細胞の制御について(MS16 マスト細胞2,ミニシンポジウム,第61回日本アレルギー学会秋季学術大会)

    篠崎 夏子, 乾 匡範, 遠藤 章太, 坂本 譲, 北口 公司, 高井 俊行

    アレルギー 60 (9) 1346-1346 2011

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.60.1346_3  

  77. Preparation of magnetite aqueous dispersion for magnetic fluid hyperthermia. Peer-reviewed

    Teppei Kikuchi, Ryo Kasuya, Shota Endo, Akira Nakamura, Toshiyuki Takai, Nils Metzler-Nolte, Kazuyuki Tohji, Jeyadevan Balachandran

    Journal of Magnetism and Magnetic Materials 323 1216-1222 2011

    DOI: 10.1016/j.jmmm.2010.11.009  

  78. The p75 receptor mediates axon growth inhibition through an association with PIR-B. Peer-reviewed

    Yuki Fujita, Reina Takashima, Shota Endo, Toshiyuki Takai, Toshihide Yamashita

    Cell Death & Disease 2 e198 2011

    DOI: 10.1038/cddis.2011.85  

  79. Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells. Peer-reviewed

    Proc. Natl. Acad. Sci. USA. 108 (45) 18360-18365 2011

    DOI: 10.1073/pnas.1110584108  

    ISSN: 0027-8424

  80. Role of PIR-B in Autoimmune Glomerulonephritis Peer-reviewed

    Toshiyuki Takai, Akira Nakamura, Shota Endo

    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY 2011 275302-275302 2011

    DOI: 10.1155/2011/275302  

    ISSN: 1110-7243

  81. The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcγ receptor IIb on CD11c(+) dendritic cells in a murine model. International-journal

    M Yamamoto, K Kobayashi, Y Ishikawa, K Nakata, Y Funada, Y Kotani, A Masuda, T Takai, T Azuma, M Yoshida, Y Nishimura

    Clinical and experimental immunology 162 (2) 315-24 2010/11

    DOI: 10.1111/j.1365-2249.2010.04243.x  

    More details Close

    Immunoglobulins (Igs) play important immunomodulatory effects on allergic asthma. Among these, IgG has been reported to regulate allergic inflammation in previous studies about immunotherapy and intravenous immunoglobulin therapy. In this study, to examine the immunomodulatory mechanisms of IgG and FcRs we evaluated the effects of intravenous (i.v.) rabbit IgG administration (IVIgG) on allergic airway inflammation and lung antigen-presenting cells (APCs) in a murine model of ovalbumin (OVA) sensitization and challenge. In OVA-challenged mice, IVIgG attenuated airway eosinophilia, airway hyperresponsiveness and goblet cell hyperplasia and also inhibited the local T helper type (Th) 2 cytokine levels. Additionally, IVIgG attenuated the proliferation of OVA-specific CD4(+) T cells transplanted into OVA-challenged mice. Ex vivo co-culture with OVA-specific CD4(+) cells and lung CD11c(+) APCs from mice with IVIgG revealed the attenuated transcription level of Th2 cytokines, suggesting an inhibitory effect of IVIgG on CD11c(+) APCs to induce Th2 response. Next, to analyse the effects on Fcγ receptor IIb and dendritic cells (DCs), asthmatic features in Fcγ receptor IIb-deficient mice were analysed. IVIgG failed to attenuate airway eosinophilia, airway inflammation and goblet cell hyperplasia. However, the lacking effects of IVIgG on airway eosinophilia in Fcγ receptor IIb deficiency were restored by i.v. transplantation of wild-type bone marrow-derived CD11c(+) DCs. These results demonstrate that IVIgG attenuates asthmatic features and the function of lung CD11c(+) DCs via Fcγ receptor IIb in allergic airway inflammation. Targeting Fc portions of IgG and Fcγ receptor IIb on CD11c(+) DCs in allergic asthma is a promising therapeutic strategy.

  82. Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor ITS SIMILARITIES TO AND DIFFERENCES FROM LMIR4/CLM-5 Peer-reviewed

    Yutaka Enomoto, Yoshinori Yamanishi, Kumi Izawa, Ayako Kaitani, Mariko Takahashi, Akie Maehara, Toshihiko Oki, Reiko Takamatsu, Masunori Kajikawa, Toshiyuki Takai, Toshio Kitamura, Jiro Kitaura

    JOURNAL OF BIOLOGICAL CHEMISTRY 285 (46) 35274-35283 2010/11

    DOI: 10.1074/jbc.M110.137166  

    ISSN: 0021-9258

    eISSN: 1083-351X

  83. Genetic Deletion of Paired Immunoglobulin-Like Receptor B Does Not Promote Axonal Plasticity or Functional Recovery after Traumatic Brain Injury Peer-reviewed

    Shusaku Omoto, Masaki Ueno, Soichiro Mochio, Toshiyuki Takai, Toshihide Yamashita

    JOURNAL OF NEUROSCIENCE 30 (39) 13045-13052 2010/09

    DOI: 10.1523/JNEUROSCI.3228-10.2010  

    ISSN: 0270-6474

  84. Paired immunoglobulin-like receptor B(PirB)ノックアウトマウスにおける外傷性脳損傷後の運動機能回復および神経可塑性(Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury)

    大本 周作, 上野 将紀, 持尾 聰一郎, 高井 俊行, 山下 俊英

    神経化学 49 (2-3) 628-628 2010/08

    Publisher: 日本神経化学会

    ISSN: 0037-3796

  85. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury Peer-reviewed

    Yoshinori Yamanishi, Jiro Kitaura, Kumi Izawa, Ayako Kaitani, Yukiko Komeno, Masaki Nakamura, Satoshi Yamazaki, Yutaka Enomoto, Toshihiko Oki, Hisaya Akiba, Takaya Abe, Tadasuke Komori, Yoshihiro Morikawa, Hiroshi Kiyonari, Toshiyuki Takai, Ko Okumura, Toshio Kitamura

    JOURNAL OF EXPERIMENTAL MEDICINE 207 (7) 1501-1511 2010/07

    DOI: 10.1084/jem.20090581  

    ISSN: 0022-1007

  86. Heat dissipation characteristics of magnetite nanoparticles and their application to macrophage cells Peer-reviewed

    Ryo Kasuya, Teppei Kikuchi, Hiroaki Mamiya, Koji Ioku, Shota Endo, Akira Nakamura, Toshiyuki Takai, Jeyadevan Balachandran

    Physics Procedia 9 186-189 2010

    DOI: 10.1016/j.phpro.2010.11.042  

    ISSN: 1875-3892

  87. NKT細胞とその他の自然リンパ球 基礎的解析 TIM1とTIM4はLMIR5/CD300bのリガンドである TIM1/4-LMIR5相互作用による肥満細胞と顆粒球におけるLMIR5介在性活性化の誘導(TIM1 and TIM4 are ligands for LMIR5/CD300b: the TIM1/4-LMIR5 interaction induces LMIR5-mediated activation of mast cells and granulocytes)

    Yamanishi Yoshinori, Kitaura Jiro, Izawa Kumi, Kaitani Ayako, Enomoto Yutaka, Oki Toshihiko, Akiba Hisaya, Takai Toshiyuki, Okumura Ko, Kitamura Toshio

    日本免疫学会総会・学術集会記録 39 59-59 2009/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  88. 【骨免疫学】RANK共刺激受容体による骨代謝の制御

    乾 匡範, 菊地 佑樹, 高井 俊行

    THE BONE 23 (4) 409-414 2009/10

    Publisher: (株)メディカルレビュー社

    ISSN: 0914-7047

  89. Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses. International-journal Peer-reviewed

    Michiyo Imada, Kyoko Masuda, Rumi Satoh, Yumi Ito, Yoshiyuki Goto, Takayuki Matsuoka, Shota Endo, Akira Nakamura, Hiroshi Kawamoto, Toshiyuki Takai

    International immunology 21 (10) 1151-61 2009/10

    DOI: 10.1093/intimm/dxp081  

    More details Close

    Activated mature T cells induce various inhibitory receptors implicated in maintaining peripheral tolerance in response to the trans-acting ligands. Interestingly, paired Ig-like receptor (PIR)-B, an inhibitory MHC class I receptor on B cells and myeloid cells, could be involved in regulating early T cell development because epitope for PIR is detected on pre-thymic T/NK progenitors but not on thymocytes or mature T cells. We hypothesized that PIR-B is not only a regulator for T cell development but is also detrimental if expressed on mature T cells. Here we demonstrated, using PIR-B-deficient fetuses, that PIR-B is indeed expressed on the T cell progenitors but failed to identify its distinctive roles in the development. Forced expression of PIR-B in thymocytes and mature T cells also resulted in no abnormalities in development. However, upon antigenic or allogeneic stimulation, peripheral T cells with the ectopic PIR-B showed reduced T(h) type 1 responses due to the suppression of proximal TCR signaling by constitutive binding of PIR-B to MHC class I on the same cell surface. Our findings suggest that T cell expression of PIR-B with the cis-interacting MHC class I is strictly prohibited in periphery so as to secure prompt immune responses.

  90. Autoimmune thyroiditis in Fc gamma receptor-deficient nonobese diabetic mice Peer-reviewed

    Hiroshi Ozaki, Kouki Mori, Yoshinori Nakagawa, Saeko Hoshikawa, Sadayoshi Ito, Yoshihiro Inoue, Toshiyuki Takai, Katsumi Yoshida

    CLINICAL IMMUNOLOGY 132 (2) 291-293 2009/08

    DOI: 10.1016/j.clim.2009.04.011  

    ISSN: 1521-6616

  91. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity Peer-reviewed

    Tomohiro Kubo, Yuki Uchida, Yuko Watanabe, Masahiro Abe, Akira Nakamura, Masao Ono, Shizuo Akira, Toshiyuki Takai

    JOURNAL OF EXPERIMENTAL MEDICINE 206 (9) 1971-1982 2009/08

    DOI: 10.1084/jem.20082392  

    ISSN: 0022-1007

  92. An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells. International-journal Peer-reviewed

    Kumi Izawa, Jiro Kitaura, Yoshinori Yamanishi, Takayuki Matsuoka, Ayako Kaitani, Masahiro Sugiuchi, Mariko Takahashi, Akie Maehara, Yutaka Enomoto, Toshihiko Oki, Toshiyuki Takai, Toshio Kitamura

    Journal of immunology (Baltimore, Md. : 1950) 183 (2) 925-36 2009/07/15

    DOI: 10.4049/jimmunol.0900552  

    More details Close

    Leukocyte mono-Ig-like receptor 3 (LMIR3) is an inhibitory receptor mainly expressed in myeloid cells. Coengagement of Fc epsilonRI and LMIR3 impaired cytokine production in bone marrow-derived mast cells (BMMCs) induced by Fc epsilonRI crosslinking alone. Mouse LMIR3 possesses five cytoplasmic tyrosine residues (Y241, Y276, Y289, Y303, Y325), among which Y241 and Y289 (Y241/289) or Y325 fit the consensus sequence of ITIM or immunotyrosine-based switch motif (ITSM), respectively. The inhibitory effect was abolished by the replacement of Y325 in addition to Y241/289 with phenylalanine (Y241/189/325/F) in accordance with the potential of Y241/289/325 to cooperatively recruit Src homology region 2 domain-containing phosphatase 1 (SHP)-1 or SHP-2. Intriguingly, LMIR3 crosslinking alone induced cytokine production in BMMCs expressing LMIR3 (Y241/276/289/303/325F) mutant as well as LMIR3 (Y241/289/325F). Moreover, coimmunoprecipitation experiments revealed that LMIR3 associated with ITAM-containing FcRgamma. Analysis of FcRgamma-deficient BMMCs demonstrated that both Y276/303 and FcRgamma played a critical role in the activating function of this inhibitory receptor. Importantly, LMIR3 crosslinking enhanced cytokine production of BMMCs stimulated by LPS, while suppressing production stimulated by other TLR agonists or stem cell factor. Thus, an inhibitory receptor LMIR3 has a unique property to associate with FcRgamma and thereby functions as an activating receptor in concert with TLR4 stimulation.

  93. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin Peer-reviewed

    Karel Otero, Isaiah R. Turnbull, Pietro Luigi Poliani, William Vermi, Elisa Cerutti, Taiki Aoshi, Ilaria Tassi, Toshiyuki Takai, Samuel L. Stanley, Mark Miller, Andrey S. Shaw, Marco Colonna

    NATURE IMMUNOLOGY 10 (7) 734-U90 2009/07

    DOI: 10.1038/ni.1744  

    ISSN: 1529-2908

  94. Peroxiredoxin III-deficiency Sensitizes Macrophages to Oxidative Stress Peer-reviewed

    Lianqin Li, Tomonori Kaifu, Masuo Obinata, Toshiyuki Takai

    JOURNAL OF BIOCHEMISTRY 145 (4) 425-427 2009/04

    DOI: 10.1093/jb/mvp011  

    ISSN: 0021-924X

  95. DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo Peer-reviewed

    Ilaria Tassi, Gaelle Le Friec, Susan Gilfillan, Toshiyuki Takai, Wayne M. Yokoyama, Marco Colonna

    EUROPEAN JOURNAL OF IMMUNOLOGY 39 (4) 1129-1135 2009/04

    DOI: 10.1002/eji.200838972  

    ISSN: 0014-2980

  96. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection Peer-reviewed

    Mark T. Orr, Joseph C. Sun, David G. T. Hesslein, Hisashi Arase, Joseph H. Phillips, Toshiyuki Takai, Lewis L. Lanier

    JOURNAL OF EXPERIMENTAL MEDICINE 206 (4) 807-817 2009/04

    DOI: 10.1084/jem.20090168  

    ISSN: 0022-1007

  97. Role of Fc Receptors as a therapeutic target. International-journal Peer-reviewed

    Atsuhiro Masuda, Masaru Yoshida, Hideyuki Shiomi, Yoshinori Morita, Hiromu Kutsumi, Hideto Inokuchi, Shigeto Mizuno, Akira Nakamura, Toshiyuki Takai, Richard S Blumberg, Takeshi Azuma

    Inflammation & allergy drug targets 8 (1) 80-6 2009/03

    DOI: 10.2174/187152809787582525  

    eISSN: 2212-4055

    More details Close

    It has been forty years since the discovery of Fc Receptors and their function. Fc Receptors include the IgG receptors (FcgammaR), high-affinity IgE receptor (FcepsilonRI), IgA and IgA/IgM receptors, and neonatal Fc receptor for IgG (FcRn). In particular, the FcgammaRs have been well known to play an important role in many biologic processes including those associated with the response to infection and cancer as well as in the pathogenesis of immune-mediated diseases. Both positive and negative regulatory function has ascribed to Fc receptors and FcgammaRs in particular which serve to establish a threshold for immune cell activation. In other cases, Fc receptors such as FcRn possess a novel structure and function by playing a major role in the transport of IgG across polarized epithelial barriers at mucosal surfaces and in the regulation of IgG half-life. These diverse functions highlight the potential effectiveness of targeting Fc receptors for therapeutic purposes. This review summarizes new information available in the therapeutic applications of this biology.

  98. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12 Peer-reviewed

    Masanori Inui, Yuki Kikuchi, Naoko Aoki, Shota Endo, Tsutomu Maeda, Akiko Sugahara-Tobinai, Shion Fujimura, Akira Nakamura, Atsushi Kumanogoh, Marco Colonna, Toshiyuki Takai

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 106 (12) 4816-4821 2009/03

    DOI: 10.1073/pnas.0900463106  

    ISSN: 0027-8424

  99. Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils Peer-reviewed

    Shigeaki Hida, Sho Yamasaki, Yuzuru Sakamoto, Masaya Takamoto, Kazushige Obata, Toshiyuki Takai, Hajime Karasuyama, Kazuo Sugane, Takashi Saito, Shinsuke Taki

    NATURE IMMUNOLOGY 10 (2) 214-222 2009/02

    DOI: 10.1038/ni.1686  

    ISSN: 1529-2908

  100. 骨疾患とシグナル伝達 ITAM型免疫レセプターによる骨ホメオスターシスの制御

    高井 俊行, 乾 匡範, 藤村 紫音, 遠藤 章太, 中村 晃

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集 81回・31回 3S6-4 2008/11

    Publisher: (公社)日本生化学会

  101. Essential Role of DAP12 Signaling in Macrophage Programming into a Fusion-Competent State Peer-reviewed

    Laura Helming, Elena Tomasello, Themis R. Kyriakides, Fernando O. Martinez, Toshiyuki Takai, Siamon Gordon, Eric Vivier

    SCIENCE SIGNALING 1 (43) ra11-ra11 2008/10

    DOI: 10.1126/scisignal.1159665  

    ISSN: 1937-9145

  102. Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development Peer-reviewed

    Yu Mori, Sukenao Tsuji, Masanori Inui, Yuzuru Sakamoto, Shota Endo, Yumi Ito, Shion Fujimura, Takako Koga, Akira Nakamura, Hiroshi Takayanagi, Eiji Itoi, Toshiyuki Takai

    Journal of Immunology 181 (7) 4742-4751 2008/10/01

    DOI: 10.4049/jimmunol.181.7.4742  

    ISSN: 0022-1767

    eISSN: 1550-6606

  103. A novel regulatory role of gp49B on dendritic cells in T-cell priming Peer-reviewed

    Satoshi Kasai, Masanori Inui, Kyohei Nakamura, Yuta Kakizaki, Shota Endo, Akira Nakamura, Sadayoshi Ito, Toshiyuki Takai

    EUROPEAN JOURNAL OF IMMUNOLOGY 38 (9) 2426-2437 2008/09

    DOI: 10.1002/eji.200737550  

    ISSN: 0014-2980

  104. PIR-B-deficient mice are susceptible to Salmonella infection Peer-reviewed

    Ikuko Torii, Satoshi Oka, Muneki Hotomi, William H. Benjamin, Toshiyuki Takai, John F. Kearney, David F. Briles, Hiromi Kubagawa

    JOURNAL OF IMMUNOLOGY 181 (6) 4229-4239 2008/09

    DOI: 10.4049/jimmunol.181.6.4229  

    ISSN: 0022-1767

  105. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells Peer-reviewed

    Shota Endo, Yuzuru Sakamoto, Eiji Kobayashi, Akira Nakamura, Toshiyuki Takai

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 105 (38) 14515-14520 2008/09

    DOI: 10.1073/pnas.0804571105  

    ISSN: 0027-8424

  106. Comparison of 30 immunity-related genes from the common marmoset with orthologues from human and muse Peer-reviewed

    Kazuyoshi Kohu, Eiji Yamabe, Ayako Matsuzawa, Daisuke Onda, Hiroshi Suemizu, Erika Sasaki, Yoshikuni Tanioka, Hideo Yagita, Daisuke Suzuki, Yoshie Kametani, Toshiyuki Takai, Atsushi Toyoda, Sonoko Habu, Masanobu Satake

    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE 215 (2) 167-180 2008/06

    DOI: 10.1620/tjem.215.167  

    ISSN: 0040-8727

    eISSN: 1349-3329

  107. イムノロジーからリウマトロジーへのメッセージ Fc受容体と自己免疫

    高井 俊行, 井上 吉浩, 海部 知則, 遠藤 章太, 中村 晃

    日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集 52回・17回 192-192 2008/04

    Publisher: (一社)日本リウマチ学会

  108. Fc gamma receptor regulation of Citrobacter rodentium infection Peer-reviewed

    Atsuhiro Masuda, Masaru Yoshida, Hideyuki Shiomi, Satoshi Ikezawa, Tetsuya Takagawa, Hiroshi Tanaka, Ryo Chinzei, Tsukasa Ishida, Yoshinori Morita, Hiromu Kutsumi, Hideto Inokuchi, Shuo Wang, Kanna Kobayashi, Shigeto Mizuno, Akira Nakamura, Toshiyuki Takai, Richard S. Blumberg, Takeshi Azuma

    INFECTION AND IMMUNITY 76 (4) 1728-1737 2008/04

    DOI: 10.1128/IAI.01493-07  

    ISSN: 0019-9567

  109. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Peer-reviewed

    Masahiro Shinohara, Takako Koga, Kazuo Okamoto, Shinya Sakaguchi, Kimiko Arai, Hisataka Yasuda, Toshiyuki Takai, Tatsuhiko Kodama, Tomohiro Morio, Raif S Geha, Daisuke Kitamura, Tomohiro Kurosaki, Wilfried Ellmeier, Hiroshi Takayanagi

    Cell 132 (5) 794-806 2008/03

    DOI: 10.1016/j.cell.2007.12.037  

    ISSN: 1097-4172

  110. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals Peer-reviewed

    Masahiro Shinohara, Takako Koga, Kazuo Okamoto, Shinya Sakaguchi, Kimiko Arai, Hisataka Yasuda, Toshiyuki Takai, Tatsuhiko Kodama, Tomohiro Morio, Raif S. Geha, Daisuke Kitamura, Tomohiro Kurosaki, Wilfried Ellmeier, Hiroshi Takayanagi

    CELL 132 (5) 794-806 2008/03

    DOI: 10.1016/j.cell.2007.12.037  

    ISSN: 0092-8674

  111. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. International-journal Peer-reviewed

    Yoshinori Yamanishi, Jiro Kitaura, Kumi Izawa, Takayuki Matsuoka, Toshihiko Oki, Yang Lu, Fumi Shibata, Satoshi Yamazaki, Hidetoshi Kumagai, Hideaki Nakajima, Mari Maeda-Yamamoto, Victor L J Tybulewicz, Toshiyuki Takai, Toshio Kitamura

    Blood 111 (2) 688-98 2008/01/15

    DOI: 10.1182/blood-2007-04-085787  

    ISSN: 0006-4971

  112. 【骨と免疫】免疫グロブリン様受容体と骨代謝

    高井 俊行, 乾 匡範, 森 優

    腎と骨代謝 21 (1) 43-50 2008/01

    Publisher: (株)日本メディカルセンター

    ISSN: 0914-5265

    eISSN: 2433-2496

  113. Fc Receptor Targeting in the Treatment of Allergy, Autoimmune Diseases and Cancer Peer-reviewed

    Akira Nakamura, Tomohiro Kubo, Toshiyuki Takai

    MULTICHAIN IMMUNE RECOGNITION RECEPTOR SIGNALING: FROM SPATIOTEMPORAL ORGANIZATION TO HUMAN DISEASE 640 220-233 2008

    DOI: 10.1007/978-0-387-09789-3_17  

    ISSN: 0065-2598

  114. Regulation of immune disorders by PIR-B, a critical inhibitory Ig-like receptor for MHC class I molecules Peer-reviewed

    Toshiyuki Takai, Akira Nakamura, Shota Endo, Tomohiro Kubo

    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN 128 41-42 2008

    ISSN: 0031-6903

  115. Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse Peer-reviewed

    Emanuele Giurisato, Marina Cella, Toshiyuki Takai, Tomohiro Kurosaki, Yungfeng Feng, Gregory D. Longmore, Marco Colonna, Andrey S. Shaw

    MOLECULAR AND CELLULAR BIOLOGY 27 (24) 8583-8599 2007/12

    DOI: 10.1128/MCB.01477-07  

    ISSN: 0270-7306

  116. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-Independent manner Peer-reviewed

    Toshiyuki Kojima, Kazushige Obata, Kaori Mukai, Shingo Sato, Toshiyuki Takai, Yoshiyuki Minegishi, Hajime Karasuyama

    JOURNAL OF IMMUNOLOGY 179 (10) 7093-7100 2007/11

    DOI: 10.4049/jimmunol.179.10.7093  

    ISSN: 0022-1767

  117. PIR-B-deficient mice are susceptible to salmonella infection Peer-reviewed

    Satoshi Oka, Ikuko Torii, Muneki Hotomi, William H. Benjamin, Toshiyuki Takai, John F. Kearney, David E. Briles, Hiromi Kubagawa

    BLOOD 110 (11) 714A-714A 2007/11

    ISSN: 0006-4971

  118. Critical negative regulation of immunopathology by signaling intracellular infection Peer-reviewed

    Maziar Divangahi, Tony Yang, Kapilan Kugathasan, Sarah McCormick, Shunsuke Takenaka, Gordon Gaschler, Ali Ashkar, Martin Stampfli, Jack Gauldie, Jonathan Bramson, Toshiyuki Takai, Earl Brown, Wayne M. Yokoyama, Naoko Aoki, Zhou Xing

    JOURNAL OF IMMUNOLOGY 179 (6) 4015-4026 2007/09

    DOI: 10.4049/jimmunol.179.6.4015  

    ISSN: 0022-1767

  119. Pathological role of osteoclast costimulation in arthritis-induced bone loss Peer-reviewed

    Sae Ochi, Masahiro Shinohara, Kojiro Sato, Hans-Juergen Gober, Takako Koga, Tatsuhiko Kodama, Toshiyuki Takai, Nobuyuki Miyasaka, Hiroshi Takayanagi

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 104 (27) 11394-11399 2007/07

    DOI: 10.1073/pnas.0701971104  

    ISSN: 0027-8424

  120. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice Peer-reviewed

    Yoshihiro Inoue, Tomonori Kaifu, Akiko Sugahara-Tobinai, Akira Nakamura, Jun-Ichi Miyazaki, Toshiyuki Takai

    JOURNAL OF IMMUNOLOGY 179 (2) 764-774 2007/07

    DOI: 10.4049/jimmunol.179.2.764  

    ISSN: 0022-1767

  121. Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. International-journal Peer-reviewed

    Kumi Izawa, Jiro Kitaura, Yoshinori Yamanishi, Takayuki Matsuoka, Toshihiko Oki, Fumi Shibata, Hidetoshi Kumagai, Hideaki Nakajima, Mari Maeda-Yamamoto, Jeffrey P Hauchins, Victor L J Tybulewicz, Toshiyuki Takai, Toshio Kitamura

    The Journal of biological chemistry 282 (25) 17997-8008 2007/06/22

    DOI: 10.1074/jbc.M701100200  

    ISSN: 0021-9258

  122. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors Peer-reviewed

    Hiromitsu Hara, Chitose Ishihara, Arata Takeuchi, Takayuki Imanishi, Liquan Xue, Stephan W. Morris, Masanori Inui, Toshiyuki Takai, Akira Shibuya, Shinobu Saijo, Yoichiro Iwakura, Naohito Ohno, Haruhiko Koseki, Hiroki Yoshida, Josef M. Penninger, Takashi Saito

    NATURE IMMUNOLOGY 8 (6) 619-629 2007/06

    DOI: 10.1038/ni1466  

    ISSN: 1529-2908

  123. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production Peer-reviewed

    Masafumi Nakayama, David M. Underhill, Timothy W. Petersen, Bin Li, Toshio Kitamura, Toshiyuki Takai, Alan Aderem

    JOURNAL OF IMMUNOLOGY 178 (7) 4250-4259 2007/04

    DOI: 10.4049/jimmunol.178.7.4250  

    ISSN: 0022-1767

  124. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress Peer-reviewed

    Lianqin Li, Wataru Shoji, Hirohisa Takano, Noriko Nishimura, Yasunobu Aoki, Ryoya Takahashi, Sataro Goto, Tomonori Kaifu, Toshiyuki Takai, Masuo Obinata

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 355 (3) 715-721 2007/04

    DOI: 10.1016/j.bbrc.2007.02.022  

    ISSN: 0006-291X

  125. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation Peer-reviewed

    Ai Masuda, Akira Nakamura, Tsutomu Maeda, Yuzuru Sakamoto, Toshiyuki Takai

    JOURNAL OF EXPERIMENTAL MEDICINE 204 (4) 907-920 2007/04

    DOI: 10.1084/jem.20060631  

    ISSN: 0022-1007

  126. Susceptibility of PIR-B deficient mice to Salmonella infection Peer-reviewed

    Ikuko Torii, Satoshi Oka, Muneki Hotomi, William H. Benjamin, John F. Kearney, Toshiyuki Takai, David E. Briles, Hiromi Kubagawa

    JOURNAL OF IMMUNOLOGY 178 2007/04

    ISSN: 0022-1767

    eISSN: 1550-6606

  127. Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcR gamma chain on peritoneal macrophages Peer-reviewed

    Chigusa Nakahashi, Satoko Tahara-Hanaoka, Naoya Totsuka, Yasushi Okoshi, Toshiyuki Takai, Nobuhiro Ohkohchi, Shin-ichiro Honda, Kazuko Shibuya, Akira Shibuya

    JOURNAL OF IMMUNOLOGY 178 (2) 765-770 2007/01

    DOI: 10.4049/jimmunol.178.2.765  

    ISSN: 0022-1767

  128. Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation Peer-reviewed

    Kenichi Kitamura, Katsuyuki Takeda, Toshiyuki Koya, Nobuaki Miyahara, Taku Kodama, Azzeddine Dakhama, Toshiyuki Takai, Atsushi Hirano, Mitsune Tanimoto, Mine Harada, Erwin W. Gelfand

    JOURNAL OF IMMUNOLOGY 178 (1) 480-488 2007/01

    DOI: 10.4049/jimmunol.178.1.480  

    ISSN: 0022-1767

  129. 【シグナル伝達病を知る その分子機序解明から新たな治療戦略まで】基礎編 免疫系のシグナル伝達 FcRを介するシグナル伝達

    中村 晃, 高井 俊行

    遺伝子医学MOOK (6) 51-54 2006/12

    Publisher: (株)メディカルドゥ

    ISSN: 1349-2527

  130. Fc receptors: their diverse functions in immunity and immune disorders Peer-reviewed

    Toshiyuki Takai

    SPRINGER SEMINARS IN IMMUNOPATHOLOGY 28 (4) 303-304 2006/12

    DOI: 10.1007/s00281-006-0055-y  

    ISSN: 0344-4325

  131. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway Peer-reviewed

    Kojiro Sato, Ayako Suematsu, Tomoki Nakashima, Sayaka Takemoto-Kimura, Kazuhiro Aoki, Yasuyuki Morishita, Hiroshi Asahara, Keiichi Ohya, Akira Yamaguchi, Toshiyuki Takai, Tatsuhiko Kodama, Talal A. Chatila, Haruhiko Bito, Hiroshi Takayanagi

    NATURE MEDICINE 12 (12) 1410-1416 2006/12

    DOI: 10.1038/nm1515  

    ISSN: 1078-8956

  132. 関節リウマチ〜基礎解析からの新知見 炎症性骨破壊における免疫受容体と新たな治療戦略の可能性について

    越智 小枝, 篠原 正浩, 佐藤 浩二郎, 高井 俊行, 宮坂 信之, 高柳 広

    日本免疫学会総会・学術集会記録 36 284-284 2006/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  133. Establishment and functional characterization of novel natural killer cell lines derived from a temperature-sensitive SV40 large T antigen transgenic mouse Peer-reviewed

    Satoru Iizuka, Tomonori Kaifu, Akira Nakamura, Masuo Obinata, Toshiyuki Takai

    JOURNAL OF BIOCHEMISTRY 140 (2) 255-265 2006/08

    DOI: 10.1093/jb/mvj153  

    ISSN: 0021-924X

  134. Novel mast cell lines with enhanced proliferative and degranulative abilities established from temperature-sensitive SV40 large T antigen transgenic mice Peer-reviewed

    Masahiko Kanehira, Tomonori Kaifu, Kozue Maya, Mitsuji Kaji, Akira Nakamura, Masuo Obinata, Toshiyuki Takai

    JOURNAL OF BIOCHEMISTRY 140 (2) 211-220 2006/08

    DOI: 10.1093/jb/mvj140  

    ISSN: 0021-924X

  135. 【炎症と破骨細胞】 破骨細胞を制御するレセプター群 Invited

    森優, 乾匡範, 高井俊行

    炎症と免疫 14 (5) 615-619 2006/08

    Publisher:

    ISSN: 0918-8371

  136. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics Peer-reviewed

    Daniel B. Graham, Marina Cella, Emanuele Giurisato, Keiko Fujikawa, Ana V. Miletic, Tracie Kloeppel, Karry Brim, Toshiyuki Takai, Andrey S. Shaw, Marco Colonna, Wojciech Swat

    JOURNAL OF IMMUNOLOGY 177 (4) 2349-2355 2006/08

    DOI: 10.4049/jimmunol.177.4.2349  

    ISSN: 0022-1767

  137. Fcγレセプターを介した免疫制御 Invited

    窪智宏, 中村晃, 高井俊行

    臨床免疫・アレルギー科 46 (1) 106-111 2006/07

    Publisher:

    ISSN: 1881-1930

  138. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis Peer-reviewed

    N Takegahara, H Takamatsu, T Toyofuku, T Tsujimura, T Okuno, K Yukawa, M Mizui, M Yamamoto, DVR Prasad, K Suzuki, M Ishii, K Terai, M Moriya, Y Nakatsuji, S Sakoda, S Sato, S Akira, K Takeda, M Inui, T Takai, M Ikawa, M Okabe, A Kumanogoh, H Kikutani

    NATURE CELL BIOLOGY 8 (6) 615-622 2006/06

    DOI: 10.1038/ncb1416  

    ISSN: 1465-7392

    eISSN: 1476-4679

  139. 【分子メカニズムから解き明かす疾患のサイエンス】 免疫(アレルギー)疾患 免疫応答とアレルギー 抑制型受容体によるアレルギー制御 Invited

    中村晃, 高井俊行

    実験医学 24 (10) 1535-1539 2006/06

    Publisher:

    ISSN: 0288-5514

  140. A critical role of Fc gamma receptors in the development of autoimmune type 1 diabetes of NOD mice Peer-reviewed

    Yoshihiro Inoue, Akira Nakamura, Toshiyuki Takai

    JOURNAL OF IMMUNOLOGY 176 S132-S132 2006/04

    ISSN: 0022-1767

  141. Constitutive binding of PIR-B to MHC class I in cis regulates mast cell activation and anaphylaxis Peer-reviewed

    Akira Nakamura, Toshiyuki Takai

    JOURNAL OF IMMUNOLOGY 176 S321-S321 2006/04

    ISSN: 0022-1767

  142. 【加齢の生化学】 破骨細胞の分化制御機構と骨疾患 Invited

    乾匡範, 森優, 高井俊行

    生化学 78 (3) 250-256 2006/03

    Publisher:

    ISSN: 0037-1017

  143. Siglec-H is an IPC-specific receptor that modulates type IIFN secretion through DAP12 Peer-reviewed

    AL Blasius, M Cella, J Maldonado, T Takai, M Colonna

    BLOOD 107 (6) 2474-2476 2006/03

    DOI: 10.1182/blood-2005-09-3746  

    ISSN: 0006-4971

  144. 目でみるバイオサイエンス ガンマグロブリン大量療法の作用機序 Invited

    窪智宏, 中村晃, 高井俊行

    内科 97 (1) 155-158 2006/01

    Publisher:

    ISSN: 0022-1961

  145. A role for high molecular weight mast cell-derived proteoglycans in mucosal immunity against gastrointestinal nematode parasites. Peer-reviewed

    Denchris Onah, Fukumi Nakamura-Uchiyama, Masao Ono, Toshiyuki Takai, Yukifumi Nawa

    CLINICAL IMMUNOLOGY 119 S175-S175 2006

    DOI: 10.1016/j.clim.2006.04.472  

    ISSN: 1521-6616

  146. 加齢による免疫機構の変化と抑制性レセプター Invited

    中村晃, 高井俊行

    生体の科学 56 (6) 639-645 2005/12

    DOI: 10.11477/mf.2425100424  

  147. Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b(-/-)Pdcd1(-/-) mice Peer-reviewed

    T Okazaki, Y Otaka, J Wang, H Hiai, T Takai, JV Ravetch, T Honjo

    JOURNAL OF EXPERIMENTAL MEDICINE 202 (12) 1643-1648 2005/12

    DOI: 10.1084/jem.20051984  

    ISSN: 0022-1007

  148. イムノグロブリン様レセプターによる免疫制御 Invited

    高井俊行

    Medical Science Digest 31 (12) 458-459 2005/11

  149. Allergy and autoimmunity mediated by IgG and Fcγ receptors Peer-reviewed

    Toshiyuki Takai

    Japanese Journal of Allergology 54 (10) 1183-1189 2005/10

    ISSN: 0021-4884 1347-7935

  150. Pathways participating in activation of mouse uterine natural killer cells during pregnancy Peer-reviewed

    XM Xie, H He, M Colonna, T Seya, T Takai, BA Croy

    BIOLOGY OF REPRODUCTION 73 (3) 510-518 2005/09

    DOI: 10.1095/biolreprod.104.033951  

    ISSN: 0006-3363

  151. 【関節リウマチの最新動向 骨免疫学的視点からの病因論・治療学】 破骨細胞分化機構 IgLRによる破骨細胞の分化制御 Invited

    高井俊行, 乾匡範, 井上和也, 森優

    日本臨床 63 (9) 1562-1568 2005/09

    Publisher:

    ISSN: 0047-1852

  152. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis Peer-reviewed

    IR Turnbull, JE McDunn, T Takai, RR Townsend, JP Cobb, M Colonna

    JOURNAL OF EXPERIMENTAL MEDICINE 202 (3) 363-369 2005/08

    DOI: 10.1084/jem.20050986  

    ISSN: 0022-1007

  153. イムノグロブリン様受容体による免疫制御と免疫疾患に関する研究 Invited

    高井俊行

    東北医学雑誌 117 (1) 115-116 2005/06

  154. 【免疫と疾患(後篇) 自己免疫と疾患】 自己免疫疾患の基礎 Fc受容体の異常 Invited

    高井俊行

    最新医学 60 (6月増刊) 1322-1332 2005/06

  155. 【自己免疫疾患研究の最先端】 病態 免疫グロブリン受容体と自己免疫疾患 Invited

    高井俊行

    医学のあゆみ 213 (1) 52-58 2005/04

  156. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B Peer-reviewed

    H Zhang, FY Meng, CL Chu, T Takai, CA Lowell

    IMMUNITY 22 (2) 235-246 2005/02

    DOI: 10.1016/j.immuni.2005.01.004  

    ISSN: 1074-7613

  157. GVH病におけるpaired immunoglobulin-like receptor B(PIR-B)の役割 Invited

    小林栄治, 中村晃, 高井俊行

    臨床免疫 43 (2) 215-218 2005/02

    Publisher:

    ISSN: 0386-9695

  158. 呼吸器系の生物学 マスト細胞とFcレセプター Invited

    遠藤章太, 中村晃, 高井俊行

    Annual Review呼吸器 2005 26-32 2005/01

  159. Role of Fcγ receptors in immune regulation and diseases Invited

    Toshiyuki Takai

    Japanese Journal of Clinical Immunology 28 (5) 318-326 2005

    DOI: 10.2177/jsci.28.318  

    ISSN: 1349-7413 0911-4300

  160. 【免疫2005】 病気と免疫 自己免疫の治療ターゲットとしてのFcγR II B Invited

    高井俊行, 中村晃

    Molecular Medicine 41 (臨増) 385-392 2004/12

  161. 【関節炎の動物モデル】 Fcレセプターと関節炎 Invited

    後藤義幸, 中村晃, 高井俊行

    分子リウマチ 1 (4) 302-308 2004/11

  162. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling Peer-reviewed

    S Pereira, H Zhang, T Takai, CA Lowell

    JOURNAL OF IMMUNOLOGY 173 (9) 5757-5765 2004/11

    ISSN: 0022-1767

  163. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-Antigen gene Peer-reviewed

    S Ebihara, S Endo, K Ito, Y Ito, Y Ito, K Akiyama, M Obinata, T Takai

    JOURNAL OF BIOCHEMISTRY 136 (3) 321-328 2004/09

    DOI: 10.1093/jb/mvh120  

    ISSN: 0021-924X

  164. ピアによるGVHDの制御 Invited

    高井俊行

    医学のあゆみ 210 (9) 776-777 2004/08

  165. Exacerbated graft-versus-host disease in Pirb(-/-) mice Peer-reviewed

    A Nakamura, E Kobayashi, T Takai

    NATURE IMMUNOLOGY 5 (6) 623-629 2004/06

    DOI: 10.1038/ni1074  

    ISSN: 1529-2908

  166. 抑制性免疫グロブリン受容体FcγRIIBと自己免疫疾患 Invited

    高井俊行, 矢島佳央里, 後藤義幸, 中村晃

    小児感染免疫 16 (1) 69-77 2004/04

    ISSN: 0917-4931

  167. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Peer-reviewed

    T Koga, M Inui, K Inoue, S Kim, A Suematsu, E Kobayashi, T Iwata, H Ohnishi, T Matozaki, T Kodama, T Taniguchi, H Takayanagi, T Takai

    NATURE 428 (6984) 758-763 2004/04

    DOI: 10.1038/nature02444  

    ISSN: 0028-0836

  168. SLPIノックアウトマウス Invited

    中村晃, 高井俊行, 貫和敏博

    分子呼吸器病 8 (2) 140-144 2004/03

    Publisher:

    ISSN: 1342-436X

  169. 【骨免疫学の世界 骨疾患と免疫異常】 免疫グロブリン様受容体と骨疾患 Invited

    乾匡範, 井上和也, 高井俊行

    医学のあゆみ 208 (11) 910-915 2004/03

    Publisher:

    ISSN: 0039-2359

  170. Roles of FcγRIIB in Nasal Eosinophilia and IgE Production in Murine Allergic Rhinitis Peer-reviewed

    Tohru Watanabe, Mitsuhiro Okano, Hisashi Hattori, Tadashi Yoshino, Nobuaki Ohno, Nobuo Ohta, Yuji Sugata, Yorihisa Orita, Toshiyuki Takai, Kazunori Nishizaki

    American Journal of Respiratory and Critical Care Medicine 169 (1) 105-112 2004/01/01

    DOI: 10.1164/rccm.200302-239oc  

    ISSN: 0003-0805

  171. Immunoglobulin-like receptors in myeloid cells: The functional regulation and the involvement in disorders Invited Peer-reviewed

    Sakamoto Y, Kaifu T, Uehori J, Nakamura A, Takai T

    Recent Research Developments in Immunology (6) 355-371 2004

  172. Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses Peer-reviewed

    A Yamaguchi, K Katsuyama, K Nagahama, T Takai, Aoki, I, S Yamanaka

    JOURNAL OF CLINICAL INVESTIGATION 113 (2) 200-208 2004/01

    DOI: 10.1172/JCI200419639  

    ISSN: 0021-9738

  173. 【アレルギーに関する新知見】 I型アレルギーにおけるPIR-Bの役割 Invited

    増田愛, 前田努, 中村晃, 高井俊行

    臨床免疫 41 (1) 43-48 2004/01

  174. Roles of Fc gamma RIIB in nasal eosinophilia and IgE production in murine allergic rhinitis Peer-reviewed

    T Watanabe, M Okano, H Hattori, T Yoshino, N Ohno, N Ohta, Y Sugata, Y Orita, T Takai, K Nishizaki

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 169 (1) 105-112 2004/01

    DOI: 10.1164/rccm.200302-2390C  

    ISSN: 1073-449X

  175. 【免疫2004】 抗原認識 PIR-Bと樹状細胞の成熟 Invited

    中村晃, 高井俊行

    Molecular Medicine 40 (臨増) 65-72 2003/12

    Publisher:

    ISSN: 0918-6557

  176. 炎症反応の制御とプロテアーゼ阻害因子 Invited

    中村晃, 高井俊行, 貫和敏博

    臨床免疫 40 (5) 576-579 2003/11

    Publisher:

    ISSN: 0386-9695

  177. 【アレルギーの動物モデル】 PIR-B欠損マウス Invited

    増田愛, 前田努, 中村晃, 高井俊行

    アレルギー科 16 (4) 295-300 2003/10

  178. Accelerated antigen presentation and elicitation of humoral response in vivo by Fc gamma RIIB- and Fc gamma RI/III-mediated immune complex uptake Peer-reviewed

    A Yada, S Ebihara, K Matsumura, S Endo, T Maeda, A Nakamura, K Akiyama, S Aiba, T Takai

    CELLULAR IMMUNOLOGY 225 (1) 21-32 2003/09

    DOI: 10.1016/j.cellimm.2003.09.008  

    ISSN: 0008-8749

  179. 【NK・NKT細胞をめぐって】 活性化アダプター分子DAP12の機能 Invited

    乾匡範, 高井俊行

    臨床免疫 40 (3) 309-313 2003/09

    Publisher:

    ISSN: 0386-9695

  180. Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation Peer-reviewed

    J Nakahara, K Tan-Takeuchi, C Seiwa, M Gotoh, T Kaifu, A Ujike, M Inui, T Yagi, M Ogawa, S Aiso, T Takai, H Asou

    DEVELOPMENTAL CELL 4 (6) 841-852 2003/06

    DOI: 10.1016/S1534-5807(03)00155-2  

    ISSN: 1534-5807

  181. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in Fc gamma RIIB-deficient mice Peer-reviewed

    A Nakamura, T Nukiwa, T Takai

    JOURNAL OF AUTOIMMUNITY 20 (3) 227-236 2003/05

    DOI: 10.1016/S0896-8411(03)00034-9  

    ISSN: 0896-8411

  182. 【B細胞レセプターシグナルを修飾する表面分子】 PIR-BによるB細胞の制御機構 Invited

    中村晃, 高井俊行

    臨床免疫 39 (5) 519-524 2003/05

  183. Fc gamma RIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease Peer-reviewed

    K Yajima, A Nakamura, A Sugahara, T Takai

    EUROPEAN JOURNAL OF IMMUNOLOGY 33 (4) 1020-1029 2003/04

    DOI: 10.1002/eji.200323794  

    ISSN: 0014-2980

  184. Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors Peer-reviewed

    C Taube, A Dakhama, YH Rha, K Takeda, A Joetham, JW Park, A Balhorn, T Takai, KR Poch, JA Nick, EW Gelfand

    JOURNAL OF IMMUNOLOGY 170 (8) 4301-4309 2003/04

    ISSN: 0022-1767

  185. Targeting of platelet integrin alpha(IIb)beta(3) determines systemic reaction and bleeding in murine thrombocytopenia regulated by activating and inhibitory Fc gamma R Peer-reviewed

    B Nieswandt, W Bergmeier, Schulte, V, T Takai, U Baumann, RE Schmidt, H Zirngibl, W Bloch, JE Gessner

    INTERNATIONAL IMMUNOLOGY 15 (3) 341-349 2003/03

    DOI: 10.1093/intimm/dxg033  

    ISSN: 0953-8178

  186. アレルギー反応におけるPaired Immunoglobulin-like Receptor(PIR)-Bの役割 Invited

    増田愛, 中村晃, 高井俊行

    アレルギー科 15 (3) 228-232 2003/03

  187. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice Peer-reviewed

    A Nakamura, Y Mori, K Hagiwara, T Suzuki, T Sakakibara, T Kikuchi, T Igarashi, M Ebina, J Miyazaki, T Takai, T Nukiwa, T Nukiwa

    JOURNAL OF EXPERIMENTAL MEDICINE 197 (5) 669-674 2003/03

    DOI: 10.1084/jem.20021824  

    ISSN: 0022-1007

  188. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice Peer-reviewed

    T Kaifu, J Nakahara, M Inui, K Mishima, T Momiyama, M Kaji, A Sugahara, H Koito, A Ujike-Asai, A Nakamura, K Kanazawa, K Tan-Takeuchi, K Iwasaki, WM Yokoyama, A Kudo, M Fujiwara, H Asou, T Takai

    JOURNAL OF CLINICAL INVESTIGATION 111 (3) 323-332 2003/02

    DOI: 10.1172/JCI200316923  

    ISSN: 0021-9738

  189. 【神経疾患と分子病態モデルをめぐるトピックス】 髄鞘障害 DAP12欠損とオリゴデンドロサイト発達障害 Invited

    高井俊行

    Clinical Neuroscience 21 (2) 162-164 2003/02

  190. Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells Peer-reviewed

    K Akiyama, S Ebihara, A Yada, K Matsumura, S Aiba, T Nukiwa, T Takai

    JOURNAL OF IMMUNOLOGY 170 (4) 1641-1648 2003/02

    DOI: 10.4049/jimmunol.170.4.1641  

    ISSN: 0022-1767

  191. 接着,共刺激分子,トラフィッキング,ホーミング Ig-like receptor分子群による免疫細胞の制御

    高井俊行, 中村晃

    Annual Review免疫 2003 142-150 2002/12

  192. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses Peer-reviewed

    Y Xiu, K Nakamura, M Abe, N Li, XS Wen, Y Jiang, DQ Zhang, H Tsurui, S Matsuoka, Y Hamano, H Fujii, M Ono, T Takai, T Shimokawa, C Ra, T Shirai, S Hirose

    JOURNAL OF IMMUNOLOGY 169 (8) 4340-4346 2002/10

    ISSN: 0022-1767

  193. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis Peer-reviewed

    Y Makabe-Kobayashi, Y Hori, T Adachi, S Ishigaki-Suzuki, Y Kikuchi, Y Kagaya, K Shirato, A Nagy, A Ujike, T Takai, T Watanabe, H Ohtsu

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 110 (2) 298-303 2002/08

    DOI: 10.1067/mai.2002.125977  

    ISSN: 0091-6749

  194. Roles of Fc receptors in autoimmunity Peer-reviewed

    T Takai

    NATURE REVIEWS IMMUNOLOGY 2 (8) 580-592 2002/08

    DOI: 10.1038/nri856  

    ISSN: 1474-1733

  195. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B-/- mice Peer-reviewed

    A Ujike, K Takeda, A Nakamura, S Ebihara, K Akiyama, T Takai

    NATURE IMMUNOLOGY 3 (6) 542-548 2002/06

    DOI: 10.1038/ni801  

    ISSN: 1529-2908

  196. 207 FcγRIIBを介する鼻アレルギー感作の制御

    渡辺 徹, 岡野 光博, 服部 央, 吉野 正, 高井 俊行, 西崎 和則

    アレルギー 51 (9) 958-958 2002

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.51.958_3  

  197. The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB Peer-reviewed

    Kato, I, T Takai, A Kudo

    JOURNAL OF IMMUNOLOGY 168 (2) 629-634 2002/01

    ISSN: 0022-1767

  198. The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB Peer-reviewed

    Kato, I, T Takai, A Kudo

    JOURNAL OF IMMUNOLOGY 168 (2) 629-634 2002/01

    ISSN: 0022-1767

  199. Role of Fc receptor in The Development of Collagen-Induced Arthritis Peer-reviewed

    Akira Nakamura, Kaori Yajima, Toshiyuki Takai

    Japanese Journal of Clinical Immunology 25 (1) 56-61 2002

    DOI: 10.2177/jsci.25.56  

    ISSN: 1349-7413 0911-4300

  200. FcγRIIB欠損(FcgRIIB-/-)及びFcεRIγ-chain(FcRγ-/-)欠損マウス由来マクロファージにおけるプロスタグランジン合成酵素の発現

    湯浅 貴恵, 横山 知永子, 後藤 淳子, 内藤 久仁子, 高井 俊行, 田辺 忠

    生化学 73 (11) 1351-1351 2001/11

    Publisher: (公社)日本生化学会

    ISSN: 0037-1017

    eISSN: 2189-0544

  201. Drastic up-regulation of Fcepsilonri on mast cells is induced by IgE binding through stabilization and accumulation of Fcepsilonri on the cell surface. Peer-reviewed

    S Kubo, K Matsuoka, C Taya, F Kitamura, T Takai, H Yonekawa, H Karasuyama

    The Journal of Immunology 167 (6) 3427-3434 2001/10

  202. Lyn is essential for Fcγ receptor III-mediated systemic anaphylaxis but not for the arthus reaction Peer-reviewed

    Takae Yuasa, Masao Ono, Takeshi Watanabe, Toshiyuki Takai

    Journal of Experimental Medicine 193 (5) 563-571 2001/03/05

    DOI: 10.1084/jem.193.5.563  

    ISSN: 0022-1007

  203. FcRとアレルギー(免疫応答の制御機構)

    高井 俊行

    アレルギー 50 (9) 885-885 2001

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.50.885_2  

  204. 318 マウス喘息モデルにおけるFcγRIIIの役割に関する検討

    平野 淳, 金廣 有彦, 北村 賢一, 谷本 安, 安原 信明, 片岡 幹男, 谷本 光音, 岡田 千春, 高橋 清, 高井 俊行, 武田 勝行, Gelfand EW

    アレルギー 50 (9) 978-978 2001

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.50.978_2  

  205. P57W5-3 Defective protection of FcRγ-knockout mice against Strongyloides venezuelensis infection at the intestinal phase is due to the failure of mucosal mast cells to release sulphated proteoglycans

    ONAH N Denis, NAKAMURA Fukumi, ISHIWATA Kenji, ONO Masao, TAKAI Toshiyuki, NAWA Yukifumi

    Medical Entomology and Zoology 52 92-92 2001

    Publisher: The Japan Society of Medical Entomology and Zoology

    DOI: 10.7601/mez.52.92_1  

  206. コラーゲン誘導関節炎におけるFcγレセプターの役割について

    中村 晃, 湯浅 貴恵, 氏家 あづさ, 小野 栄夫, 貫和 敏博, 高井 俊行

    日本免疫学会総会・学術集会記録 30 171-171 2000/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  207. Stimulatory function of gp49A, a murine Ig-like receptor, in rat basophilic leukemia cells Peer-reviewed

    Kwang Ho Lee, M. Ono, M. Inui, T. Yuasa, T. Takai

    Journal of Immunology 165 (9) 4970-4977 2000/11/01

    ISSN: 0022-1767

  208. 関節炎モデルの作製 FcγRIIB欠損DBA/1Jマウスにおける関節炎誘導について

    中村 晃, 湯浅 貴恵, 氏家 あづさ, 小野 栄夫, 貫和 敏博, 高井 俊行

    炎症 20 (4) 497-497 2000/07

    Publisher: (一社)日本炎症・再生医学会

    ISSN: 0389-4290

    eISSN: 1884-4006

  209. Signal Transduction and Role in Immune Responses for Inhibitory Fc Receptor

    ONO Masao, TAKAI Toshiyuki

    KAGAKU TO SEIBUTSU 38 (3) 154-160 2000/03/25

    Publisher: Japan Society for Bioscience, Biotechnology, and Agrochemistry

    DOI: 10.1271/kagakutoseibutsu1962.38.154  

    ISSN: 0453-073X

  210. Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. Peer-reviewed

    Nakamura A, Yuasa T, Ujike A, Ono M, Nukiwa T, Ravetch JV, Takai T

    The Journal of experimental medicine 191 (5) 899-906 2000/03

    DOI: 10.1084/jem.191.5.899  

    ISSN: 0022-1007

  211. アレルギー性疾患の発症機序とFcレセプター

    高井 俊行

    アレルギー 49 (9) 794-794 2000

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.49.794_2  

  212. 441 マウス喘息モデルにおける気道炎症に対するFcレセプターの役割

    北村 賢一, 金廣 有彦, 平野 淳, 武田 明子, 木村 五郎, 谷本 安, 片岡 幹男, 原田 実根, 高井 俊行, 武田 勝行, Erwin W.Gelfand

    アレルギー 49 (9) 1003-1003 2000

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.49.1003_1  

  213. Igファミリーレセプターによる細胞活性化とDAP12

    高井 俊行, 小野 栄夫, 乾 匡範, 石川 陽子

    臨床免疫 33 (1) 130-136 2000/01

    Publisher: (有)科学評論社

    ISSN: 0386-9695

  214. Interaction between galectin-3 and FcγRII induces down-regulation of IL-5 gene: Implication of the promoter sequence IL-SREIII Peer-reviewed

    Isabel Cortegano, Victoria Del Pozo, Blanca Cárdaba, Ignacio Arrieta, Soledad Gallardo, Marta Rojo, Esther Aceituno, Toshiyuki Takai, Sjef Verbeek, Pilar Palomino, Fu-Tong Liu, Carlos Lahoz

    Glycobiology 10 (3) 237-242 2000

    Publisher: Oxford University Press

    DOI: 10.1093/glycob/10.3.237  

    ISSN: 0959-6658

  215. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice Peer-reviewed

    Hisashi Wakayama, Yoshinori Hasegawa, Tsutomu Kawabe, Toru Hara, Seiichi Matsuo, Masashi Mizuno, Toshiyuki Takai, Hitoshi Kikutani, Kaoru Shimokata

    European Journal of Immunology 30 (4) 1182-1190 2000

    DOI: 10.1002/(SICI)1521-4141(200004)30:4<1182::AID-IMMU1182>3.0.CO;2-H  

    ISSN: 0014-2980

  216. IgEによるFcεRI発現上昇の機構とそれに伴うマスト細胞の短期記憶の形成

    久保秀一, 松岡邦枝, 多屋長治, 北村ふじ子, 高井俊行, 米川博通, 烏山一

    日本免疫学会総会・学術集会記録 30 41 2000

  217. Stimulatory function of paired immunoglobulin-like receptor-A in mast cell line by associating with subunits common to Fc receptors Peer-reviewed

    Masao Ono, Takae Yuasa, Chisei Ra, Toshiyuki Takai

    Journal of Biological Chemistry 274 (42) 30288-30296 1999/10/15

    DOI: 10.1074/jbc.274.42.30288  

    ISSN: 0021-9258

  218. FcγRIIB欠損マウスにおけるGoodpasture症候群モデルの作製

    中村 晃, 湯浅 貴恵, 氏家 あづさ, 小野 栄夫, 高井 俊行, 貫和 敏博

    加齢医学研究所雑誌 51 (1) 37-38 1999/10

    Publisher: 東北大学加齢医学研究所

    ISSN: 1340-3397

  219. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low- affinity Fc receptors for IgG Peer-reviewed

    Azusa Ujike, Yoko Ishikawa, Masao Ono, Takae Yuasa, Tadashi Yoshino, Manabu Fukumoto, Jeffrey V. Ravetch, Toshiyuki Takai

    Journal of Experimental Medicine 189 (10) 1573-1579 1999/05/17

    DOI: 10.1084/jem.189.10.1573  

    ISSN: 0022-1007

  220. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors Peer-reviewed

    Raphael Clynes, Jay S. Maizes, Rodolphe Guinamard, Masao Ono, Toshiyuki Takai, Jeffrey V. Ravetch

    Journal of Experimental Medicine 189 (1) 179-185 1999/01/04

    DOI: 10.1084/jem.189.1.179  

    ISSN: 0022-1007

  221. Deletion of Fcγ receptor IIB renders H-2b mice susceptible to collagen-induced arthritis Peer-reviewed

    Takae Yuasa, Satoshi Kubo, Tadashi Yoshino, Azusa Ujike, Kimio Matsumura, Masao Ono, Jeffrey V. Ravetch, Toshiyuki Takai

    Journal of Experimental Medicine 189 (1) 187-194 1999/01/04

    DOI: 10.1084/jem.189.1.187  

    ISSN: 0022-1007

  222. 108 マウス喘息モデルにおける抑制性レセプターFcγRIIbの役割

    北村 賢一, 武田 勝行, 武田 明子, 木村 五郎, 谷本 安, 片岡 幹男, 原田 実根, 高井 俊行, 金廣 有彦, Gelfand Eriwin W.

    アレルギー 48 (8) 971-971 1999

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.48.971_4  

  223. 107 Fcγ鎖欠損マウスを用いた喘息モデルの解析

    武田 勝行, 北村 賢一, 武田 明子, 木村 五郎, 谷本 安, 片岡 幹男, 金廣 有彦, Gelfand Erwin W., 高井 俊行, 原田 実根

    アレルギー 48 (8) 971-971 1999

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.48.971_3  

  224. 465 遺伝子欠損マウスを用いたFcγレセプターによる抗原提示機能の解析

    石川 陽子, 矢田 あゆみ, 松村 公男, 小野 栄夫, 相場 節也, 高井 俊行

    アレルギー 48 (8) 1061-1061 1999

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.48.1061_1  

  225. REGULATION OF ANAPHYLACTIC RESPONSES BY Fc RECEPTORS

    Takai Toshiyuki

    Japanese Journal of Allergology 48 (12) 1291-1295 1999

    Publisher: Japanese Society of Allergology

    DOI: 10.15036/arerugi.48.1291  

    ISSN: 0021-4884

  226. 4 Fcγレセプターによるアレルギーと自己免疫の制御 (15 アレルギーの動物モデル)

    高井 俊行

    アレルギー 48 (8) 926-926 1999

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.48.926_1  

  227. Fcレセプターとアレルギー

    高井 俊行

    アレルギー 48 (2) 181-181 1999

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.48.181_1  

  228. 【NK細胞をめぐって】NK活性とキラー抑制レセプター

    高井 俊行, 小野 栄夫, 乾 匡範

    臨床免疫 31 (1) 40-46 1999/01

    Publisher: (有)科学評論社

    ISSN: 0386-9695

  229. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells Peer-reviewed

    Yumi Yamashita, Masao Ono, Toshiyuki Takai

    Journal of Immunology 161 (8) 4042-4047 1998/10/15

    ISSN: 0022-1767

  230. Regulation of murine hypersensitive responses by Fc receptors

    TAKAI Toshiyuki, ONO Masao, UJIKE Azusa, YUASA Takae

    Allergol. Int. 47 (2) 75-83 1998/06/01

    Publisher: Japanese Society of Allergology

    DOI: 10.2332/allergolint.47.75  

    ISSN: 1323-8930

    More details Close

    Humoral and cellular immune responses communicate with each other via Fc receptors (FcR) expressed on various hematopoietic cells. Recent studies on several FcR knockout mice demonstrated pivotal roles of an IgG/FcγR system in the regulation of immune responses and the onset of hypersensitivity. The γ subunit of FcR is an essential component of the complex and is required for both receptor assembly and signal transduction. FcR γ chain-deficient mice have lost the functional expression of FcεRI, FcγRI, and FcγRIII and are unable to mount several types of hypersensitive reactions, including the skin Arthus reaction. In contrast, FcγRII-deficient mice exhibit augmented humoral immune responses and IgG-mediated anaphylaxis reactions. Thus, the regulatory system of murine hypersensitive responses involves both positive and negative signaling through FcR. In B cells, FcγRIIb modulates membrane Ig-induced Ca2+ mobilization by inhibiting Ca2+ influx through phosphorylation of its immunoreceptor tyrosine-based inhibition motif and recruitment of cytoplasmic phosphatases. Elucidation of the detailed mechanisms of negative regulatory signaling in the inflammatory effector cells by FcγRIIb as well as several groups of potent inhibitory molecules expressed on such cells should be valuable in the development of novel therapeutic procedures for allergic disorders.

  231. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal Peer-reviewed

    Akito Maeda, Mari Kurosaki, Masao Ono, Toshiyuki Takai, Tomohiro Kurosaki

    Journal of Experimental Medicine 187 (8) 1355-1360 1998/04

    DOI: 10.1084/jem.187.8.1355  

    ISSN: 0022-1007

  232. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5- phosphatase SHIP with gp49B1, and chromosomal assignment of the gene Peer-reviewed

    Asato Kuroiwa, Yumi Yamashita, Masanori Inui, Takae Yuasa, Masao Ono, Akira Nagabukuro, Yoichi Matsuda, Toshiyuki Takai

    Journal of Biological Chemistry 273 (2) 1070-1074 1998/01/09

    DOI: 10.1074/jbc.273.2.1070  

    ISSN: 0021-9258

  233. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family Peer-reviewed

    Yumi Yamashita, Daisuke Fukuta, Atsushi Tsuji, Akira Nagabukuro, Yoichi Matsuda, Yasuhiro Nishikawa, Yukiya Ohyama, Hitoshi Ohmori, Masao Ono, Toshiyuki Takai

    Journal of Biochemistry 123 (2) 358-368 1998

    Publisher: Oxford University Press

    DOI: 10.1093/oxfordjournals.jbchem.a021945  

    ISSN: 0021-924X

  234. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis Peer-reviewed

    Yusuke Suzuki, Isao Shirato, Ko Okumura, Jeffrey V. Ravetch, Toshiyuki Takai, Yasuhiko Tomino, Chisei Ra

    Kidney International 54 (4) 1166-1174 1998

    Publisher: Blackwell Publishing Inc.

    DOI: 10.1046/j.1523-1755.1998.00108.x  

    ISSN: 0085-2538

  235. Characterization of B Cells Expressing Recombination Activating Genes in Germinal Centers of Immunized Mouse Lymph Nodes Peer-reviewed

    Masaki Hikida, Masaharu Mori, Teruyuki Kawabata, Toshiyuki Takai, Hitoshi Ohmori

    Journal of Immunology 158 (6) 2509-2512 1997/03/15

    ISSN: 0022-1767

  236. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors Peer-reviewed

    Keiko Hayami, Daisuke Fukuta, Yasuhiro Nishikawa, Yumi Yamashita, Masanori Inui, Yukiya Ohyama, Masaki Hikida, Hitoshi Ohmori, Toshiyuki Takai

    Journal of Biological Chemistry 272 (11) 7320-7327 1997/03/14

    DOI: 10.1074/jbc.272.11.7320  

    ISSN: 0021-9258

  237. 512 マウスマスト細胞におけるFcγRIIとFcγRIIIの発現

    熱田 了, 鈴木 勝宏, 松田 浩則, 奥村 康, 高井 俊行, 羅 智靖

    アレルギー 46 (8) 944-944 1997

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.46.944_4  

  238. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells Peer-reviewed

    Masaki Hikida, Masaharu Mori, Toshiyuki Takai, Ken-Ichi Tomochika, Kiyohiro Hamatani, Hitoshi Ohmori

    Science 274 (5295) 2092-2094 1996/12/20

    DOI: 10.1126/science.274.5295.2092  

    ISSN: 0036-8075

  239. Suppression of in vitro cellular immune response by nitrogen-containing terpene alcohol derivatives Peer-reviewed

    Y Okada, N Matono, M Shiono, T Takai, M Hikida, H Ohmori

    BIOLOGICAL & PHARMACEUTICAL BULLETIN 19 (11) 1443-1446 1996/11

    DOI: 10.1248/bpb.19.1443  

    ISSN: 0918-6158

  240. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: Effectiveness of 8-mercaptoguanosine Peer-reviewed

    Masaki Hikida, Toshiyuki Takai, Hitoshi Ohmori

    Journal of Immunology 156 (8) 2730-2736 1996/04/15

    ISSN: 0022-1767

  241. Augmented humoral and anaphylactic responses in FcγRII-deficient mice Peer-reviewed

    Toshiyuki Takai, Masao Ono, Masaki Hikida, Hitoshi Ohmori, Jeffrey V. Ravetch

    Nature 379 (6563) 346-349 1996/01/25

    DOI: 10.1038/379346a0  

    ISSN: 0028-0836

  242. 4. FCRγ鎖ノックアウトマウスによるアレルギー発症のメカニズム (<シンポジウム>2 アレルギーとFcレセプター)

    高井 俊行

    アレルギー 45 (8) 804-804 1996

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.45.804_1  

  243. Multiple loss of effector cell functions in FcRγ-deficient mice Peer-reviewed

    Toshiyuki Takai

    International Reviews of Immunology 13 (4) 369-381 1996

    Publisher: Informa Healthcare

    DOI: 10.3109/08830189609061759  

    ISSN: 0883-0185

  244. Induction of antigen-specific IgE response in murine lymphocytes by IL-10 Peer-reviewed

    Hitoshi Ohmori, Tsutomu Kanda, Toshiyuki Takai, Masaki Hikida

    Immunology Letters 47 (1-2) 127-132 1995

    DOI: 10.1016/0165-2478(95)00084-I  

    ISSN: 0165-2478

  245. 5-Azacytidine enhances transient expression of a transfected gene in cultured mammalian cells Peer-reviewed

    Toshiyuki Takai, Tatsuji Yasuda, Hitoshi Ohmori

    Journal of Fermentation and Bioengineering 79 (6) 617-619 1995

    DOI: 10.1016/0922-338X(95)94758-J  

    ISSN: 0922-338X

  246. Enhancement of transgene expression in mammalian cell line by a Δ7-prostaglandin A1 analogue Peer-reviewed

    Taichi Matsuda, Toshiyuki Takai, Masaki Hikida, Tatsuji Yasuda, Seizi Kurozumi, Hitoshi Ohmori

    Journal of Fermentation and Bioengineering 79 (3) 281-283 1995

    DOI: 10.1016/0922-338X(95)90617-9  

    ISSN: 0922-338X

  247. Phorbol Ester-Induced Reversible Inactivation of Cytotoxic T Cell Function: Correlation with Down-Regulation of Protein Kinase C Activity Peer-reviewed

    Hitoshi Ohmori, Toshitaka Shimada, Masaki Hikida, Toshiyuki Takai

    Japanese Journal of Pharmacology 66 (4) 427-432 1994

    DOI: 10.1254/jjp.66.427  

    ISSN: 0021-5198

  248. Predominant suppression of anti-TNP IgE response in mice by monoclonal anti-TNP IgG1 antibody: characterization of its mode of action by in vitro and in vivo studies Peer-reviewed

    Naoki Hase, Toshiyuki Takai, Masaki Hikida, Hitoshi Ohmori

    International Journal of Immunopharmacology 16 (10) 787-794 1994

    DOI: 10.1016/0192-0561(94)90052-3  

    ISSN: 0192-0561

  249. Enzyme release assay of human NK cell activity using β-galactosidase-expressing K562 target cell line Peer-reviewed

    Hitoshi Ohmori, Hidenori Ikeda, Takahiro Tanigawa, Toshiyuki Takai, Masaki Hikida

    Journal of Immunological Methods 164 (1) 131-135 1993/08/26

    DOI: 10.1016/0022-1759(93)90283-D  

    ISSN: 0022-1759

  250. Enhancement of expression of an introduced gene by 5-azacytidine in mammalian cell lines Peer-reviewed

    Takahiro Tanigawa, Masaki Hikida, Toshiyuki Takai, Tatsuji Yasuda, Hitoshi Ohmori

    Journal of Fermentation and Bioengineering 75 (4) 254-258 1993

    DOI: 10.1016/0922-338X(93)90147-Z  

    ISSN: 0922-338X

  251. Enhancement of expression of introduced β-galactosidase gene by 2-aminopurine in mammalian cell lines Peer-reviewed

    Takahiro Tanigawa, Masaki Hikida, Toshiyuki Takai, Hitoshi Ohmori

    Journal of Fermentation and Bioengineering 76 (2) 145-147 1993

    DOI: 10.1016/0922-338X(93)90072-G  

    ISSN: 0922-338X

  252. Enhancement of DNA transfection efficiency by heat treatment of cultured mammalian cells Peer-reviewed

    Toshiyuki Takai, Hitoshi Ohmori

    BBA - Gene Structure and Expression 1129 (2) 161-165 1992/01/06

    DOI: 10.1016/0167-4781(92)90481-E  

    ISSN: 0167-4781

  253. Enhancement of antigen-induced interleukin 4 and IgE production by specific IgG1 in murine lymphocytes Peer-reviewed

    Hitoshi Ohmori, Naoki Hase, Masaki Hikida, Toshiyuki Takai, Noriaki Endo

    Cellular Immunology 145 (2) 299-310 1992

    DOI: 10.1016/0008-8749(92)90333-K  

    ISSN: 1090-2163 0008-8749

  254. Selective regulation of antigen-specific IgE response by cyclic AMP level in murine lymphocytes Peer-reviewed

    Masaki Hikida, Toshiyuki Takai, Hitoshi Ohmori

    Immunology Letters 33 (3) 301-306 1992

    DOI: 10.1016/0165-2478(92)90077-2  

    ISSN: 0165-2478

  255. Establishment of an enzyme release assay for cytotoxic T lymphocyte activity Peer-reviewed

    Hitoshi Ohmori, Toshiyuki Takai, Takahiro Tanigawa, Yoichi Honma

    Journal of Immunological Methods 147 (1) 119-124 1992

    DOI: 10.1016/S0022-1759(12)80036-6  

    ISSN: 0022-1759

  256. Regulation of prostaglandin E2 synthesis by cyclooxygenase induction in osteoblast MC3T3-E1 Peer-reviewed

    Shozo Yamamoto, Takeo Oshima, Tanihiro Yoshimoto, Chieko Yokoyama, Toshiyuki Takai, Tadashi Tanabe, Masayoshi Kumegawa

    Journal of Bone and Mineral Metabolism 9 (2) 45-48 1991/08

    Publisher: Springer-Verlag

    DOI: 10.1007/BF02377985  

    ISSN: 0914-8779 1435-5604

  257. DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure Peer-reviewed

    Toshiyuki Takai, Hitoshi Ohmori

    BBA - Gene Structure and Expression 1048 (1) 105-109 1990/01/30

    DOI: 10.1016/0167-4781(90)90029-2  

    ISSN: 0167-4781

  258. Highly efficient DNA transfection of hematopoietic cell lines by an improved DEAE-dextran method: A synergistic enhancement by hypertonic treatment and dimethyl sulfoxide

    T. Takai, H. Ohmori

    Methods in Molecular and Cellular Biology 2 (2) 82-90 1990

    ISSN: 0898-7750

  259. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes Peer-reviewed

    T. Yoshimoto, H. Suzuki, S. Yamamoto, T. Takai, C. Yokoyama, T. Tanabe

    Proceedings of the National Academy of Sciences of the United States of America 87 (6) 2142-2146 1990

    DOI: 10.1073/pnas.87.6.2142  

    ISSN: 0027-8424

  260. Prostaglandin E2 as a selective stimulator of antigen‐specific IgE response in murine lymphocytes Peer-reviewed

    Hitoshi Ohmori, Masaki Hikida, Toshiyuki Takai

    European Journal of Immunology 20 (11) 2499-2503 1990

    DOI: 10.1002/eji.1830201121  

    ISSN: 1521-4141 0014-2980

  261. Cytidylate cyclase activity in mouse tissues: the enzymatic conversion of cytidine 5′-triphosphate to cytidine 3′,5′-cyclic monophosphate (cyclic CMP) Peer-reviewed

    Itaru Yamamoto, Toshiyuki Takai, Shuji Mori

    BBA - General Subjects 993 (2-3) 191-198 1989/12/08

    DOI: 10.1016/0304-4165(89)90163-3  

    ISSN: 0304-4165

  262. Developmental changes of the content of acetyl-CoA carboxylase mRNA in chicken liver Peer-reviewed

    Toshiyuki Takai, Yoko Saito, Kazuhiko Yamamoto, Tadashi Tanabe

    Archives of Biochemistry and Biophysics 266 (2) 313-318 1988/11/01

    DOI: 10.1016/0003-9861(88)90263-9  

    ISSN: 1096-0384 0003-9861

  263. Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence Peer-reviewed

    Chieko Yokoyama, Toshiyuki Takai, Tadashi Tanabe

    FEBS Letters 231 (2) 347-351 1988/04/25

    DOI: 10.1016/0014-5793(88)80847-0  

    ISSN: 0014-5793

  264. Primary structure of chicken liver acetyl-CoA carboxylase deduced from cDNA sequence Peer-reviewed

    T. Takai, C. Yokoyama, K. Wada, T. Tanabe

    Journal of Biological Chemistry 263 (6) 2651-2657 1988

    ISSN: 0021-9258

  265. Primary structure of the biotin-binding site of chicken liver acetyl-CoA carboxylase Peer-reviewed

    Toshiyuki Takai, Kenji Wada, Tadashi Tanabe

    FEBS Letters 212 (1) 98-102 1987/02/09

    DOI: 10.1016/0014-5793(87)81564-8  

    ISSN: 0014-5793

  266. Amino acid sequence of chicken liver cathepsin L Peer-reviewed

    Kenji WADA, Toshiyuki TAKAI, Tadashi TANABE

    European Journal of Biochemistry 167 (1) 13-18 1987

    DOI: 10.1111/j.1432-1033.1987.tb13298.x  

    ISSN: 1432-1033 0014-2956

  267. Erratum: Molecular distinction between fetal and adult forms of muscle acetylcholine receptor (Nature (1986) 321 (406-411))

    M. Mishina, T. Takai, K. Imoto, M. Noda, T. Takahashi, S. Numa, C. Methfessel, B. Sakmann

    Nature 322 90 1986/12/01

    DOI: 10.1038/322090a0  

    ISSN: 0028-0836

  268. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor Peer-reviewed

    Masayoshi Mishina, Toshiyuki Takai, Keiji Imoto, Masaharu Noda, Tomoyuki Takahashi, Shosaku Numa, Christoph Methfessel, Bert Sakmann

    Nature 321 (6068) 406-411 1986

    DOI: 10.1038/321406a0  

    ISSN: 0028-0836

  269. Role of acetylcholine receptor subunits in gating of the channel Peer-reviewed

    Bert Sakmann, Christoph Methfessel, Masayoshi Mishina, Tomoyuki Takahashi, Toshiyuki Takai, Masaaki Kurasaki, Kazuhiko Fukuda, Shosaku Numa

    Nature 318 (6046) 538-543 1985

    DOI: 10.1038/318538a0  

    ISSN: 0028-0836

  270. Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle Peer-reviewed

    Toshiyuki Takai, Masaharu Noda, Masayoshi Mishina, Shin Shimizu, Yasuji Furutani, Toshiaki Kayano, Takayuki Ikeda, Tai Kubo, Hideo Takahashi, Tomoyuki Takahashi, Motoy Kuno, Shosaku Numa

    Nature 315 (6022) 761-764 1985

    DOI: 10.1038/315761a0  

    ISSN: 0028-0836

  271. Primary structure of δ subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence Peer-reviewed

    Tai KUBO, Masaharu NODA, Toshiyuki TAKAI, Tsutomu TANABE, Toshiaki KAYANO, Shin SHIMIZU, Ken‐ichi TANAKA, Hideo TAKAHASHI, Tadaaki HIROSE, Seiichi INAYAMA, Reiko KIKUNO, Takashi MIYATA, Shosaku NUMA

    European Journal of Biochemistry 149 (1) 5-13 1985

    DOI: 10.1111/j.1432-1033.1985.tb08885.x  

    ISSN: 1432-1033 0014-2956

  272. Primary structure of β subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence Peer-reviewed

    Tsutomu TANABE, Masaharu NODA, Yasuji FURUTANI, Toshiyuki TAKAI, Hideo TAKAHASHI, Ken‐ichi TANAKA, Tadaaki HIROSE, Seiichi INAYAMA, Shosaku NUMA

    European Journal of Biochemistry 144 (1) 11-17 1984

    DOI: 10.1111/j.1432-1033.1984.tb08424.x  

    ISSN: 1432-1033 0014-2956

  273. Primary structure of γ subunit precursor of calf‐muscle acetylcholine receptor deduced from the cDNA sequence Peer-reviewed

    Toshiyuki TAKAI, Masaharu NODA, Yasuji FURUTANI, Hideo TAKAHASHI, Mitsue NOTAKE, Shin SHIMIZU, Toshiaki KAYANO, Tsutomu TANABE, Ken‐ichi TANAKA, Tadaaki HIROSE, Seiichi INAYAMA, Shosaku NUMA

    European Journal of Biochemistry 143 (1) 109-115 1984

    DOI: 10.1111/j.1432-1033.1984.tb08348.x  

    ISSN: 1432-1033 0014-2956

  274. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence Peer-reviewed

    Masaharu Noda, Shin Shimizu, Tsutomu Tanabe, Toshiyuki Takai, Toshiaki Kayano, Takayuki Ikeda, Hideo Takahashi, Hitoshi Nakayama, Yuichi Kanaoka, Naoto Minamino, Kenji Kangawa, Hisayuki Matsuo, Michael A. Raftery, Tadaaki Hirose, Seiichi Inayama, Hidenori Hayashida, Takashi Miyata, Shosaku Numa

    Nature 312 (5990) 121-127 1984

    DOI: 10.1038/312121a0  

    ISSN: 0028-0836

  275. Isolation and structural organization of the human preproenkephalin Bgene Peer-reviewed

    Saburo Horikawa, Toshiyuki Takai, Mitsuyoshi Toyosato, Hideo Takahashi, Masaharu Noda, Hitoshi Kakidani, Tai Kubo, Tadaaki Hirose, Seiichi Inayama, Hidenori Hayashida, Takashi Miyata, Shosaku Numa

    Nature 306 (5943) 611-614 1983

    DOI: 10.1038/306611a0  

    ISSN: 0028-0836

  276. Enzyme immunoassay for cytidine 3′,5′-cyclic monophosphate (cyclic CMP) Peer-reviewed

    Itaru Yamamoto, Toshiyuki Takai, Jun-ichi Tsuji

    Immunopharmacology 4 (4) 331-340 1982

    DOI: 10.1016/0162-3109(82)90054-6  

    ISSN: 0162-3109

Show all ︎Show first 5

Misc. 131

  1. Hot topic徹底討論 タンパク質蓄積病態に影響するファクターとは アルツハイマー病におけるアミロイドβおよびタウ蓄積病態形成とミクログリアの関与

    高鳥 翔, 井口 明優, 木村 新伍, 堀 由起子, 佐々木 純子, 斉藤 貴志, 西道 隆臣, 池津 庸哉, 高井 俊行, 佐々木 雄彦, 富田 泰輔

    Dementia Japan 35 (4) 595-595 2021/10

    Publisher: (一社)日本認知症学会

    ISSN: 1342-646X

  2. Roles of inhibitory Fc receptor FcgammaRIIB on the peripheral B cell tolerance

    NISHIMURA Hiroyuki, IIDA Noriko, OHTSUJI Mareki, KODERA Yo, TAKAI Toshiyuki, SUDO Katsuko, VERBEEK Sjef, HIROSE Sachiko

    日本免疫学会総会・学術集会記録(CD-ROM) 50 2021

    ISSN: 0919-1984

  3. Fcγレセプター,抑制性レセプター Invited Peer-reviewed

    遠藤 章太, 蘇 美慈, 高井 俊行

    臨床免疫・アレルギー科 73 (1) 43-50 2020/01

  4. Immune regulation by PirB/LILRB2 and gp49B/LILRB4 Invited Peer-reviewed

    Endo S, Su MT, Takai T

    Seitai no Kagaku 70 (3) 223-229 2019/06

  5. Epistatic interaction between Fcgr2b and Slam family genes in susceptibility to the defective peripheral immune tolerance and autoimmunity

    NISHIMURA Hiroyuki, IIDA Noriko, OHTSUJI Mareki, KODERA Yo, TAKAI Toshiyuki, SUDO Katsuko, VERBEEK Sjef J, HIROSE Sachiko

    日本免疫学会総会・学術集会記録(CD-ROM) 48 2019

    ISSN: 0919-1984

  6. 脳内インフラストラクチャー: 脳細胞社会の恒常性維持機構と物流システムを担う機能的構造体 アルツハイマー病遺伝学的リスク因子INPP5Dの病態関与に関する研究

    高鳥 翔, 井口 明優, 木村 新伍, 佐々木 純子, 佐々木 雄彦, 高井 俊行, 斉藤 貴志, 西道 隆臣, 富田 泰輔

    日本生化学会大会プログラム・講演要旨集 92nd [1S17m-05] 2019

    Publisher: (公社)日本生化学会

  7. アルツハイマー病リスク遺伝子INPP5DがTREM2シグナル伝達において果たす役割の解明

    井口 明優, 高鳥 翔, 木村 新伍, 佐々木 純子, 斉藤 貴志, 西道 隆臣, 高井 俊行, 佐々木 雄彦, 富田 泰輔

    Dementia Japan 33 (4) 551-551 2019

    Publisher: (一社)日本認知症学会

    ISSN: 1342-646X

  8. Epistatic interaction between fcgr2b and Slam family genes in susceptibility to defective foreign protein-induced tolerance

    NISHIMURA Hiroyuki, OBATA Masaomi, OHTSUJI Mareki, KODERA Yo, TAKAI Toshiyuki, SUDO Katsuko, VERBEEK J. Sjef, HIROSE Sachiko

    日本免疫学会総会・学術集会記録(CD-ROM) 47 2018

    ISSN: 0919-1984

  9. Epistatic interaction between fcgr2b and Slam family genes in susceptibility to defective foreign protein-induced tolerance

    NISHIMURA Hiroyuki, OBATA Masaomi, OHTSUJI Mareki, KODERA Yo, TAKAI Toshiyuki, SUDO Katsuko, HIROSE Sachiko

    日本免疫学会総会・学術集会記録(CD-ROM) 46 2017

    ISSN: 0919-1984

  10. Epistatic interaciton between fcgr2b and Slam family genes in susceptibility to defective foreign protein induced tolerance

    NISHIMURA Hiroyuki, FUJII Takuma, OBATA Masaomi, OHTSUJI Mareki, KODERA Yo, TAKAI Toshiyuki, SUDO Katsuko, HIROSE Sachiko

    日本免疫学会総会・学術集会記録 45 (Proceedings) 2016

    ISSN: 0919-1984

  11. [Ligand recognition and immune regulation system of inhibitory receptor PIR-B]. Invited Peer-reviewed

    Endo S, Takai T

    Seikagaku. The Journal of Japanese Biochemical Society 86 (5) 662-665 2014/10

    Publisher: 日本生化学会

    ISSN: 0037-1017

  12. Regulation of inflammatory responses by PIR-B Invited Peer-reviewed

    60 (5) 486-491 2013

    Publisher: 科学評論社

    ISSN: 1881-1930

  13. [Regulation of osteoclast development by immunoglobulin-like receptors].

    Masanori Inui, Toshiyuki Takai

    Clinical calcium 22 (11) 1651-1657 2012

    ISSN: 0917-5857

  14. Fc gamma receptor targeting in RA

    Toshiyuki Takai, Akira Nakamura, Akiko Tobinai, Shota Endo, Masanori Inui

    ARTHRITIS RESEARCH & THERAPY 14 2012

    ISSN: 1478-6354

  15. B細胞におけるPIR-Bの発現制御転写因子. Invited Peer-reviewed

    北口公司, 遠藤章太, 高井俊行

    臨床免疫・アレルギー科 57 500-505 2012

  16. Paired immunoglobulin-like receptor(PIR)-Bの自己免疫疾患における役割

    中村 晃, 高井 俊行

    リウマチ科 46 (2) 184-189 2011/08

    Publisher: (有)科学評論社

    ISSN: 0915-227X

  17. Presumptive role of 129 strain-derived Sle16 locus for rheumatoid arthritis in a new mouse model with Fc γ RIIB-deficient C57BL/6 genetic background

    SATO Aya, OHTSUJI Mareki, LIN Qingshun, OHTSUJI Naomi, NISHIKAWA Keiko, TSURUI Hiromichi, ONO Masao, SHIRAI Toshikazu, TAKAI Toshiyuki, NISHIMURA Hiroyuki, HIROSE Sachiko

    日本免疫学会総会・学術集会記録 40 2011

    ISSN: 0919-1984

  18. 骨髄球系細胞におけるMDL-1/DAP12の機能. Invited Peer-reviewed

    北口公司, 遠藤章太, 乾匡範, 高井俊行

    リウマチ科 45 (5) 531-535 2011

    Publisher: (有)科学評論社

    ISSN: 0915-227X

  19. Presumptive role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new mouse model with Fcgamma receptor type IIb-deficient C57BL/6 genetic background.

    Sato-Hayashizaki Aya, Ohtsuji Mareki, Lin Qingshun, Hou Rong, Ohtsuji Naomi, Nishikawa Keiko, Tsurui Hiromichi, Sudo Katsuko, Ono Masao, Izui Shozo, Shirai Toshikazu, Takai Toshiyuki, Nishimura Hiroyuki, Hirose Sachiko

    Arthritis Rheum 63 (10) 2930-2938 2011

    DOI: 10.1002/art.30485  

    ISSN: 0004-3591

    eISSN: 1529-0131

  20. 【アレルギーの感作と発症】 免疫抑制性レセプターPIR-Bによるアレルギー制御

    北口 公司, 中村 晃, 高井 俊行

    臨床免疫・アレルギー科 54 (5) 540-545 2010/11

    Publisher: (有)科学評論社

    ISSN: 1881-1930

  21. PIR-BによるNogo/MHCクラスI認識の相違性に基づくマスト細胞の新しい制御機構

    遠藤 章太, 北口 公司, 中村 晃, 高井 俊行

    アレルギー 59 (9-10) 1428-1428 2010/10

    Publisher: (一社)日本アレルギー学会

    ISSN: 0021-4884

    eISSN: 1347-7935

  22. 炎症とDAP12/DAP10/FcRγ

    中村 晃, 乾 匡範, 高井 俊行

    感染・炎症・免疫 40 (2) 120-129 2010/07

    Publisher: 鳥居薬品(株)

    ISSN: 0387-1010

  23. 【B細胞の分化・生存・機能制御の分子機能】 PIR-B、CD22、CD72からのシグナルによるB細胞活性化抑制の機序

    中村 晃, 高井 俊行

    臨床免疫・アレルギー科 54 (1) 35-43 2010/07

    Publisher: (有)科学評論社

    ISSN: 1881-1930

  24. Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury

    Shusaku Omoto, Masaki Ueno, Soichiro Mochio, Toshiyuki Takai, Toshihide Yamashita

    NEUROSCIENCE RESEARCH 68 E254-E254 2010

    DOI: 10.1016/j.neures.2010.07.1126  

    ISSN: 0168-0102

  25. Paired immunoglobulin-like receptor B knockout does not enhance axonalregeneration or locomotor recovery after spinal cord injury

    Yuka Nakamura, Yuki Fujita, Masaki Ueno, Toshiyuki Takai, Toshihide Yamashita

    NEUROSCIENCE RESEARCH 68 E254-E254 2010

    DOI: 10.1016/j.neures.2010.07.1125  

    ISSN: 0168-0102

  26. 【アレルギー疾患の免疫機構 免疫細胞・サイトカインからみたアレルギー発症機序と治療へ向けた臨床的アプローチ】 アレルギー疾患の基礎研究 アレルギー疾患に関連する免疫細胞群 受容体による肥満細胞の活性化制御

    中村 晃, 高井 俊行

    実験医学 27 (20) 3259-3263 2009/12

    Publisher: (株)羊土社

    ISSN: 0288-5514

  27. The study of allergy by Japanese researchers: a historical perspective

    Toshiyuki Takai, Hajime Karasuyama

    INTERNATIONAL IMMUNOLOGY 21 (12) 1311-1316 2009/12

    DOI: 10.1093/intimm/dxp105  

    ISSN: 0953-8178

    eISSN: 1460-2377

  28. Ectopically expressed PIR‐B on T cells constitutively binds to MHC class I cis and attenuates T helper type 1 responses.

    IMADA Michiyo, MASUDA Kyoko, SATOH Rumi, ITO Yumi, GOTOH Yoshiyuki, MATSUOKA Takayuki, ENDO Shota, NAKAMURA Akira, KAWAMOTO Hiroshi, TAKAI Toshiyuki

    日本免疫学会総会・学術集会記録 39 236 2009/11/10

    ISSN: 0919-1984

  29. アレルギーの感作成立=発症なのか? 免疫抑制性レセプターPIR-Bによるアレルギー制御

    高井 俊行, 中村 晃

    アレルギー 58 (8-9) 1132-1132 2009/09

    Publisher: (一社)日本アレルギー学会

    ISSN: 0021-4884

    eISSN: 1347-7935

  30. 【感染現象 その理解の深化から疾患制御への展望】 生体防御機構研究の新展開 PIRによる新規CTL活性調節システム

    遠藤 章太, 中村 晃, 高井 俊行

    蛋白質・核酸・酵素 54 (8) 1108-1113 2009/06

    Publisher: 共立出版(株)

    ISSN: 0039-9450

  31. 破骨細胞分化における免疫受容体会合性シグナルアダプター分子DAP10の重要性

    藤村 紫音, 乾 匡範, 菊地 佑樹, 青木 直子, 遠藤 章太, 前田 努, 飛内 章子, 原, 中村 晃, 熊ノ郷 淳, Colonna Marco, 高井 俊行

    Clinical Calcium 19 (6) 860-860 2009/05

    Publisher: (株)医薬ジャーナル社

    ISSN: 0917-5857

  32. 【自己免疫の発生に関与する要因】 自己免疫の発生とPIR-B

    中村 晃, 窪 智宏, 高井 俊行

    臨床免疫・アレルギー科 51 (4) 325-330 2009/04

    Publisher: (有)科学評論社

    ISSN: 1881-1930

  33. Fc受容体と自己免疫

    中村 晃, 高井 俊行

    リウマチ科 41 (2) 214-221 2009/02

    Publisher: (有)科学評論社

    ISSN: 0915-227X

  34. LMIR3 transmits both an inhibitory signal via ITIM in the cytoplasmic region and an activating signal by associating with ITAM‐containing FcRgamma in mast cells.

    IZAWA Kumi, KITAURA Jiro, YAMANISHI Yoshinori, MATSUOKA Takayuki, OKI Toshihiko, TAKAI Toshiyuki, KITAMURA Toshio

    日本免疫学会総会・学術集会記録 38 253 2008/11/05

    ISSN: 0919-1984

  35. 【シグナル伝達研究 2008'09 疾患発症の分子メカニズムと実現化する分子標的薬開発】 シグナル伝達研究 現象から因子へ PIRシグナルと免疫疾患

    高井 俊行, 中村 晃, 遠藤 章太

    実験医学 26 (15) 2411-2417 2008/09

    Publisher: (株)羊土社

    ISSN: 0288-5514

  36. Inhibitory MHC class I receptors on myeloid cells

    Akira Nakamura, Toshiyuki Takai

    Current Immunology Reviews 4 (2) 80-87 2008/05

    DOI: 10.2174/157339508784325082  

    ISSN: 1573-3955

  37. Mucosal CD11b+DCs were Increased in PIRB Knockout Mice

    Ryoki Kobayashi, Hiromi Kubagawa, Toshiyuki Takai, Shinichi Sekine, Jerry R. McGhee, Kohtaro Fujihashi

    FASEB JOURNAL 22 2008/04

    ISSN: 0892-6638

  38. キラーT細胞のはたらきを調節する受容体分子を発見. Invited Peer-reviewed

    遠藤章太, 高井俊行

    Medical Bio 5 (6) 12-13 2008

  39. Functional analysis of an inhibitory reseptor LMIR3 and an activating receptor LMIR4

    IZAWA Kumi, KITAURA Jiro, YAMANISHI Yoshinori, MATSUOKA Takayuki, OKI Yoshihiko, TAKAI Toshiyuki, KITAMURA Toshio

    日本免疫学会総会・学術集会記録 37 197 2007/10/25

    ISSN: 0919-1984

  40. Analysis of mouse LMIR5/CLM7 as an activating receptor: differential regulation of LMIR5/CLM7 in mouse verus human cells.

    YAMANISHI Yoshinori, KITAURA Jiro, IZAWA Kumi, MATSUOKA Takayuki, OKI Toshihiko, TAKAI Toshiyuki, KITAMURA Toshio

    日本免疫学会総会・学術集会記録 37 197 2007/10/25

    ISSN: 0919-1984

  41. Fc receptors: their diverse functions in immunity and immune disorders. (Springer Semin Immunopathol)

    Takai Toshiyuki

    Springer Semin Immunopathol 28 (4) 303-304 2006/12

    DOI: 10.1007/s00281-006-0055-y  

  42. The characterization of a novel immunoglobulin‐like receptor, leukocyte mono‐Ig‐like receptor 5 (LMIR5)

    YAMANISHI Yoshinori, KITAURA Jiro, IZAWA Kumi, MATSUOKA Takayuki, OKI Toshihiko, TAKAI Toshiyuki, KITAMURA Toshio

    日本免疫学会総会・学術集会記録 36 256 2006/11/15

    ISSN: 0919-1984

  43. Charachterization of LMIR4, an activating receptor, which could pair with LMIR3, an inhibitory receptor

    IZAWA Kumi, KITAURA Jiro, YAMANISHI Yoshinori, OKI Toshihiko, MATSUOKA Takayuki, TAKAI Toshiyuki, KITAMURA Toshio

    日本免疫学会総会・学術集会記録 36 151 2006/11/15

    ISSN: 0919-1984

  44. 活性化CD200レセプターを介したNK細胞の新たな腫瘍細胞認識機構

    佐藤 毅史, 石川 哲, 白鳥 行大, 荒瀬 規子, 高井 俊行, Lanier Lewis L, 荒瀬 尚

    日本癌学会総会記事 65回 457-458 2006/09

    Publisher: 日本癌学会

    ISSN: 0546-0476

  45. Enhanced mucosal IgA ab responses in PIR-B knockout mice

    Ryoki Kobayashi, H. Kubagawa, T. Takai, S. Sekine, Jerry R. McGhee, K. Fujihashi

    JOURNAL OF IMMUNOLOGY 176 S244-S244 2006/04

    ISSN: 0022-1767

  46. Regulatory mechanisms of osteoclast development and bone disorders

    Masanori Inui, Y. Mori, Toshiyuki Takai

    Seikagaku. The Journal of Japanese Biochemical Society. 78 (3) 250-256 2006/03/01

    ISSN: 0037-1017

  47. ジェネラルレビュー:樹状細胞とT細胞のインターフェイス (抗原認識,co-raceptor)

    高井 俊行

    免疫 2006 70-76 2006

    Publisher: 中山書店

    ISSN: 0918-6557

  48. 抑制性MHCクラス1レセプターPIR-BによるGVHDの制御 (病気と免疫)

    中村 晃, 高井 俊行

    免疫 2006 318-324 2006

    Publisher: 中山書店

    ISSN: 0918-6557

  49. PIR. Invited Peer-reviewed

    遠藤章太, 高井俊行

    分子細胞治療 5 372-373 2006

  50. 第三の自己認識セレプターPIR (臨床免疫)

    中村晃, 高井俊行

    臨床免疫 44 (6) 647-653 2005/12

    Publisher: 科学評論社

    ISSN: 0386-9695

  51. NK細胞の活性化CD200レセプターを介した新たな標的細胞認識機構

    石川 哲, 白鳥 行大, 荒瀬 規子, 高井 俊行, Lanier Lewis L, 荒瀬 尚

    日本免疫学会総会・学術集会記録 35 99-99 2005/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  52. IgGとアレルギー (アレルギー)

    高井俊行

    アレルギー 54 (10) 1183-1189 2005/10

    DOI: 10.15036/arerugi.54.1183  

  53. Fcγレセプターによる免疫制御と疾患

    高井 俊行

    耳鼻咽喉科免疫アレルギー 23 (2) 7-13 2005/09/30

    ISSN: 0913-0691

  54. Paired immunoglobulin-like receptors and their MHC class I recognition

    T Takai

    IMMUNOLOGY 115 (4) 433-440 2005/08

    DOI: 10.1111/j.1365-2567.2005.02177.x  

    ISSN: 0019-2805

  55. 造血幹細胞移植の成否の鍵を握るペア型イムノグロブリン様受容体 : ドナー細胞によるレシピエントへの攻撃をいかに回避・コントロールするか

    高井 俊行

    化学と生物 43 (7) 424-426 2005/07/01

    Publisher: 日本農芸化学会

    ISSN: 0453-073X

  56. IgGとアレルギー (アレルギー)

    高井俊行

    アレルギー 54 (3〜4) 215-215 2005/04

    Publisher: 一般社団法人 日本アレルギー学会

    DOI: 10.15036/arerugi.54.215  

  57. 自己免疫性糖尿病モデルマウス(NOD)におけるFcレセプターの関与

    井上 吉浩, 中村 晃, 高井 俊行

    加齢医学研究所雑誌 56 (2) 59-59 2005/02

    Publisher: 東北大学加齢医学研究所

    ISSN: 1340-3397

  58. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer

    Akira Nakamura, Kenichi Akiyama, Toshiyuki Takai

    Expert Opinion on Therapeutic Targets 9 (1) 169-190 2005/02

    DOI: 10.1517/14728222.9.1.169  

    ISSN: 1472-8222

  59. 自己免疫の治療ターゲットとしてのFcγR2B (病気と免疫)

    高井 俊行, 中村 晃

    免疫 2005 385-392 2005

    Publisher: 中山書店

    ISSN: 0918-6557

  60. Regulation of osteoclast development by immunoglobulin-like receptors

    Toshiyuki Takai, Masanori Inui, Kazuya Inoue, Y. Mori

    Nippon rinsho. Japanese journal of clinical medicine 63 (9) 1562-1568 2005/01/01

    ISSN: 0047-1852

  61. Fc receptors and their role in immune regulation and autoimmunity

    T Takai

    JOURNAL OF CLINICAL IMMUNOLOGY 25 (1) 1-18 2005/01

    DOI: 10.1007/s10875-005-0353-8  

    ISSN: 0271-9142

  62. A novel recognition system for MHC class I molecules constituted by PIR

    T Takai

    ADVANCES IN IMMUNOLOGY, VOL 88 88 161-192 2005

    DOI: 10.1016/S0065-2776(05)88005-8  

    ISSN: 0065-2776

  63. Sema6Dはplexin-A1を介して免疫細胞を活性化する

    竹ヶ原 宜子, 熊ノ郷 淳, 山本 みどり, 高松 漂太, 識名 崇, 丸川 聡子, 石田 勲, 高井 俊行, 菊谷 仁

    日本免疫学会総会・学術集会記録 34 201-201 2004/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  64. アダプター分子DAP12およびFcRγを介するITAMシグナルは破骨細胞分化に必須である

    乾 匡範, 古賀 貴子, 井上 和也, 谷口 維紹, 高柳 広, 高井 俊行

    日本免疫学会総会・学術集会記録 34 231-231 2004/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  65. Fcレセプターと関節炎 Invited

    後藤 義幸, 中村 晃, 高井 俊行

    分子リウマチ 1 (4) 50-56 2004/11

  66. Paired immunoglobulin-like receptor(PIR)による移植片対宿主病(GVHD)の制御

    中村 晃, 小林 栄治, 高井 俊行

    日本免疫学会総会・学術集会記録 34 148-148 2004/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  67. ITAM-mediated costimulatory signals cooperate with RANKL for osteoclastogenesis.

    T Koga, M Inui, A Suematsu, T Taniguchi, T Takai, H Takayanagi

    JOURNAL OF BONE AND MINERAL RESEARCH 19 S82-S82 2004/10

    ISSN: 0884-0431

  68. ITAMを介した共刺激シグナルはRANKLによる破骨細胞分化に必須である

    古賀 貴子, 乾 匡範, 末松 綾子, 谷口 維紹, 高井 俊行, 高柳 広

    日本骨代謝学会学術集会プログラム抄録集 22回 122-122 2004/08

    Publisher: (一社)日本骨代謝学会

    ISSN: 1349-0761

  69. A role of Fc gamma RIIB in the development of collagen-induced arthritis

    A Nakamura, T Takai

    BIOMEDICINE & PHARMACOTHERAPY 58 (5) 292-298 2004/06

    DOI: 10.1016/j.biopha.2004.04.005  

    ISSN: 0753-3322

  70. 免疫グロブリン様受容体(IgLR)分子群による免疫制御 (日本小児血液学会雑誌)

    中村晃, 高井俊行

    日本小児血液学会雑誌 18 (2) 59-68 2004/04

    DOI: 10.11412/jjph1987.18.59  

  71. Defective ligation of PIR-B to MHC class I molecules leads to accelerated graft-versus-host disease (GVHD)

    A Nakamura, E Kobayashi, T Takai

    FASEB JOURNAL 18 (4) A84-A84 2004/03

    ISSN: 0892-6638

  72. Augmented anaphylactic responses in PIR-B-deficient mice

    A Masuda, T Maeda, A Nakamura, T Takai

    FASEB JOURNAL 18 (5) A792-A792 2004/03

    ISSN: 0892-6638

  73. PIR-B欠損マウスにおける移植片対宿主病の増悪

    中村 晃, 小林 栄治, 高井 俊行

    加齢医学研究所雑誌 55 (1) 29-29 2004/03

    Publisher: 東北大学加齢医学研究所

    ISSN: 1340-3397

  74. 自己免疫疾患におけるFcγレセプターの役割 (臨床免疫)

    後藤義幸, 金田崇文, 高井俊行

    臨床免疫 41 (2) 180-189 2004/02

    Publisher: 科学評論社

    ISSN: 0386-9695

  75. Role of paired Ig-like receptor-B in the humoral immune response

    Toshiyuki Takai

    Allergology International 53 (2) 93-99 2004

    Publisher: Blackwell Publishing

    DOI: 10.1111/j.1440-1592.2004.00327.x  

    ISSN: 1323-8930

  76. Antigen targeting to Fc gamma receptors on bone marrow-derived dendritic cells efficiently elicits humoral response and cytotoxic T lymphocytes in vivo

    S Endo, K Akiyama, A Yada, S Ebihara, K Matsumura, T Maeda, A Nakamura, S Aiba, T Nukiwa, T Takai

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 121 (5) 1250-1250 2003/11

    ISSN: 0022-202X

  77. 温度感受性SV40 Large T抗原トランスジェニックマウスからの株化マスト細胞の樹立ならびに機能解析

    兼平 雅彦, 伊藤 梢, 伊藤 由美, 中村 晃, 高井 俊行

    日本免疫学会総会・学術集会記録 33 162-162 2003/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  78. Paired Immunoglobulin-like Receptor(PIR)-Bによるマスト細胞の恒常的抑制

    前田 努, 増田 愛, 中村 晃, 高井 俊行

    日本免疫学会総会・学術集会記録 33 158-158 2003/11

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  79. PIR-B欠損マウスにおけるI型アレルギーの亢進

    高井 俊行, 増田 愛, 前田 努, 小林 栄治, 中村 晃

    アレルギー 52 (8-9) 765-765 2003/09

    Publisher: (一社)日本アレルギー学会

    DOI: 10.15036/arerugi.52.765_1  

    ISSN: 0021-4884

  80. Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer. (Curr Drug Targets Immune Endocr Metabol Disord)

    Takai Toshiyuki, Nakamura Akira, Akiyama Kenichi

    Curr Drug Targets Immune Endocr Metabol Disord 3 (3) 187-197 2003/09

    DOI: 10.2174/1568008033340180  

  81. Fc gamma RIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease

    K Yajima, A Nakamura, A Sugahara, T Takai

    FASEB JOURNAL 17 (7) C41-C41 2003/04

    ISSN: 0892-6638

  82. Paired Immunoglobulin-like Receptor(PIR)-B欠損マウスの解析

    浅井 あづさ, 氏家, 竹田 和彦, 中村 晃, 海老原 伸, 秋山 健一, 高井 俊行

    加齢医学研究所雑誌 54 (1〜2) 53-53 2003/03

    Publisher: 東北大学加齢医学研究所

    ISSN: 1340-3397

  83. Fcレセプター欠損マウスにおける免疫異常 (免疫研究の最前線--高次複雑系免疫システムの包括的理解をめざして) -- (免疫疾患・異常とその制御)

    高井 俊行

    蛋白質核酸酵素 47 (16) 2375-2381 2002/12

    Publisher: 共立出版

    ISSN: 0039-9450

  84. 話題 マスト細胞活性化と過敏反応におけるLynキナーゼの役割

    湯浅 貴恵, 小野 栄夫, 高井 俊行

    臨床免疫 37 (5) 567-572 2002/05

    Publisher: 科学評論社

    ISSN: 0386-9695

  85. Hypersensitive B cells and Th2-prone immune responses in paired immunoglobulin-like receptor (PIR)-B-deficient mice.

    T Takai, A Ujike, K Takeda, A Nakamura, S Ebihara, K Akiyama

    FASEB JOURNAL 16 (4) A313-A313 2002/03

    ISSN: 0892-6638

  86. 【知っておきたい200words 現代医学理解のために】 抑制性Fc受容体

    中村 晃, 高井 俊行

    医学のあゆみ 200 (13) 1273-1273 2002/03

    Publisher: 医歯薬出版(株)

    ISSN: 0039-2359

  87. 【免疫疾患 state of arts】 病態に関する基礎的研究の進歩 Fcレセプター欠損マウス

    中村 晃, 高井 俊行

    医学のあゆみ 別冊 (免疫疾患-state of arts Ver.2) 307-310 2002/03

    Publisher: 医歯薬出版(株)

    ISSN: 0039-2359

  88. 免疫疾患とその動物モデル 関節炎の発症におけるFcレセプターの役割

    中村 晃, 矢島 佳央里, 高井 俊行

    日本臨床免疫学会会誌 25 (1) 56-61 2002/02

    Publisher: 日本臨床免疫学会

    DOI: 10.2177/jsci.25.56  

    ISSN: 0911-4300

  89. DAP12遺伝子欠損マウスにおける骨形成異常の解析

    乾匡範, 海部知則, 金沢潔, 鍛冶光司, 菅原章子, 中村晃, 工藤明, 高井俊行

    日本免疫学会総会・学術集会記録 32 2002

    ISSN: 0919-1984

  90. Secretory leukoprotease inhibitor(SLPI)遺伝子欠損マウスはLPSによるendotoxin shockに高感受性である

    中村晃, 森ゆり子, 萩原弘一, 鈴木拓児, 菊地利明, 海老名雅仁, 阿部達也, 高井俊行, 貫和敏博

    日本免疫学会総会・学術集会記録 32 126-126 2002

    Publisher: (NPO)日本免疫学会

    ISSN: 0919-1984

  91. 免疫疾患 Fcレセプター欠損マウスと免疫異常

    中村 晃, 貫和 敏博, 高井 俊行

    Annual Review免疫 2002 283-289 2001/12

    Publisher: (株)中外医学社

  92. 免疫疾患とその動物モデル 関節炎の発症におけるFcレセプターの役割

    高井 俊行, 中村 晃, 矢島 佳央里

    日本臨床免疫学会会誌 24 (5) 222-222 2001/10

    Publisher: 日本臨床免疫学会

    ISSN: 0911-4300

  93. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection

    T Yoneto, S Waki, T Takai, Y Tagawa, Y Iwakura, J Mizuguchi, H Nariuchi, T Yoshimoto

    JOURNAL OF IMMUNOLOGY 166 (10) 6236-6241 2001/05

    ISSN: 0022-1767

  94. RA疾患遺伝子候補Dblノックアウトマウスの作製

    向江直子, 乾匡範, 駒井浩一郎, 小西良武, 高井俊行, 塩沢俊一

    リウマチ 41 (2) 473-473 2001/04/17

    Publisher: (一社)日本リウマチ学会

    ISSN: 0300-9157

  95. 【慢性関節リウマチ 遺伝子異常とその修復】 遺伝子変異による疾患モデルマウス Fcγ受容体遺伝子欠損マウス

    中村 晃, 小野 栄夫, 貫和 敏博, 高井 俊行

    最新医学 56 (4) 871-876 2001/04

    Publisher: (株)最新医学社

    ISSN: 0370-8241

  96. 【アレルギーと慢性炎症の分子医学】 炎症とFcレセプター

    中村 晃, 氏家 あづさ, 小野 栄夫, 貫和 敏博, 高井 俊行

    Molecular Medicine 38 (5) 538-543 2001/04

    Publisher: (株)中山書店

    ISSN: 0918-6557

  97. Functional association of CD9 with the Fc gamma receptors in macrophages

    K Kaji, S Takeshita, K Miyake, T Takai, A Kudo

    JOURNAL OF IMMUNOLOGY 166 (5) 3256-3265 2001/03

    ISSN: 0022-1767

  98. Fcγレセプターとアレルギー反応

    氏家 あづさ, 中村 晃, 小野 栄夫, 高井 俊行

    アレルギー科 11 (3) 268-274 2001/03

    Publisher: (有)科学評論社

    ISSN: 1341-7584

  99. DAP12欠損マウスにおける前脳・視床中心性のオリゴデンドロサイト発達障害とゲート異常

    海部知則, 乾匡範, 氏家あづさ, 高井俊行, 鍛冶光司, 中原仁, 竹内京子, 三島健一, 藤原道弘

    日本神経科学大会プログラム・抄録集 24th 2001

    ISSN: 1347-8583

  100. DAP12欠損マウスにおける前脳・視床中心性のオリゴデンドロサイト発達障害とゲート異常

    海部知則, 乾匡範, 氏家あづさ, 高井俊行, 鍛治光司, 中原仁, 阿相ひろ晃, 三島健一, 藤原道弘

    神経化学 40 (2/3) 2001

    ISSN: 0037-3796

  101. Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family

    Toshiyuki Takai, Masao Ono

    Immunological Reviews 181 215-222 2001

    DOI: 10.1034/j.1600-065X.2001.1810118.x  

    ISSN: 0105-2896

  102. Fc受容体による免疫抑制とその破綻

    高井 俊行

    日本皮膚科学会雑誌 110 (12) 1801-1802 2000/11/15

    ISSN: 0021-499X

  103. 【Fc受容体の基礎と臨床】 Fc受容体と自己免疫疾患モデルマウス

    中村 晃, 小野 栄夫, 貫和 敏博, 高井 俊行

    最新医学 55 (10) 2310-2315 2000/10

    Publisher: (株)最新医学社

    ISSN: 0370-8241

  104. RAの疾患遺伝子候補DblホモログマウスMcf‐2 cDNAの単離

    向江直子, 北川道憲, 駒井浩一郎, 小西良武, 乾匡範, 高井俊行, 塩沢俊一

    リウマチ 40 (2) 416-416 2000/04/26

    Publisher: (一社)日本リウマチ学会

    ISSN: 0300-9157

  105. Fc gamma receptor IIB-deficient mice develop Goodpasture's Syndrome upon immunization with type IV collagen.

    T Takai, A Nakamura, T Yuasa, A Ujike, M Ono, T Nukiwa, JV Ravetch

    FASEB JOURNAL 14 (6) A994-A994 2000/04

    ISSN: 0892-6638

  106. Fc受容体による免疫抑制とその破綻

    高井 俊行

    日本皮膚科学会雑誌 = THE JAPANESE JOURNAL OF DERMATOLOGY 110 (4) 534-536 2000/03/20

    ISSN: 0021-499X

  107. 【アレルギー反応の機構をめぐって】 マスト細胞の活性化とFcγレセプター

    中村 晃, 氏家 あづさ, 石川 陽子, 小野 栄夫, 高井 俊行

    臨床免疫 33 (2) 149-153 2000/02

    Publisher: (有)科学評論社

    ISSN: 0386-9695

  108. 活性化・抑制の両者を制御するPIR (免疫系を調節する分子)

    高井 俊行, 小野 栄夫

    免疫 (1999) 46-54 1999/07

    Publisher: 中山書店

    ISSN: 0918-6557

  109. Modulation of IGE-mediated systemic anaphylaxis by murine low affinity Fc receptors for IgG.

    A Ujike, Y Ishikawa, M Ono, T Yuasa, T Yoshino, M Fukumoto, JV Ravetch, T Takai

    FASEB JOURNAL 13 (4) A324-A324 1999/03

    DOI: 10.1084/jem.189.10.1573  

    ISSN: 0892-6638

    eISSN: 1530-6860

  110. Deletion of Fc gamma RIIB renders H-2(b) mice susceptible to collagen-induced arthritis.

    T Yuasa, S Kubo, T Yoshino, A Ujike, K Matsumura, M Ono, JV Ravetch, T Takai

    FASEB JOURNAL 13 (5) A1120-A1120 1999/03

    DOI: 10.1084/jem.189.1.187  

    ISSN: 0892-6638

  111. Stimulatory function of Paired Immunoglobulin-like Receptor-A in mast cell line by associating with subunits comm on to Fc receptors

    ONO Masao, YUASA Takae, RA Chisei, TAKAI Toshiyuki

    21 185-185 1998/12/01

  112. Generation and analysis of FcγRIII-deficient mice

    ISHIKAWA Yoko, UJIKE Azusa, YUASA Takae, ONO Masao, TAKAI Toshiyuki

    21 587-587 1998/12/01

  113. Inhibitory function of paired immunoglobulin-like receptor-B(PIR-B)in RBL-2H3 cells

    TAKEDA Kazuhiko, YAMASHITA Yumi, ONO Masao, TAKAI Toshiyuki

    21 587-587 1998/12/01

  114. Positive and Negative Immune Regulation via Fc Receptors

    TAKAI T.

    110 (2) 189-192 1998/12

    ISSN: 0040-8700

  115. Functional analysis of Fc receptors in hypersensitive responses by gene targeting.

    Takai Toshiyuki

    10 119-119 1998

    Publisher: 日本生物工学会

  116. Fcレセプタ-とアレルギ- (特集 アレルギ-疾患の分子機構)

    高井 俊行, 小野 栄夫

    モレキュラ-メディシン 34 (12) 1464-1476 1997/12

    Publisher: 中山書店

    ISSN: 0918-6557

  117. Fcレセプタ-と抗体産生制御

    高井 俊行

    臨床免疫 29 (7) 898-904 1997/07

    Publisher: 科学評論社

    ISSN: 0386-9695

  118. Immunoregulatory functions of Fc receptors

    TAKAI Toshiyuki

    69 (6) 394-409 1997/06/25

    Publisher: 日本生化学会

    ISSN: 0037-1017

  119. Fcレセプタ-欠損マウス (特集 B細胞・免疫グロブリンと疾患)

    高井 俊行, 山下 由美

    モレキュラ-メディシン 34 (1) 44-54 1997/01

    Publisher: 中山書店

    ISSN: 0918-6557

  120. Fcγレセプターによる免疫制御 (免疫生物学)

    高井 俊行

    免疫 (1996) 144-153 1996/08

    Publisher: 中山書店

    ISSN: 0918-6557

  121. Fc受容体ノックアウトマウスを用いた炎症反応の解析

    高井 俊行, 久保 聡司, 疋田 正喜, 大森 斉, 羅 智靖, 小野 栄夫, RAVETCH Jeffrey v.

    日本分子生物学会年会プログラム・講演要旨集 19 20-20 1996/08

  122. 8-メルカプトグアノシンによる抗原レセプター依存性のIgEクラススイッチ誘導機構の解析

    疋田 正喜, 高井 俊行, 大森 斉

    日本分子生物学会年会プログラム・講演要旨集 19 342-342 1996/08/01

  123. Isolation and analysis of B cell hybridoma that can undergo isotype switching to IgE by stimulation via antigen-receptor.

    Hikida Masaki, Ueura Norichika, Takai Toshiyuki, Ohmori Hitoshi

    8 26-26 1996

    Publisher: 日本生物工学会

  124. Generation and analysis of Fcy RII-deficient mice by gene targeting.

    Ueura Norichika, Takai Toshiyuki, Kubo Satoshi, Hikida Masaki, Ohmori Hitoshi, Ono Masao, Ravetch J. V.

    7 156-156 1995

    Publisher: 日本生物工学会

  125. Screening of novel immunosuppressive agents from fish enteric bacteria.

    Raito Masayuki, Hikida Masaki, Takai Toshiyuki, Yazawa Kazunaga, Omori Hitoshi

    7 156-156 1995

    Publisher: 日本生物工学会

  126. Isolation and charachterization of helper T cell subclones with different potencies to induce IgE response

    Ujike Azusa, Hikida Masaki, Takai Toshiyuki, Ohmori Hitoshi

    7 157-157 1995

    Publisher: 日本生物工学会

  127. Generation of FcγRII-deficient mouse by targeted disruption of the gene in ES cells.

    Takai Toshiyuki, Hayami Keiko, Ohmori Hitoshi, Ravetch Jeffrey V.

    6 241-241 1994

    Publisher: 日本生物工学会

  128. Enhancement of introduced gene expression in mammalian cells by heat shock and a prostaglandin derivative.

    Matsuda Taichi, Tanigawa Takahiro, Hikida Masaki, Takai Toshiyuki, Ohmori Hitoshi

    5 195-195 1993

    Publisher: 日本生物工学会

  129. Stimulation of introduced gene expression in mammalian cells by 5-azacytidine and L-azetidine-2-carboxylic acid.

    Matsuda Taichi, Tanigawa Takahiro, Hikida Masaki, Takai Toshiyuki, Yasuda Tatsuji, Takebe Yutaka, Ohmori Hitoshi

    4 188-188 1992

    Publisher: 日本生物工学会

  130. Establishment of a target cell line for the assay of cytotoxic T cell activity.

    Ohmori Hitoshi, Takai Toshiyuki, Honma Yoichi, Tanigawa Takahiro

    3 159-159 1991

    Publisher: 日本醗酵工学会

  131. ニワトリ成長過程における肝アセチルCoAカルボキシラーゼmRNAの変動

    田辺 忠, 高井 俊行, 横山 知永子

    脂質生化学研究 31 159-162 1989/07

    Publisher: 日本脂質生化学会

    ISSN: 0285-1520

Show all ︎Show first 5

Presentations 140

  1. Immunoreceptors Regulating Autoantibody Production in Aging. International-presentation

    TAKAI Toshiyuki

    Tohoku Forum for Creativity Thematic Program 2017 Aging Science: from Molecules to Society 2017/05/11

  2. 免疫制御と疾患におけるIgGとFcレセプター. Invited

    高井 俊行

    第3回FcR研究フォーラム2017 2017/03/01

  3. Regulatory receptor LILRB4 characterizes pathogenic plasma cells in SLE. International-presentation

    TAKAI Toshiyuki

    11th International Symposium of The Institute Network “Frontiers in Biomedical Sciences” 2017/01/27

  4. 免疫制御と疾患におけるIgGとFcレセプター. Invited

    高井 俊行

    Fc Summit 2016/11/26

  5. 川崎病患者に対する免疫グロブリン大量療法前後における抑制性受容体LILRB発現の変化について.

    久間木悟, 乾匡範, 飛内章子, 三浦舞子, 目時嵩也, 渡邊庸平, 大沼良一, 野口理恵, 貴田岡節子, 高井俊行

    日本川崎病学会 2016/09/30

  6. TREM2/DAP12を介するミクログリア活性化は神経障害性疼痛を増悪させる.

    小西博之, 小林正明, 高井俊行, 木山博資

    第59回日本神経化学会大 2016/09/08

  7. 全身性エリテマトーデスにおけるBリンパ球系細胞の抑制性受容体. Invited

    高井 俊行

    第65回日本アレルギー学会学術大会 2016/06/18

  8. Regulatory receptors characterizing peripheral B-lineage cells in SLE. International-presentation Invited

    TAKAI Toshiyuki

    Antibody and Fc Receptor Biology: Bench to Bedside–A Special Symposium to Honor Jeffrey V. Ravetch on his 65th Birthdayシンポジウム 2016/05/09

  9. B-cell regulatory receptors in SLE. Invited

    高井 俊行

    第44回日本免疫学会学術集会共催テクニカルセミナー 2015/11/18

  10. 自己抗体の産生源を探る. Invited

    高井 俊行

    第11回東北大学REDEEMシンポジウム 2015/09/12

  11. Roles of Inhibitory Immunoreceptors in Autoimmunity. International-presentation Invited

    高井 俊行

    International Mini-symposium for immune regulation 2015/04/06

  12. 疾患制御におけるIgGとFcレセプター. Invited

    高井 俊行

    免疫グロブリンセミナー2015 2015/03/04

  13. Putative B1 cells and plasmablasts are distinguishable in their inhibitory receptor expression and immunoglobulin secretion profiles.

    Wong Yi Li, INUI Masanori, TAKAI Toshiyuki

    第43回日本免疫学会学術集会 2014/12/12

  14. The endoplasmic reticulum-resident membrane protein Nogo-B modulates Toll-like receptor responses to nucleic acids in macrophages.

    KIMURA Toshihfumi, INUI Masanori, TAKAI Toshiyuki

    第43回日本免疫学会学術集会 2014/12/11

  15. ヒトFcRⅡの免疫制御における役割. Invited

    高井 俊行

    第1回FcRフォーラム研究会2014 2014/10/22

  16. 血小板を介する新たな炎症制御機構の同定.

    乾匡範, 田澤樹乃, 岸義朗, 高井俊行

    第87回日本生化学会大会 2014/10/17

  17. Nogo-B(Reticulon 4B) regulates unreacellular TLR pathway through interaction with GRAMD4.

    木村俊文, 乾匡範, 高井俊行

    第87回日本生化学大会 2014/10/17

  18. Fc受容体による自己免疫の制御. Invited

    高井 俊行

    第79回インターフェロン・サイトカイン学会学術集会 2014/06/19

  19. Modulation of Toll-like receptor signaling by Nogo in macrophages.

    木村俊文, 乾匡範, 高井俊行

    第42回日本免疫学会学術集会 2013/12/13

  20. Identification of a novel regulatory pathway of inflammation via platelets.

    田澤樹乃, 乾匡範, 髙井俊行

    第42回日本免疫学会学術集会 2013/12/13

  21. 抑制性Fcレセプターによる自己抗体の産生制御. Invited

    高井 俊行

    Advanced Seminar Series on Microbiology and Immunology 2013/11/12

  22. 抑制性FcレセプターFcγRIIBによる自己抗体の産生制御. Invited

    高井 俊行

    金沢医科大学大学院医学系セミナー 2013/06/14

  23. Negative Regulation of Autoantibody Production by a B Cell Inhibitory. International-presentation

    TAKAI Toshiyuki

    2013/05/10

  24. Negative Regulation of Autoantibody Production by a B Cell Inhibitory Receptor, FcγRIIB. International-presentation Invited

    高井 俊行

    Centennial of Hashimoto Disease Symposium, International Symposium II: Autoimmune Diseases–Etiology and Therapeutics 2012/12/03

  25. Autoimmune disease in B6.Slam129 mice.

    Kanari Y, Sugahara-Tobinai A, Takai T

    CREST Workshop on Inflammation and Autoimmunity 2012/11/15

  26. Regulatory effects of IgG on B cell functions. Invited

    高井 俊行

    RCAI Workshop 2012/03/23

  27. Updata understanding of the mechanism of action of IVIG. International-presentation

    高井 俊行

    10th International Kawasaki Disease Symposium 2012/02/08

  28. Regulation of TLR9 and autoimmunity by PirB, a multiligand inhibitory receptor. Invited

    高井 俊行

    Second CSI/JSI/KAI Joint Symposium on Immunology “Regulation of Immune Responses in Health and Diseases” 2011/12/06

  29. Differential but competitive binding of Nogo and MHC class I to PIR-B regulates LPS-activated mast cells.

    Shinozaki N, Inui M, Endo S, Sakamoto Y, Kitaguchi K, Kuroki K, Maenaka K, Takai T

    2011 The annual meeting of the Japanese society for immunology 2011/11/29

  30. Transcriptional activation of the PIR-B gene in B cells by PU.1 and Runx3.

    Kitaguchi K, Arita K, Endo S, Kaifu T, Nakamura A, Takai T

    2011 The annual meeting of the Japanese society for immunology 2011/11/28

  31. A suppressive effect of IVIg on B1 cell activation and production of natural antibodies.

    Hirano K, Tanaka J, Sakamoto Y, Looi CY, Nakano A, Itoh Y, Takai T

    The annual meeting of the Japanese society for immunology 2011/11/27

  32. Fcγ receptor targeting–How ITIM receptors regulate. International-presentation Invited

    高井 俊行

    Bio-Rheumatology International Congress (BRIC) Tokyo / The 8th GARN Meeting 2011/11/15

  33. NogoおよびMHCクラスIによるPIR-Bへの競合的結合によるマスト細胞の制御について

    篠﨑夏子, 乾 匡範, 遠藤章太, 坂本 譲, 北口公司, 高井俊行

    第61回日本アレルギー学会秋季学術大会 2011/11/11

  34. NogoおよびMHC class IによるPIR-Bを介した新たなマスト細胞の制御機構

    乾 匡範, 篠﨑夏子, 遠藤章太, 高井俊行

    第61回日本アレルギー学会秋季学術大会 2011/11/11

  35. 抗体療法とFcレセプター Invited

    高井 俊行

    第31回日本川崎病学会・学術集会ランチョンセミナー2 2011/10/01

  36. Fc受容体と免疫疾患について Invited

    高井 俊行

    第16回シェーグレン症候群セミナー 2011/06/04

  37. Targeting Fc receptors. Invited

    高井 俊行

    第32回日本炎症・再生医学会 2011/06/02

  38. Regulation of TLR9 activation and autoantibody production in B-1 cells by PIR-B, an MHC class I receptor. International-presentation Invited

    高井 俊行

    8th German–Japanese Symposium. 2010/09/26

  39. Regulation of autoimmunity by PIR-B. International-presentation Invited

    高井 俊行

    Asian Aging Core for Longevity 2010 2010/08/22

  40. 自己免疫疾患におけるIVIG療法の作用機序の最新知見 Invited

    高井 俊行

    献血ベニロン-I発売30周年記念講演会 2010/07/10

  41. Regulation of cytotoxic T lymphocyte activity by CD8 and PIR-B. International-presentation

    Endo S, Sakamoto Y, Kobayashi E, Nakamura A, Takai T

    The 5th International Symposium of Institute Network 2010/06/24

  42. 制性受容体による免疫制御機構の解析

    高井 俊行

    日本薬学会第130年会 2010/03/28

  43. A novel regulatory system for TLR9 and autoimmunity mediated by PIR-B in B-1 cells. International-presentation Invited

    高井 俊行

    Tohoku University Gloval COE “Network Medicine” The 1st International Symposium 2009/12/07

  44. 免疫抑制性レセプターPIR-Bによるアレルギー制御 Invited

    高井 俊行

    第59回日本アレルギー学会秋季学術大会 2009/10/29

  45. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. International-presentation Invited

    高井 俊行

    2009 4th Medical Biotech Forum. 2009/08/08

  46. Fcレセプターによる免疫制御について Invited

    高井 俊行

    第43回大和免疫アレルギー研究会 2009/07/14

  47. Immunogenicity and Antibodies as Immunodiagnostics. International-presentation Invited

    Takai T, Kubo T, Uchida Y, Watanabe Y, Abe M, Nakamura A

    BIT’s 1st Annual International Congress of Antibody-2009 Beijing 2009/05/09

  48. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive rheumatoid factor production and autoimmunity. International-presentation Invited

    高井 俊行

    BIT’s Life Sciences’ 2nd Annual Protein and Peptide Conference (PepCon 2009) 2009/04/03

  49. Activation of osteoclastogenesis by ITAM-bearing immunoreceptors Invited

    高井 俊行

    日本分子生物学会BMB2008 2008/12/11

  50. Fc受容体と自己免疫. Invited

    高井 俊行

    52回日本リウマチ学会総会・学術集会シンポジウム 2008/04/20

  51. Regulation of autoimmunity by PIR-B, an inhibitory receptor for class I MHC. International-presentation Invited

    高井 俊行

    The Joint Symposium of the 3rd International Symposium of Institutes Network and Hot spring Harbor International Symposium” Cell-fate Decision: Function and Dysfunction in Host Defense -Tumor, Infection and Immunity- Venue 2008/02/02

  52. ペア型制御レセプターPIRのクラスI MHC認識を介した免疫調節機構 Invited

    高井 俊行

    生化学会,分子生物学会合同年会ワークショップ 2007/12/11

  53. 「自己免疫疾患におけるIVIGの作用機序とFcレセプター」

    高井 俊行

    第27回日本川崎病研究会ランチョンセミナー 2007/10/11

  54. Immune regulation by PIR-B, a novel receptor for MHC class I molecules International-presentation

    Toshiyuki Takai

    Centre of Excellence Joint Symposium 2007/09/05

  55. A murine inhibitory integrin gp49B negatively regulates dendritic cell function in vitro and in vivo

    KASAI Satoshi, INUI Masanori, NAKAMURA Akira, TAKAI Toshiyuki

    第36回 日本免疫学会総会・学術集会 2006/12/26

  56. Constitutive binding of PIR-B to MHC class I regulates mast cell activation and anaphylaxis

    NAKAMURA Akira, SAKAMOTO Yuzuru, TAKAI Toshiyuki

    第36回 日本免疫学会総会・学術集会 2006/12/11

  57. Regulation of human osteoclast development by LILRB4 in vitro

    MORI Yu, INUI Masanori, TSUJI Sukenao, NAKAMURA Akira, TAKAI Toshiyuki

    第36回 日本免疫学会総会・学術集会 2006/12/11

  58. Regulation of in vitro osteoclast development by paired Ig-like receptor (PIR)-B

    TSUJI Sukenao, INUI Masanori, MORI Yu, NAKAMURA Akira, TAKAI Toshiyuki

    第36回 日本免疫学会総会・学術集会 2006/12/11

  59. Paired immunoglobulin-like receptor (PIR)-B on antigen-presenting cells recognize MHC class I expressed on T cells at the immunological synapus

    SAKAMOTO Yuzuru, NAKAMURA Akira, TAKAI Toshiyuki

    第36回 日本免疫学会総会・学術集会 2006/11/11

  60. Hydronephrosis associated with anti-urothelial and anti-nuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- mice

    Taku Okazaki, Yumi Otaka, Jian Wang, Toshiyuki Takai, Jeffrey V. Ravetch, d Tasuku

    国際分子生物学会京都 2006/10/24

  61. 破骨細胞の分化をコントロールする免疫系のレセプター」

    高井俊行, 招待講演, 東北大加齢

    東北大学大学院歯学研究科インターフェインターフェイス口腔健康科学第15回学術フォーラム 2006/07/19

  62. Paired Immunoglobulin-like Receptor (PIR)-Bによるリガンド認識機構

    小林栄治, 小林圭輔, 中村晃, 高井俊行

    第1回COE相互交流、若手研究者の会 2006/07/14

  63. “Role of paired immunoglobulin-like receptor (PIR)-B in allergic responses”

    Takai T, speaker, IDAC, Tohoku Universi

    RCAI-JSI International Symposium on Immunology 2006/06/16

  64. “Role of paired immunoglobulin-like receptor (PIR)-B in allergic responses”

    高井俊行

    RCAI-JSI International Symposium on Immunology 2006/06/16

  65. Regulation of human osteoblast development by LILRB4 in vitro. 1st International-presentation

    Mori Y, Inui M, Tsuji S, Nakamura A, Takai T (IDAC, Tohoku Universi

    International Conference on Osteoimmunology 2006/05/28

  66. Cis binding of PIR-B to MHC class I on mast cells suppress allergic responses International-presentation

    Nakamura A, Masuda A, Maeda T, Takai T, ite, Speaker, IDAC, Tohoku Universi

    Immunology 2006 2006/05/12

  67. Enhanced mucosal IgA responses in PIR-B deficient mice International-presentation

    Kobayashi R, Alabama at Birmingham, USA, Kubagawa H, Takai T, Sekine S, McGhee J.R, Fujihashi K

    Immunology 2006 2006/05/12

  68. Fcg receptors participate in the development of autoimmune diabetes in NOD mice International-presentation

    Inoue Y, Nakamura A, Takai T (IDAC, Tohoku Universi

    Immunology 2006 2006/05/12

  69. 「Paired immunoglobulin-like receptor (PIR)-B欠損樹状細胞によるMHCクラスI拘束性抗原提示の増強」

    遠藤章太, 中村晃, 高井俊行

    東北免疫研究会 2006/03/17

  70. Fcレセプター

    高井俊行, 指定講演, 東北大加齢

    第35回日本免疫学会総会・学術集会 2005/12/13

  71. Fcレセプター

    高井俊行, 指定講演, 東北大加齢

    第35回日本免疫学会総会・学術集会 レビュートーク 2005/12/13

  72. Involvement of Fcγ receptors in the autoimmune type I diabetes of NOD mice

    Inoue Y, Nakamura A, Takai T (IDAC, Tohoku Universi

    第35 回 日本免疫学会総会・学術集会 2005/12/13

  73. Enhanced MHC class I-restricted antigen presentation by Paired immunoglobulin-like receptor (PIR)-B deficient dendritic cell

    Endo S, Nakamura A, Takai T (IDAC, Tohoku Universi

    第35 回 日本免疫学会総会・学術集会 2005/12/13

  74. LANIER Lewis L.、荒瀬尚:NK細胞の活性化 CD200レセプターを介した新たな標的細胞認識機構

    石川 哲, 阪大, 微研, 免疫化学, 千葉大, 院医, 加齢呼吸器病態制御学, 白鳥行大, 荒瀬規子, 高井俊行

    第35回日本免疫学会総会・学術集会 2005/12/13

  75. Plexin-A1 utilizes the Trem-2/DAP12 receptor complex as a co-receptor in the immune system

    Takegahara N, Kumanogoh A, Takamatsu H, Takai T, Kikutani H, Dept.Molecular, Immunology, BIKEN, Osaka Un

    第35回日本免疫学会総会・学術集会 2005/12/13

  76. Fcレセプター International-presentation

    高井俊行

    2005年日本免疫学会総会・学術集会 レビュートーク 2005/12/13

  77. 新しい自己認識レセプターPIRによる免疫制御と疾患

    高井俊行, 指定講演, 東北大加齢

    2005年日本分子生物学会 シンポジウム 2005/12/07

  78. 免疫系における分子認識とその制御

    高井俊行, 指定講演, 東北大加齢

    2005年日本分子生物学会 シンポジウム「免疫系における分子認識とその制御」 2005/12/07

  79. 新しい自己認識レセプターPIRによる免疫制御と疾患

    高井俊行

    2005年日本分子生物学会 シンポジウム 「免疫系における分子認識とその制御」 2005/12/07

  80. イムノグロブリンとその受容体をめぐる最近の話題最近の話題

    高井俊行, 招待講演, 東北大加齢

    第1回神経治療を考える会 2005/11/21

  81. イムノグロブリンとその受容体をめぐる最近の話題

    高井俊行, 招待講演, 東北大加齢

    第1回神経治療を考える会 2005/11/21

  82. 「免疫制御レセプターFcRとPIRをめぐる最近の話題」

    高井俊行

    献血ベニロンI発売25周年記念学術講演会 2005/11/11

  83. 免疫制御レセプターFcRとPIRをめぐる

    高井俊行, 招待講演, 東北大加齢

    愛媛県医師会主催 2005/11/11

  84. 免疫制御レセプターFcRとPIRをめぐる最近の話題

    高井俊行

    愛媛県医師会主催 免疫制御レセプターFcRとPIRをめぐる最近の話題 2005/11/11

  85. PIRによる新しい自己認識システム

    高井俊行

    神戸大学大学院医学研究科セミナー 2005/09/13

  86. 加齢と免疫〜調節性レセプターの観点から〜

    高井俊行

    第1回加齢皮膚医学研究会 2005/08/20

  87. Immunoreceptors, calcium, and bone remodeling International-presentation

    Takai T, ite, Speaker, IDAC, Tohoku Universi

    Gordon Conference on Bones and Teeth 2005/07/13

  88. PIRによるMHCクラスI分子認識とその意義

    高井俊行, 招待講演, 東北大加齢

    第5回日本蛋白質科学会年会ワークショップ「免疫シグナル伝達におけるタンパク質の分子認識」 2005/07/01

  89. 破骨細胞分化におけるPaired Immunoglobulin-like receptor (PIR)-Bの役割の検討

    乾 匡範, 辻 佑直, 森 優, 高井俊行

    「シグナル伝達病の治療戦略創生拠点」COE第2回若手研究交流会 2005/07/01

  90. IgGとアレルギー

    高井俊行, 教育講演, 東北大加齢

    第17回日本アレルギー学会春季臨床大会 2005/06/01

  91. Fcレセプターによる免疫制御とその応用

    高井俊行

    東京小児感染免疫懇話会 2005/05/24

  92. Exacerbated GVHD in mice devoid of PIR-B, an inhibitory receptor for MHC class I molecules

    Takai T, ite, Speaker, IDAC, Tohoku University

    . The Sixth Nagoya International Blood and Marrow Transplantation Symposium 2005/05/22

  93. PIRによる新しい自己認識システム

    高井俊行, 招待講演, 東北大加齢

    科学技術振興機構2005年第1回基礎研究報告会 2005/04/15

  94. Establishment of Immortalized Natural Killer Cell Lines with Natural Killing and Cytokine Production from Temperature-sensitive SV40T Transgenic Mice International-presentation

    Kaifu T, Iizuka S, Itou K, Obinata M, Takai T (IDAC, Tohoku Universi

    Experimental Biology 2005 2005/04/02

  95. Fcγレセプターによる免疫制御と疾患

    高井俊行, 招待講演, 東北大加齢

    第23回日本耳鼻咽喉科免疫アレルギー学会 2005/03/03

  96. PIRによる新しい自己認識システム

    高井俊行

    群馬大学生体調節研究所ゼミ 2005/02/21

  97. FcレセプターとPIRによる免疫制御と疾患

    高井俊行

    三風会 2005/01/28

  98. GVHDにおけるPaired Immunoglobulin-like Receptorの役割

    高井俊行, シンポジウム招待講演

    第27回日本造血細胞移植学会スポンサードシンポジウム2「GVHD:基礎研究から臨床応用への時代 2004/12/16

  99. A novel MHC class I recognition system by Paired immunoglobulin-like receptor

    中村 晃, 小林栄治, 高井俊行

    第27回日本分子生物学会年会 2004/12/08

  100. : A novel MHC class I recognition system by paired immunoglobulin- like receptor

    小林栄治, 中村晃, 高井俊行

    第27回日本分子生物学会年会 2004/12/08

  101. Exacerbated Graft-versus-Host Disease in PIR-B-Deficient Mice

    Takai T, Nakamura A, Kobayashi E, Invi

    日米医学協力計画40周年記念事業シンポジウム 2004/12/08

  102. Exacerbated Graft-versus-Host Disease in PIR-B-Deficinet Mice

    Toshiyuki Takai, Akira Nakamura, Eiji Kobayashi

    40th Anniversary United States?Japan Cooperative Medical Science Program 2004/12/07

  103. Paired immunoglobulin-like receptor (PIR)による移植片対宿主病 (GVHD)の制御

    中村 晃, 小林栄治, 高井俊行

    第34回 日本免疫学会総会・学術集会 2004/12/02

  104. Sema6Dはplexin-A1を介して免疫細胞を活性化する

    竹ヶ原宣子, 熊ノ郷淳, 山本みどり, 高松漂太, 識名 崇, 丸川聡子, 石田 勲, 高井俊行, 菊谷 仁

    第34回 日本免疫学会総会・学術集会 2004/12/02

  105. アダプター分子DAP12およびFcR?を介するITAMシグナルは破骨細胞分化に必須である

    乾 匡範, 古賀貴子, 井上和也, 谷口維紹, 高柳 広, 高井俊行

    第34 回 日本免疫学会総会・学術集会 2004/12/02

  106. ITAM-dependent costimulatory signals are essential for the maintenance of bone homeostasis

    Inoue K, Inui M, Koga T, Taniguchi T, Takayanagi H, Takai T (IDAC, Tohoku Universi

    第77回日本生化学学会大会 2004/10/14

  107. ITAM-dependent costimulatory signals are essential for the maintenance of bone homeostasis

    Inoue K, Inui M, Koga T, Taniguchi T, Takayanagi H, Takai T (IDAC, Tohoku Universi

    第77回日本生化学学会大会 2004/10/14

  108. ITAMを介した共刺激シグナルはRANKLによる破骨細胞分化に必須である

    古賀貴子, 乾 匡範, 末松綾子, 谷口維紹, 高井俊行, 高柳 広

    日本骨代謝学会 2004/08/04

  109. ITAMを介した共刺激シグナルはRANKLによる破骨細胞分化に必須である

    古賀貴子, 乾 匡範, 末松綾子, 谷口維紹, 高井俊行, 高柳 広

    日本骨代謝学会 2004/08/04

  110. Augmented anaphylactic responses due to hypersensitive mast cells in PIR-B-deficient Mice International-presentation

    Nakamura A, Masuda A, Maeda T, Takai T (IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  111. Defective ligation of paired Ig-like receptor (PIR)-B to MHC Class I molecules leads to exacerbated graft-versus-host disease (GVHD) International-presentation

    Nakamura A, Kobayashi E, Takai T. (IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  112. Establishment and characterization of novel mast cell lines derived from temperature-sensitive mutant of SV40 large T antigen transgenic mice International-presentation

    Kanehira M, Yumi Y, Ito K, Kaifu T, Nakamura A, Obinata M, Takai T (IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  113. Antigen targeting to Fc?RIIB and Fc?RI/III on bone marrow-derived dendritic cells efficiently elicits humoral response and cytotoxic T lymphocytes in vivo International-presentation

    Endo S, Akiyama K, Yada A, Ebihara S, Matsumura K, Maeda T, Nakamura A, Aiba S, Nukiwa T, Takai T(IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  114. Immortalized dendritic cell line with efficient cross-presentation ability established from transgenic mice harboring temperature-sensitive SV40 large T-antigen gene International-presentation

    Kaifu T, Ebihara S, Endo S, Itoh Y, Akiyama K, Nakamura A, Obinata M, Takai T. (IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  115. Exacerbated graft-versus-host diseases in Pirb-/-mice International-presentation

    Kobayashi E, Nakamura A, Takai T (IDAC, Tohoku Universi

    International congress of immunology 2004/07/26

  116. : Exacerbated graft-versus-host disease in Pirb-/-mice International-presentation

    Eiji Kobayashi, Akira Nakamura, Toshiyuki Takai

    12th International Congress of Immunology and 4th Annual Conference of FOCIS 2004/07/18

  117. ペア型イムノグロブリン様受容体PIR-BによるGVHDの抑制

    高井俊行

    第7回造血器腫瘍シンポジウム 2004/07/10

  118. Defective ligation of PIR-B to MHC class I molecules leads to accelerated graft-versus-host disease (GVHD) International-presentation

    Nakamura A, Kobayashi E, Takai T. (IDAC, Tohoku Universi

    Experimental biology 2004 2004/04/26

  119. Augmented anaphylactic responses in PIR-B-deficient mice International-presentation

    Masuda A, Maeda T, Nakamura A, Takai T. (IDAC, Tohoku Universi

    Experimental biology 2004 2004/04/26

  120. Targeting apoptotic tumor cells to Fc? receptors provides efficient and versatile vaccination against tumors by dendritic cells International-presentation

    Akiyama K, Ebihara S, Yada A, Matsumura K, Aiba S, Nukiwa T, Takai T (IDAC, Tohoku Universi

    International Symposium on Predictive Oncology and Intervention 2004/02/26

  121. DAP12遺伝子欠損マウスの骨形成異常と視床中心性のミエリン形成低下,劣性遺伝子Nasu-Hakora との関連について

    乾 匡範, 高井俊行

    .第25回日本分子生物学会年会 2003/12/13

  122. サンドホフ病における抗ガングリオシド抗体による中枢神経系への影響

    山口 章, 勝山佳代子, 山中正二, 高井俊行, 青木一郎

    第26回日本分子生物学会年会 2003/12/13

  123. GM2 GangliosidesとFcR : FcR 欠損によるサンドホフ病モデルでの神経症状の改善

    山口 章, 勝山佳代子, 山中正二, 高井俊行, 青木一郎

    第33回日本免疫学会総会・学術集会 2003/12/10

  124. Paired Immunoglobulin-like Receptor(PIR)-Bによるマスト細胞の恒常的抑制

    前田努, 高井俊行

    第33回日本免疫学会総会 2003/12/09

  125. Paired Immunogobuli-like Receptor (PIR)-Bによるマスト細胞の恒常的抑制

    前田 努, 増田 愛, 中村 晃, 高井俊行

    第33回 日本免疫学会総会・学術集会 2003/12/09

  126. 温度感受性SV40 Large T抗原トランスジェニックマウスからの株化マスト細胞の樹立ならびに機能解析

    兼平雅彦, 伊藤 梢, 伊藤由美, 中村 晃, 高井俊行

    第33回日本免疫学会総会 2003/12/09

  127. Synergistic regulation of autoimmune disease by PD-1 and Fc?RIIB

    Otaka Y, e, t, Med. Chem, Kyoto University, Okazaki T, Wang J, Takai T, Honjo T

    第33回 日本免疫学会総会・学術集会 2003/12/09

  128. 温度感受性SV40Large Tトランスジェニックマウス由来の新規樹状細胞クローンによる強い抗腫瘍活性

    遠藤章太, 海老原伸, 前田 努, 秋山健一, 伊藤 梢, 伊藤由美, 中村 晃, 高井俊行

    第33回日本免疫学会総会 2003/12/08

  129. 抑制性免疫グロブリン受容体FcγRIIBと自己免疫疾患

    高井俊行

    第35回日本小児感染症学会総会 2003/11/07

  130. DAP12 deficiency results in osteopetrosis and thalamic hypomyelinosis with synaptic degeneration International-presentation

    Inui M, Nakahara J, Kaifu T, Mishima K, Momiyama T, Kaji M, Sugahara A, Koito H, Ujike-Asai A, Nakamura A, Kanazawa K, Tan-Takeuchi K, Iwasaki K, Yokoyama W.M, Kudo A, Fujiwara M, Asou H, Takai T (IDAC, Tohoku Universi

    HUPO 2nd annual and IUBMB XIX Joint World Congress 2003/10/26

  131. PIR-B欠損マウスにおけるI型アレルギーの亢進.アレルギー

    高井俊行

    PIR-B欠損マウスにおけるI型アレルギーの亢進.アレルギー学会総会 シンポジウム8:関連トピックス 2003/10/24

  132. T helper 2-prone immune responses and enhanced severity of anaphylaxis in Paired Immunoglobulin-like Receptor(PIR)-B-deficient mice

    高井俊行

    第76回日本生化学大会 2003/10/18

  133. Antigen targeting to Fc? receptors on bone marrow-derived dendritic cells efficiently elicits humoral response and cytotoxic T lymphocytes In Vivo

    Endo S, Akiyama K, Yada A, Ebihara S, Matsumura K, Maeda T, Nakamura A, Aiba S, Nukiwa T, Takai T (IDAC, Tohoku Univer

    International Workshop on Langerhans Cells 2003/09/26

  134. FcRおよびPIR-Bによるアレルギーの制御Inhibition of allergic responses by FcR and PIR-B

    高井俊行

    国際痒みシンポジウム大阪 2003/09/06

  135. 痴呆を必発する那須ハコラ病の脂質代謝異常の病態生理の解析

    高井俊行

    財団法人 小野医学研究財団 第14回研究成果発表会 2003/06/07

  136. Increased susceptibility to LPS-induced endotoxin shock in Secretory leukoprotease inhibitor (SLPI)-deficient mice International-presentation

    Nakamura A, Mori Y, Hagiwara K, Suzuki T, Kikuchi T, Ebina M, Takai T, Nukiwa T

    Association of Immunologists IMMUNOLOGY 2003 2003/05/26

  137. Yajima K, Nakamura A, Sugahara A, Takai T International-presentation

    Yajima K, Nakamura A, Sugahara A, Takai T

    Association of Immunologists IMMUNOLOGY 2003 2003/05/26

  138. PIR-B欠損マウスにおけるI型アレルギーの亢進

    高井俊行

    第15回日本アレルギー学会春季臨床大会 2003/05/12

  139. Increased Susceptibility to LPS-Induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-Deficient Mice International-presentation

    中村晃, 高井俊行

    米国免疫学会 2003/05/10

  140. FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease International-presentation

    高井俊行

    米国免疫学会 2003/05/09

Show all Show first 5

Industrial Property Rights 19

  1. IMMUNE CHECKPOINT INHIBITOR

    Toshiyuki TAKAI, Masanori INUI, Shota ENDO, Mei-Tzu SU

    Property Type: Patent

  2. 炎症性疾患のマーカー

    高井俊行, 石井智徳, 藤井博司, 乾 匡範

    Property Type: Patent

  3. リウマチ関節炎高発症モデルマウス

    中村晃, 貫和敏博, 高井俊行

    特許3570674

    Property Type: Patent

  4. 大理石骨病モデル非ヒト動物

    高井俊行, 高柳 広, 乾 匡範, 古賀貴子

    特許5230893

    Property Type: Patent

  5. 移植片対宿主病モデル動物

    高井俊行, 中村 晃

    特許5242882

    Property Type: Patent

  6. 脳組織変性の診断方法

    高井俊行, 西條芳文, 菅原章子

    特許4550356

    Property Type: Patent

  7. ギランバレー症候群及び/又はフィッシャー症候群発症モデル非ヒト動物

    高井俊行, 中村晃, 矢島佳央里

    Property Type: Patent

  8. 骨髄由来の不死化樹状細胞株

    高井俊行, 海老原伸, 帯刀益夫, 伊藤由美, 伊藤梢

    特許4219789

    Property Type: Patent

  9. 死化ナチュラルキラー細胞株

    高井俊行, 飯塚悟, 帯刀益夫, 伊藤由美, 伊藤梢

    特許4033390

    Property Type: Patent

  10. 免疫応答の誘導方法

    秋山健一, 高井俊行, 貫和敏博

    Property Type: Patent

  11. Th2型過剰免疫応答モデル非ヒト動物

    高井俊行, 氏家あづさ

    特許3926603

    Property Type: Patent

  12. 全身性エリテマトーデスモデル非ヒト動物

    高井俊行, 中村晃, 矢島佳央里

    特許4653915

    Property Type: Patent

  13. オリゴデンドロサイト発達障害モデル非ヒト動物

    高井俊行, 阿相皓晃, 藤原道弘

    Property Type: Patent

  14. III型アレルギー炎症モデル動物

    湯浅貴恵, 小野栄夫, 渡邊武, 高井俊行

    特許3453348

    Property Type: Patent

  15. Fc受容体を介する寄生虫感染症治療薬のスクリーニング方法

    名和行文, 小野栄夫, 高井俊行

    Property Type: Patent

  16. Goodpasture症候群モデルマウス

    中村 晃, 貫和敏博, 高井俊行

    特許3410679

    Property Type: Patent

  17. Mice mutant for Fc receptors and method of treating autoimmune disease.

    effrey V. Ravetch, Toshiyuki Takai, Dianna Sylvestre, Raphael Clynes

    特許U.S. Patent 5,877,396

    Property Type: Patent

  18. 脱リン酸化酵素を阻害する新規ペプチド

    高井俊行, 山下由美, 小野栄夫

    Property Type: Patent

  19. アナフィラキシー抑制物質のスクリーニング方法

    濱田宗雄, 岡本全泰, 中田勝彦, 高井俊行

    Property Type: Patent

Show all Show first 5

Research Projects 31

  1. Mechanism of LILRB4-mediated immune checkpoint

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    2019/04/01 - 2022/03/31

    More details Close

    Regulatory mechanism of the immune checkpoint LILRB4 expressed mainly on myeloid-lineage cells such as macrophages and dendritic cells has not been clarified yet. We successfully identified its physiological ligand as fibronectin (FN), more specifically its N-terminal 30 kDa domain (FN30). We also found that upon recognition of FN30 by LILRB4, this regulatory receptor could suppress FN-binding integrin signal as well as focal adhesion-related signal associated with cell adhesion. Our findings identify for the first time a unique regulator of cell-adhesion-related intracellular signal.

  2. Modulating immunological memory of antibody-producing cells

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Research (Exploratory)

    Institution: Tohoku University

    2017/06/30 - 2020/03/31

    More details Close

    We established an experimental system composed of culturing murine bone marrow-derived mesenchymal stem cells (MSC) and plasma cells (PC) in vitro and monitoring antibody production levels after the 7-day culture. We found that the antibody production by PC was influenced by IL-6 and other soluble factors secreted by MSC and unidentified direct interaction between MSC and PC. We also suggested that the direct interaction involves binding between an immunoregulatory receptor LILRB4 (B4) on PC and a novel B4 ligand, B4L1, expressed on MSC.

  3. Identification of molecular characteristics of pathogenic autoantibody-producing cells

    TAKAI Toshiyuki, Inui Masanori, Itou Ari, Endo Shota, Su Mei-Tzu

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    2016/04/01 - 2019/03/31

    More details Close

    In this study, first we have found that expression of leukocyte immunoglobulin-like receptor (LILR)B4, an inhibitory member of the human LILR family, is augmented in autoantibody-producing plasmablasts/plasma cells (PCs) of systemic lupus erythematosus (SLE) patients. However, the mechanism behind the upregulation of LILRB4 upon pathogenic antibody-secreting cells is yet to be known. To clarify the mechanism, next we have examined if glycoprotein 49B (gp49B), the murine counterpart of human LILRB4, is also elevated in autoantibody-producing cells in several SLE mouse models. We have found that gp49B is indeed expressed on PC of SLE-prone models but not of healthy C57BL/6 mice, and the level was positively correlated to the autoantibody IgG titer in serum. Gp49B genetic deletion, however, did not abolish the serum autoantibodies or fully ameliorate the lethal glomerulonephritis, indicating that gp49B is not the sole regulator of lupus but a pathogenic element in the disease.

  4. The role of immunosuppressive receptor LILRB in the pathogenesis of Kawasaki disease, and its application to the therapy.

    Kumaki Satoru

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: Department of Clinical Research, National Hospital Organization Sendai Medical Center

    2014/04/01 - 2017/03/31

    More details Close

    Kawasaki disease (KD) is an acute vasculitis of unknown pathogenesis which occurs most frequently in early childhood, and intravenous immunoglobulin (IVIG) is effective. To obtain a mechanistic insight into the humoral immune response in KD patients, B cell subpopulations and the expression pattern of immunosuppressive receptor LILRB was analyzed. As a result, proportion of memory B cells increased in acute phase of the KD patients when compared with normal controls. Furthermore, the proportion of plasmablasts was significantly elevated in the acute phase of KD, which returned to the basal level after IVIG. From these results, it was suggested that adaptive immunity is involved in the pathogenesis of KD. In addition, we demonstrate that the expression of LILRB4 was enhanced in the acute phase of KD, and the expression was controlled by IVIG. These results suggest that plasmablasts with increased LILRB4 expression play an important role in the pathogenesis of KD.

  5. Platelets convert peripheral blood circulating monocytes to regulatory cells via immunoglobulin G and activating-type Fcg receptors.

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Exploratory Research

    Institution: Tohoku University

    2014/04/01 - 2016/03/31

    More details Close

    Augmented production of an immunoregulatory cytokine IL-10 with a concomitant reduction of proinflammatory cytokines in macrophages in vitro is attained by doubly stimulating the cells with a TLR ligand and IgG immune complexes, a response known as that of regulatory macrophages. However, it has not been explored sufficiently how such a regulatory response occurs in more physiologic settings. We showed that IgG-opsonized platelets convert human peripheral blood circulating monocytes to IL-10-producing regulatory monocytes in vitro and in vivo. This novel way of enhancing IL-10 was mediated by activating-type Fc receptor FcγRIIA. A therapeutic preparation of human polyclonal IgG (or IVIG) was found to react to platelets via the Fab portion, thereby converting circulating monocytes to regulatory cells. These findings indicate that the IgG-bound platelet-induced conversion provides a novel mechanism for homeostatic generation of regulatory monocytes.

  6. The role and networks of immune and nonimmune cells in the small intestine in the early stage of gastrointestinal parasite infection.

    MORIMOTO Motoko, TAKAI TOSHIYUKI

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: Miyagi University

    2013/04/01 - 2016/03/31

    More details Close

    The coordinated actions of lymphocytes, innate immune cells, epithelium, and smooth muscles can play an important role in host intestinal immune function and homeostasis. We investigated type2 immune responses in early stage against nematode parasite in the murine intestine. The results suggested that innate immune cells initiate production of type2 cytokines, communicate with other immune cells including T cells and mediate adaptive pathogen-specific immune responses to eliminate pathogens. INFgamma; might regulate the termination of innate immune responses in the early stage. While, Th2 play mainly in memory responses against re-infection of nematode parasite.

  7. Novel immune regulation by PirB-related multiple ligands

    TAKAI Toshiyuki, INUI Masanori, ENDO Shota

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2012/04/01 - 2015/03/31

    More details Close

    We have attempted to elucidate a whole spectrum of PirB (or human LILRB)-mediated immune regulation through its binding to the multiple ligands such as Nogo and MHC class I molecules, and to develop novel therapeutic strategies against immune disorders such as allergy and autoimmune diseases. We have found that Nogo is preferentially localized to endoplasmic reticulum and regulates TLR9-mediated immune activation via interacting with GRAMD4 but not PirB. Also, we have characterized a human novel B-lineage cell subset, CD43+ B cells, as an intermittent pre-plasmablastic population but not human B1-like cells, being positioned between memory B cells and plasmablasts in terms of its surface LILRB expression, antibody and cytokine secretion, and transcriptional factor expression profiles.

  8. Elucidation of Regulatory Mechanism of B1 Cells by Human IgG Natural Antibodies

    TAKAI TOSHIYUKI

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Exploratory Research

    Institution: Tohoku University

    2012/04/01 - 2014/03/31

    More details Close

    We defined human peripheral blood CD20+CD27+CD43+CD70- B cells as "putative (puB1) B1 cells", and characterized them in terms of expression profiles for B cell inhibitory receptors including several isoforms of ILT/LILR and Ig production. We found a grossly similar profiles of the inhibitory receptors on puB1 cells and memory B cells, but distinctive receptor expression and Ig secretion profiles between the puB1 subset and CD43high plasmablasts.

  9. 免疫抑制受容体PIR-Bによる自己応答性の制御

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究

    Institution: 東北大学

    2010 - 2011

    More details Close

    【研究内容】自己の分子認識機構を解明するため,本年度はB1細胞,B2細胞におけるPIR-Bとそのリガンドによる抗体産生制御の機構の解析に注力した。 【研究結果】新たなPIR-Bのリガンドであることが示唆されたNogoについて,Nogo欠損マウスの表現型の解析を行った。またヒトB細胞集団の中で,マウスB1細胞に相当すると思われるサブセットが同定されたため(Griffin DO et al., J. Exp. Med. 2011)これに倣い末梢血B細胞集団中のB1細胞の分画,表面LILRBアイソフォーム発現の解析を行った。結果として,Nogo欠損はB細胞分化の過程と末梢での維持に影響を与えることが分かった。また「ヒト末梢血からCD20,CD27,CD43発現を指標としてごくマイナーな分画であるB1細胞の集団を分取できることが分かった。興味深いことにこの集団は前記マーカーの発現のみならずB2細胞と異なる抑制系レセプターLILRB発現プロファイルを示すことが示唆され,さらにこれが末梢血単球のLILRB発現プロファイルとも異なる傾向にあった。 【成果の意義】B細胞の制御は,非自己に効果的に反応する一方で自己への有害な反応を回避するために極めて重要である。このシステムが崩壊すると自己抗体が過剰に生産されて自己免疫疾患を惹起する。そのためB細胞は多様な制御機能を持った分子群により調節されている。自己反応性を有する血中抗体のソースであるB細胞のうち,マイナーなB1細胞集団の分画ができるようになり,B1細胞とB2細胞の抗体産生に関する抑制機構の相違を示唆する知見が得られた。PIR-B,ヒトLILRB,そのリガンドNogo等の抑制性受容体システムの調節により免疫学的な自己の確立が維持される可能性が示唆された。本研究により免疫疾患を予防,治療することも可能になる将来展開の基盤が構築された。

  10. Prediction of immune disorders by evaluation of serum IgG reactivity to random peptide library

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Challenging Exploratory Research

    Institution: Tohoku University

    2010 - 2011

    More details Close

    Based on an assumption that reactivities of natural antibodies in sera will be changed before and after onset of immune disorders such as autoimmune diseases, we first analyzed the effect of human polyclonal IgG preparations on immune cell functions such as that of B cells. We found that F(ab')_2 fragment of IgG can bind to various cell surfaces and swiftly internalized into the cytosol. Interestingly, the polyclonal IgG was able to suppress cytokine production from B cells stimulated with CpG.

  11. Molecular Basis for the Immune Regulatory Receptor System

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2008 - 2010

    More details Close

    Paired immunoglobulin-like receptor (PIR)-B, an immunoreceptor tyrosine-based inhibitory motif-harboring receptor for MHC class I molecules, could participate in the regulation of B-1 cells, because PIR-B expression is several times higher in B-1 cells than in B-2 cells or conventional B cells. Recent unexpected findings pointed to a novel inhibitory role of PIR-B in neurite regeneration through binding to three axonal outgrowth inhibitors of myelin including Nogo. Thus, it becomes interesting to determine whether the actions of the inhibitory myelin proteins and MHCI could coexist or be mutually exclusive as to the PIR-B-mediated immune and neural cell inhibition. We studied this subject and obtained data supporting the coexistence of Nogo- and MHCI-mediated inhibition. We now propose a novel mechanism by which PIR-B-mediated regulation is achieved dually via MHCI and Nogo in cells of the immune system.

  12. 免疫抑制受容体PIRーBによる自己応答性の制御

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究

    Institution: 東北大学

    2008 - 2009

    More details Close

    いくつかのB細胞表面の抑制性レセプターの欠損マウスに共通して見ちれる現象として,自然免疫を担うB1細胞集団の増加がある。B1細胞の自己増殖性を維持するためにはB細胞受容体から入力されるシグナルが必要であり,これを抑制性受容体が阻害するため,と大くくりに理解されているが,その実体はよく分かっていない。他の抑制性受容体欠損の場合と同様にPIR-B(ヒトLILRB1/B2に相当)欠損においても腹腔B1細胞が加齢とともに増加する現象が見られていたが(Ujike A.et al.A.Nat.Immunol.2002),我々はB1細胞からのIgMタイプのリウマチ因子(RF;抗IgG Fc自己抗体)の産生が特に亢進していること,さらに今回,世界に先駆けて,Fas^<Ipr>変異との合併によりこの産生が顕著に亢進してIgGタイプのRFが増加し,糸球体腎炎を発症して死亡率が上昇することを観察した。この制御機構においてはTLR9の活性亢進が関係し,PIR-B欠損によってとりわけBtkのリン酸化が亢進してこれがTLR9下流のNF-κBのリン酸化亢進につながっていることが解明された(Kubo et al.J.Exp.Med.2009)。現在ではさらにB1細胞,およびB2細胞上でのPIR-Bの制御様式,B細胞レセプターやTLRシグナルの制御,細胞膜上での動態,抗体産生制御,新規リガンドの探索と作用解明を進めている。

  13. 免疫抑制レセプターgp49B/LILRB4の新機能に関する研究

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 萌芽研究

    Institution: 東北大学

    2007 - 2008

    More details Close

    gp49Bおよびそのヒト相同分子LILRB4は, 樹状細胞(DC)の末梢性免疫寛容の維持に大きく貢献している可能性が代表者らの最近の研究により強く示唆される免疫抑制レセプターである. 近年, 免疫細胞の機能制御に関わる多様なレセプターが同定され, 様々な免疫反応の制御に重要な役割を演じていることが明らかになってきている. Ig-like receptor分子群がその中で主要なファミリーを形成しており, これにはFcreceptor, leukocyte Ig-like receptor(LILR), paired Ig-like receptor(PIR)などが含まれ, DC上では活性化型と抑制性のレセプターが共に発現し, DCの機能をそれぞれ正または負に制御する. これらのレセプターによる寛容誘導性DC(tolerogenic DC)の分化制御機構, 寛容維持の機構について分子レベルで活発な展開がスタートしようとしているのが世界的潮流である. 本年度の研究ではこの寛容誘導性DCの分子メカニズムにおいて, 世界で初めてgp49Bの関与を証明し, その機構を, gp49Bに結合するT細胞上のインテグリンv3を含めたリガンドとの相互作用によることを明確に示した. これにより, DC, 更には骨髄系細胞上のgp49BおよびLILRB4などがT細胞や他の細胞上のリガンドとの相互作用を経て免疫制御を行っていることを利用した免疫制御方法の開発, および免疫病の治療方法の開発に道を拓くことになった.

  14. Pre-Translational Approaches to the Conquest of Immune Disorders by Targeting Fcγ Receptors

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2005 - 2007

    More details Close

    Fc receptors play pivotal roles in immune regulation, and their dysregulation leads to immune-related diseases including allergic inflammationand aud autoimmunity. We have obtained in this project the following accomplishments: 1) Establishment of the importance of inhibitory Fcγ receeptor, FcγRIIB, in immune regulation and autoimmune dieseases, such as autoimmune glomerulonephritis. 2) Establishment of animal models for immune disorders by the use of Feγ receptor gene-targeted mice. 3) Establishment of immune cells with the immortalized growth and immune functions by the use of SV40LT-transgenic mice. Among these, in particular, we have identified the pivotal roles of activating-type Fcγ receptors, but not inhibitory FcγRIB, in the development of autoimmune diabetes of NOD mice. Type 1 diabetes mellitus (T1D) in humans is an organ-specific autoimmune disease in which pancreatic islet β cell are ruptured by autoreactive T cells. NOD mice, the most commonly used animal model of T1D, show early infiltration of leukocytes in the islets (insulitis), resulting in islet destruction and diabetes later. NOD mice produce various islet β cell-specific autoantibodies, although it remains a subject of debate regarding whether these autoantibodies contribute to the development of T1D or not. To investigate the possible role of FcγRs in NOD mice, we have generated several FcγR-less NOD lines, namely FcR common γ chain (FcRγ)-deficient ((NOD.γ^<-/->), FcγRIII-deficient (NOD.III^<-/->), FcγRIIB-deficient (NOD.IIB^<-/->), and both FcRγ and Fcγ and FcγRIIB-deficient NOD (NOD.null) mice. We have shown significant protection from diabetes in NOD.γ^<-/->, NOD.III^<-/->, and NOD.null but not in NOD.IIB^<-/-> mice even with grossly comparable production of autoantibodies among them. Insulitis in NOD.γ^<-/-> mice was also alleviated. Adoptive transfer of bone marrow-derived dendritic cells or NK cells from NOD mice rendered NOD.γ^<-/-> animals more susceptible to diabetes, suggesting a possible scenario in which activating FcγRIII on NK cells trigger antibody-dependent effector functions and inflammation. These findings highlight the critical roles of activating FcγRs in the development of T1D, and indicate that FcγRs are novel targets for therapies for T1D.

  15. イムノグロブリン様受容体分子郡による破骨細胞分化制御に関する研究

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 萌芽研究

    Institution: 東北大学

    2005 - 2006

    More details Close

    慢性関節リウマチにおける骨軟骨破壊のメカニズムの一つとして,破骨細胞の分化と異常活性化が挙げられる.しかしながら破骨細胞の分化プロセス,活性化プロセスにどのような分子機構がはたらいているのかについては十分に理解されていない.これまで破骨細胞の分化には骨芽細胞などから提供されるRANKL (receptor activator of NF-κB ligand)が必要十分と考えられていたが,我々はRANKL以外に多数のIgLR群が活性化する必要があることを突き止めた.つまりIgLRの活性化に利用されている膜アダプターであるFcRγとDAP12が同時に欠損することで破骨細胞の試験官内での分化は完全に阻害され,このマウスは重度の大理石骨病となる.破骨細胞のこの経路による活性化にはPIR-A,OSCAR,TREM-2,SIRPβ1などの既知の活性化型IgLR群および未知の活性化型IgLR群が関与していることが示された.この成果により,慢性関節リウマチ患者の破骨細胞のはたらきの制御は,IgLRを介する活性化経路を人為的に修飾することで達成できる可能性が指摘される.さらに抑制系レセプターの破骨細胞分化に及ぼす影響について研究を進め,PIR-B,ヒトのLILRBのアイソフォームのいくつかのものが破骨細胞上に発現して実際に破骨細胞分化を制御していることを示すデータが得られつつある.これらの成果は破骨細胞分化制御において,免疫系細胞と同様の抑制プロセスの存在を示唆するものであり,その創薬への応用を含めて今後の展開が期待できるレベルに達した.

  16. IMMUNE REGULATION BY IMMUNOGLOBULIN-LIKE RECEPTORS

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (A)

    Institution: Tohoku University

    2002 - 2004

    More details Close

    PIRs expressed on B and myeloid cells form a unique 'self' recognition. Activating PIR-A and inhibitory PIR-B were shown to bind various murine MHC class I (H-2) molecules. In vitro H-2 tetramer stimulation of PIRs induced intracellular phosphotyrosine signaling. PIR-B-deficient mice transferred with allogeneic splenocytes showed exacerbated graft-versus-host disease, which was due to the augmented activation of the recipient's dendritic cells (DCs) with the concomitant up-regulation of PIR-A and increased IFN-production. PIR-A-induced DC activation also led to increased proliferation of donor cytotoxic T cells. Thus, PIR-A and PIR-B are counter-acting receptors that play key roles for successful tissue transplantation, and may regulate irrelevant reaction to autologous tissues in a constitutive fashion under physiological circumstances. To analyze the etiology of mild osteopetrosis in DAP12 (DNAX protein 12)-deficient mice, we examined the bone morphology in FcRγ-deficient (FcRγ--) mice and DAP12/FcRγ double deficient (DKO) mice. Histological examination revealed that FcRγ--mice did not show any remarkable osteopetrosis. However, we found that DKO mice exhibited much more severe osteopetrosis than DAP12--mice, suggesting that either DAP12 or FcRγ is required for normal bone remodeling. In osteoclast precursor cells, FcRγ and DAP12 associate with multiple IgLRs including OSCAR and PIR-A ; and TREM-2 and SIRPβ1, respectively, and activate Ca^2 signal through PLCγ. Thus, ITAM-dependent costimulatory signals activated by multiple IgLRs are indispensable for the maintenance of bone homeostasis, indicating that RANK and M-CSF receptor are not sufficient to activate signals required for osteoclastogenesis.

  17. Fc受容体による中枢神経系の制御機構

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 萌芽研究

    Institution: 東北大学

    2002 - 2003

    More details Close

    1970年代初頭に初めて症例が報告されたNasu-Hakola病は,多発性の病的骨折,および性格変化などの統合失調症に似た精神神経症状ののち若年性痴呆を必発して死に至る,予後不良の劣性遺伝病である.フィンランドのグループの地道な家系調査とゲノムスクリーニングの結果,2000年に至ってNasu-Hakola病の原因が,免疫系において見い出されていた活性化シグナル伝達を担う膜アダプター分子、DNAX activating protein(DAP)12をコードする遺伝子の欠損であることが同定された.我々はNasu-Hakola病の発症機序を解明する目的でDAP12欠損マウスを作製し,骨および中枢神経系におけるDAP12の役割を検討したところ,このマウスは破骨細胞の発達障害ならびにオリゴデンドロサイトの視床領域での発達障害を示すことを見いだした.Nasu-Hakola病の原因として,従来から脂質代謝の異常,あるいは血管壁の変化によって惹起された大脳白質の慢性循環障害とする説など,確定されていなかったが,DAP12欠損マウスでは脂質代謝異常,ならびに大脳血管の内皮細胞に異常は見いだせなかった.とりわけヒトで若年性の痴呆に至る過程は全く不明であり,DAP12欠損マウスでは2年齢の老化マウスでさえ明白な行動異常は観察されないし、神経細胞の顕著な減少も見られない.DAP12が如何なるレセプターと会合し,その生理的リガンドは何なのか.さらにそのリガンドの脳内分布はどのようになっているのか,などの基本的な知見を蓄積することがヒトのNasu-Hakola病とDAP12欠損マウスとの間に存在する分子レベルでの相違の同定につがなり,これがいずれヒトの精神分裂病や若年性痴呆のひとつのメカニズムの解明につながることを目指したい.本年度は特に骨疾患についての更なる解析を行い,DAP12とともにFcRγも骨形成に関与していることを突き止め,これらアダプター分子群がイムノグロブリン様受容体分子群と会合し,RANKLからのシグナルとともに破骨細胞形成に不可欠であることを解明した.

  18. Fc受容体を介したIgE,IgGによるマスト細胞機能の調節

    高井 俊行, 中村 晃

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究

    Institution: 東北大学

    2000 - 2003

    More details Close

    Immunoglobulin(Ig)-like receptor(IgLR)という範疇に属する新規なレセプター分子群が続々と単離され,その機能が注目され始めてまだ5年ほどしか経過していないが,これらが免疫調節に重要な役割を担う証拠が次々と挙がっている.マウスのPaired IgLR(PIR)は活性化シグナルを伝達するPIR-Aと,逆に抑制性シグナルを伝達するPIR-Bのペアからなる代表的なIgLRであるが,PIR-Bが欠損するとB細胞,樹状細胞のシグナル伝達が撹乱され,その免疫応答はTh2型に著しく偏ることを我々は本研究課題において示してきた.本年度は,正常な免疫応答に不可欠であるこのレセプター・ペアが何を認識し,どのようなシグナルを細胞内に導入しているのか,さらに免疫疾患にどのように関連しているのかを明らかにすることでマスト細胞機能,およびアレルギーや自己免疫などの発症に関する新規な機構を解明することを目的とした.その縞果,PIR-B,PIR-AともにMHC class I分子を認識し,PTR-Bの欠損によって移植片対宿主反応が亢進してホストのGVHDが増悪することが分かった,さらにマスト細胞はこの識別機構を喪失した結果,刺激感受性が増大し,アレルギーを発症しやすくなる素地を形成することが分かった.したがってPIRはTCRやKIRとともに自己MHC class Iを認識する第3のシステムを構築し,自己反応性および外界からの無用な刺激応答性を回避していることが示唆された.

  19. Development of Autoimmune Disease Models Based on FcyRIIB-Deficient Mice

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    2000 - 2001

    More details Close

    The receptors for Fc protion of immunoglobulins, Fc receptors (FcRs), combine innate and adaptive immunity and are critical elements to activate or down-modulate the immune responses. Activity of various cells in the immune system is intimately regulated by the balanced signaling through FcRs. Development of many autoimmune diseases in humans may now be interpreted by the impairement in the FcR regulatory system. To address the question whether the type IIB Fc receptor for IgG (FcγRIIB)-deficient mice (RIIB-/-) are susceptible to induction of various autoimmune diseases, we tested to induce type II collagen-induced arthritis (CIA), a model for rheumatoid arthritis in humans. We found that RIIB-/- on a non-permissive H-2b background become susceptible to CIA induction. Moreover, we could induce Goodpasture' s syndrome (GPS) in RIIB-/- by immunization with type IV collagen. Quite similar to human GPS, RIIB-/- develop massive pulmonary hemorrhage and glomerulonephritis. These results highlight the role of FcγRIIB in maintaining tolerance and suggest that it may play a critical role in the pathogenesis of rheumatoid arthritis and GPS in humans.

  20. Analysis of Physiological Roles of Novel Immunoglobulin-Like Receptors, PIR

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    1999 - 2001

    More details Close

    Paired immunoglobulin-like receptor (PIR)-B inhibits receptor-mediated activation signaling in vitro, while neither the physiological role nor ligand for PIR has been elucidated. PIR-B-/- mice had an increased number of peritoneal B-1 cells with age that, along with splenic B-2 cells, were hypersensitive to B cell receptor ligation. T helper (TH)2-prone humoral responses were augmented in the mutant mice upon immunization with T-dependent antigens in terms of both interleukin-4-rich/interferon-γ-poor cytokine profile and enhanced IgG1 and IgE production. Impaired maturation of dendritic cells possibly due to perturbed intracellular signaling was responsible for the skewing. Thus, PIR-B is critical for B cell suppression, DC maturation, and for balancing TH1/TH2 immune responses.

  21. Molecular mechanism of response of living body to environmental stress

    TAMURA Shinri, KOBAYASHI Takayasu, HIRAGA Akira, TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (B)

    Institution: Tohoku University

    1998 - 2001

    More details Close

    Protein phosphatase 2C (PP2C) is implicated in the negative regulation of tress-activated protein kinase (SAPK) cascades in yeast and mammalian cells. In this study, we determined the role of PP2Cβ-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a SAPK cascade that is activated by interleukin-1 (IL-1), transforming growth factor-β or stress. Ectopic expression of PP2Cβ-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4 (MKK4)-c-Jun N-terminal kinase (JNK) and MKK6-p38 signaling pathways. In vitro, PP2Cβ-1 dephosphorylated and inactivated TAK1. Co-immunoprecipitation experiments indicated that PP2Cβ-1 associates with the central region of TAK1. A phosphatase-negative mutant of PP2Cβ-1, PP2Cβ-1(R/G), acted as a dominant negative mutant, inhibiting dephosphorylation of TAK1 by wild-type PP2Cβ-1 in vitro. In addition, ectopic expression of PP2Cβ-1(R/G) enhanced IL-1-induced activation of an AP-1 reporter gene. Collectively, these results indicate that PP2Cβ negatively regulates the TAK1 signaling pathway by direct dephosphorylation of TAK1.

  22. 樹状細胞Fcγ受容体へのがん抗原ターゲティングによるがん免疫賦活方法の開発

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究(C)

    Institution: 東北大学

    2000 - 2000

    More details Close

    樹状細胞(DC)に発現されているFcγレセプター(FcγR)に特定の癌抗原あるいは癌細胞をIgG免疫複合体として試験管内で結合させ,処理させることでDCの抗原提示能を飛躍的に亢進させる.これを担癌マウスに移入することで癌抗原特異的免疫応答を誘導する方法を開発することを目的とした.DCによる免疫賦活では,非特異的に抗原を取り込ませる方法,および糖鎖レセプターなどを介して取り込み効率を上昇させる方法が検討されている.レセプターを介する方法は少量の抗原で済むため効率良く行える利点があるが,糖鎖など特定のレセプターに認識される構造を持っていないものについては利用できない難点がある.今回の方法はどのような蛋白質であっても,それに対する特異的IgG抗体との複合体にすることでDC上のFcγRに結合させることができ,CD4+およびCD8+T細胞の活性化を誘導する抗原提示をおこなうことが可能となる.本法が発展することで癌の新規免疫療法の開発が行えるようになることが期待される.本年度はまずDCのFcγRへの抗原ターゲティングによりCD4+T細胞への抗原提示能力が約100倍亢進する結果が得られた.さらにCTLに対する活性化も得られることが分かり,特異的FcγRターゲティングにより癌免疫の賦活が可能であることが示された.

  23. NK細胞の分化におけるFcR,KAR,gp49の役割に関する研究

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究(A)

    Institution: 東北大学

    2000 - 2000

    More details Close

    ナチュラルキラー(NK)細胞の分化と機能獲得に関してはその多くが未だ謎に包まれている.NK細胞はヒト末梢血中に5%程度存在し,前感作なしに異種細胞や自己の異常細胞を破壊する,いわゆる自然免疫の一翼を担う細胞である.本研究の目的は,KARの活性化シグナル伝達を司るKARAP分子の欠損マウス,機能未知なgp49分子欠損マウス,そしてFcRγ鎖欠損マウスにおけるNK細胞の分化状態および標的細胞破壊機能を調査し,KAR分子群,FcR分子群,gp49分子群とNK細胞の分化との関係を解明する.本年度はgp49B欠損マウス,KARAP欠損マウスの作製を完了し,解析を行ったところ,gp49が欠損していてもNK細胞は正常に分化しており,標的細胞の障害もコントロールと同等の能力を有していることを見いだした.またKARAP欠損マウスにおいてはNK細胞は正常に分化し,一般的標的細胞に対しては正常な障害能力を有する一方,中枢神経系に異常が見られることが発見された.

  24. 炎症のバイオサイエンスの新しい展開

    宮坂 昌之, 高井 俊行, 松島 綱治, 義江 修, 長澤 丘司, 木全 弘治

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 基盤研究(C)

    Institution: 大阪大学

    1999 - 1999

    More details Close

    最近、炎症反応を媒介する接着分子、ケモカイン、Fcレセプターなどの分子群が次々に同定され、炎症反応の分子生物学は飛躍的な進歩を遂げつつある。しかし、各分野を越えての研究交流は比較的少なかった。このため本研究では、これらの研究を行っている第一線の研究者10名を集め、お互いの持つ新知見を交換するとともに、新しい戦略の構築にむけて統合的な活動を行った。特にわが国で発見された新規ケモカイン、Fcレセプター、接着分子間のクロストーク現象の解析、これらの分子を標的とした抗炎症剤免疫抑制剤の開発に向けて活動を行った。そして、その成果を公開することを目的として、平成11年12月21日(火)に大阪大学銀杏会館において文部省科学研究費基盤C1公開シンポジウム「炎症のバイオサイエンスの新しい展開」を行った。このシンポジウムでは全班員による公開発表を行うとともに、関連研究者、聴衆に対する啓蒙活動を行った。

  25. ナチュラルキラー細胞の分化におけるFcR,KAR,gp49の役割に関する研究

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 特定領域研究(A)

    Institution: 東北大学

    1999 - 1999

    More details Close

    ナチュラルキラー(NK)細胞の分化と機能獲得に関してはその多くが未だ謎に包まれている.NK細胞はヒト末梢血中に5%程度存在し,前感作なしに異種細胞や自己の異常細胞を破壊する,いわゆる自然免疫の一翼を担う細胞である.本研究の目的は,KARの活性化シグナル伝達を司るKARAP分子の欠損マウス,機能未知なgp49分子欠損マウス,そしてFcRg鎖欠損マウスにおけるNK細胞の分化状態および標的細胞破壊機能を調査し,KAR分子群,FcR分子群,gp49分子群とNK細胞の分化との関係を解明する.本年度はgp49B欠損マウス,KARAP欠損マウスの作製を完了し,解析を開始した.また各種FcR欠損マウスにおける胎児胸腺中のNK細胞とT細胞の分化について,胎児胸腺培養系を構築し,FcRに対する抗体を添加した際のNK細胞とT細胞の分化の変化を追跡できるようになった.FcRがNK細胞の分化に影響を及ぼしていることを示唆するデータが得られた.gp49B欠損マウスについてもこの培養系を応用し,興味深い知見を得た.

  26. ANALYSIS OF IGA NETWORK BY GENE TARGETING

    TAKAI Toshiyuki

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for Scientific Research (C)

    Institution: OKAYAMA UNIVERSITY

    1996 - 1997

    More details Close

    We hae found a novel murine cell-surface glycoprotein, designated as q91, expressed mainly in myeloid cells such as macrophages and mast cells. The molecule has six immunoglobulin-line extracellular domains, a transmembrane segment, and a cytoplasmic tail containing four immunoreceptor tyrosine-based inhibition motif (ITIM) or ITIM-like sequences, resembling the structural features of human killer-cell inhibitory receptors (KIR). p91 comprises a polymorphic gene family, harboring one potent inhibitory-type p91 and at least two other p91 genes. Tyrosine-phosphorylated, but not nonphosphorylated, synthetic peptides matching each of the third ITIM and the fourth ITIM-like sequences found in the cytoplasmic portion of p91A,the sole inhibitory-type p91, associated with the tyrosine phosphatases SHP-1 and SHP-2. In addition, the phosphotyrosyl peptide matching the third ITIM sequence also bound the inositol 5-phosphatase SHIP. Thses results support the notion that p91A may function as an inhibitory cell-surface molecule against cell activation. The p91 genes were shown to be clustered in the proximal region of mouse chromosome 7, a syntenic position of human chromosome 19 where the genes for the KIR family are found. A human cDNA clone cross-hybridizing to a murine p91 probe was isolated from a human spleen cDNA library, and was found to be coding for a molecule quits similar to members of the immunoglobulin-like transcript (or ILT) family. The gene was found to locate on human chromosome 19q13.3-13.4. These results will establish the existence of a novel set of potent regulatory receptors in mouse and man, similar but different from the KIR family.

  27. Fcレセプター欠損マウスを用いたアレルギーの分子機構の解明とその修復法の開発

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 重点領域研究

    Institution: 岡山大学

    1996 - 1996

    More details Close

    イムノグロブリン・スーパーファミリーに属する分子などの細胞内領域にimmunoreceptor tyrosine-based activation motif (ITAM)と呼ばれるアミノ酸配列が存在する場合,このモチーフはチロシンキナーゼの基質となることでその後の細胞活性化シグナリングに重要な役割を演じる.最近,ITAMのコア配列であるYXXL/Iに類する配列を有し,かつ細胞内シグナリングに抑制的にはたらくモチーフであるITIMおよびその抑制メカニズムが注目されている.ITIMを持つ分子としてこれまでNKレセプター,CD22,Fcレセプター(FcR),CTLA-4などが知られているが,これまでの知見ではITIMは,ITAMと同様にチロシンキナーゼによりリン酸化されたのち細胞内の脱リン酸化酵素SHP-1やSHIPとアソシエ-トすることで抑制機能を発揮するらしい.これまで本研究者はITAMを持つFcRγ鎖のノックアウトおよびITIMを持つFcγRIIBのノックアウトマウスを作成し,これらの免疫機能を解析した.FcRはこれまで,液性免疫と細胞性免疫の調節因子としての役割や,炎症・アレルギーとの関係を中心にその機能の解析が進められてきたが,FcRγ鎖ノックアウトマウスではマクロファージの貧食機能が消失するなど,種々のエフェクター機能が消失し,炎症の開始機構においてFcεRIやFcγRIIIが中心的役割を担っていることが示された.逆にFcγRIIBノックアウトマウスにおいては抗体応答や貧食機能に亢進が見られ,更にIgGを介するアナフィラキシ-や接触過敏症反応,コラーゲン関節炎などが野生型マウスに比べ強く現れることを観察した.即ち,免疫システムの抑制機構としてFcγRIIBを介する経路が存在することが示された.よって生体は,IgG免疫複合体とFcγRによる,免疫系を活性化あるいは抑制する巧妙な調節システムを備えていると理解できる.

  28. Fc受容体遺伝子ノックアウトマウスを用いた免疫制御機構の解析

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 重点領域研究

    Institution: 岡山大学

    1995 - 1995

    More details Close

    Fcレセプター(FcR)は,IgGやIgEのFc部分と結合することで免疫系の細胞内に情報伝達を行う分子群である.以前からFcRは.抗体や補体を中心とする体液性免疫と,エフェクター細胞を中心とする細胞性免疫との間の橋渡し役として免疫系を調節しているのではないかと考えられてきたが,FcRノックアウトマウスの作成により,個々のFcRの生理的機能を詳細に解き明かすことができるようになった。まず,(1)FcRγサブユニット欠損マウスの作成により,マクロファージの貧食機能が消失するなど,FcRγ鎖が複数のFcRの共通のサブユニットでることを証明し,アレルギーの開始機能においてFcRが中心的役割を担っていることを示した。また(2)FcγRII欠損マウス作成により,抗体応答などに顕著な亢進が見られる事を見い出し,免疫応答にはFcγRIIを介する負のフィードバック機構が存在することを明らかにした.即ち,これまでアレルギーといえばIgEこそメインであり,炎症エフェクター細胞がIgEを介してどのように活性化されるかという機序の解明が中心課題であると考えられてきたが,実は生体にはIgGとそのレセプターであるFcγRIIによる,免疫系を巧妙に抑制するシステムが存在しているということが明らかになったわけである.

  29. 遺伝子ターゲティングによるFcγ受容体欠損マウスの作成およびその解析に関する研究

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 奨励研究(A)

    Institution: 岡山大学

    1994 - 1994

    More details Close

    [目的]Fcγレセプター(FcγR)は、免疫担当細胞表面上に存在し、IgGのFc部分と結合することでエフェクター機能の発現の引金を引く重要な分子である。マウスII型FcγRは、ほとんど全ての血球系細胞に発現しており、B細胞では抗原レセプターを介する情報伝達に対して抑制的に作用することが示唆されているが、詳細は明かでない。今回我々は、FcγRIIの生理的機能を個体レベルで明らかにするために、胚性幹(ES)細胞での遺伝子ターゲティングによってFcγRII欠損マウスを作成した。[方法及び結果]マウスFcγRII遺伝子を単離し、Neo^R遺伝子及びヘルペス・TK遺伝子を組み込んだターゲティング・ベクターを構築した。これをES細胞J1及びE14にトランスフェクトし、G418とFIAU両耐性となったクローンの中から、サザンブロット法により相同組換え体を同定した。これらをマウス初期胚にマイクロインジェクションしてキメラ個体を得、これらと野生型マウスとの交配により、FcγRIIヘテロ欠損個体を得た。現在、ホモ欠損個体の作成を行っており、今後これらのマウスにおける各種免疫機能の解析を行う予定である。

  30. 遺伝子ノックアウト法による免疫グロブリンGFc受容体の機能解析

    高井 俊行

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 奨励研究(A)

    Institution: 岡山大学

    1993 - 1993

    More details Close

    免疫グロブリンFc受容体(FcR)は免疫担当細胞の膜表面上に存在し、抗原抗体複合体の結合によって貧食活性、細胞傷害活性、エフェクター細胞からの炎症メディエーターの放出などの引金を引く重要な分子である。しかしその分子的実体が遺伝子クローニングによって明らかになったのは比較的最近であり、IgGのFcR(FcgammaR)はマウスでは3種類存在し、それぞれ発現されている免疫担当細胞に特異性が見られることなどが解明された。申請者は、近年特にその有用性と結果の明快さが注目されている遺伝子ノックアウト法に着目し、これまで生体の免疫系においてその機能がほとんど分かっていないII型FcgammaRの機能を遺伝子ノックアウト法を用いて明らかにするために以下の研究を行った。まず、129系マウスのゲノムライブラリーからII型FcgammaRのcDNAをプローブとして遺伝子を単離し、制限酵素マップを作成した。相同組換え効率を上昇させるためにポリ(A)トラップタイプのベクターおよび通常のpPNTを骨格としたターゲティングベクターの構築に取り組み、相同領域が約7.5kbと約8.5kbのベクターを組み立てた。これらを129系マウス由来の胚幹(ES)細胞であるJ1にトランスフェクトし、G418およびFIAUを用いる2重選択により両耐性のES細胞クローンを単離した。これらのゲノムDNAのサザンプロットによる解析の結果、数個のクローンにおいてII型FcgammaR遺伝子座にターゲティングが起こっていることを確認した。現在C57BL/6マウス由来の胚にこれらのクローンをマイクロインジェクションし、キメラマウスの作成に取り組んでいる。

  31. Molecular biological study on the regulation of fatty acid biosynthesis

    TANABE Tadashi, TAKAI Toshiyuki, YOKOYAMA Chieko, IMADA Masaru

    Offer Organization: Japan Society for the Promotion of Science

    System: Grants-in-Aid for Scientific Research

    Category: Grant-in-Aid for General Scientific Research (C)

    Institution: National Cardiovascular Center Research Institute

    1988 - 1989

    More details Close

    Fatty acids are essential substance for organisms as membrane components, energy sources etc. Accumulation of fatty acids, however, causes various cardiovascular diseases and obesity. In the present study we have investigated the regulatory mechanism of fatty acid biosynthesis to overcome these diseases. According to the previous study by our and other groups, biosynthesis of fatty acid is regulated by modulating the activity of acetyl-CoA carboxylase (ACC). Following results have been obtained by the present study. 1. With use of our cDNA clones of chicken liver ACC as probes and specific antibodies, expression of ACC was studied. ACC mRNA and the enzyme protein was found in liver, brain, testis, kidney, lung and heart. The changes of the hepatic and heart contents of ACC mRNA and the enzyme protein in growing chicks were measured. In the post-hatching period, the bepatic mRNA markedly increased at least 70- fold when compared to that before hatching. This increase was not observed in chicks receiving no diet These changes were closely paralleled with the rise of the hepatic content of ACC protein in chicks up to 10 days old. Contents of ACC mRNA and the enzyme protein in heart were not changed during development. 2. Primary structure of various biotin-dependent carboxylase including chicken and rat liver ACC was compared and a genealogical tree was constructed. The results indicated the animal ACC, a multifunctional polypeptide has been formed by gene fusion of monofunctional polypeptide chains found in Escherichia coli ACC during molecular evolution. The result is completely agreed with the previous enzymological observations of biotin-dependent enzymes. 3. Cloning of ACC gene has been attempted by screening human genomic libraries with chicken ACC cDNA as a probe and the obtained colones covered approximately 40 kb of the gene. The 13.4 kb-region of the gene was characterized. The 404 residues of the protein-coding region determined was distributed into 4 exons. The deduced primary structure of human ACC coincided with that of chicken and rat enzymes in 95 and 98 %, respectively. Cloning and characterization of the remaining portion of the gene are now in progress.

Show all Show first 5

Social Activities 5

  1. [日本国内] 加齢研における中学校理科教諭研修会

    2004/09/16 - Present

    More details Close

    中学校理科教諭研修会

  2. [日本国内] 夏休み大学探検

    2004/09 - Present

    More details Close

    市内中学生有志への研究室公開(仙台市教育委員会主催)

  3. [日本国内] 中学生職場見学

    2001/07 - Present

    More details Close

    研究室公開

  4. [日本国内] 「私たちはこんな病気と闘っています3」

    2007/10/09 -

    More details Close

    大理石骨病などの難病とそれに向き合う患者,家族たちの紹介番組「私たちはこんな病気と闘っています3」(TBS系列 2007年10月9日火曜夜9時〜2時間放送)においてDAP12/FcRgamma二重欠損マウスの骨組織像(Koga et al. Nature 2004)が利用された.

  5. [日本国内] 「科学技術振興機構 戦略的創造研究推進事業CREST研究から」

    2006/02/24 -

Media Coverage 7

  1. [日本国内] 科学技術振興機構 戦略的創造研究推進事業CREST研究から

    科学新聞

    2006/02/24

    Type: Newspaper, magazine

  2. [日本国内] 骨髄移植成功へのカギ 免疫抑制たんぱく質発見 東北大

    読売新聞

    2004/05/17

    Type: Newspaper, magazine

  3. [日本国内] 骨髄移植の拒絶反応和らげるたんぱく質 東北大発見

    日経新聞

    2004/05/17

    Type: Newspaper, magazine

  4. [日本国内] 骨髄移植などの不適合反応 抑制遺伝子を発見 東北大

    毎日新聞

    2004/05/17

    Type: Newspaper, magazine

  5. [日本国内] 骨髄移植 合併症抑制の受容体を発見 東北大グループ

    産経新聞

    2004/05/17

    Type: Newspaper, magazine

  6. [日本国内] 骨髄移植 成否握るタンパク質発見

    河北新報

    2004/05/17

    Type: Newspaper, magazine

  7. [日本国内] 骨髄移植の成否を握るタンパク質の発見について

    NHK

    2004/05/17

    Type: TV or radio program

Show all Show first 5

Other 2

  1. ミエリン発達障害を非侵襲的に検出する新規な精神・神経障害診断法の開発

    More details Close

    ミエリン発達障害を非侵襲的に検出する新規な精神・神経障害診断法の開発

  2. Fc受容体による中枢神経系グリアの発達制御機構の解明

    More details Close

    Fc受容体による中枢神経系グリアの発達制御機構の解明